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Abstract 
Disorders affecting the basal ganglia can have a severe effect on speech motor control. 
The effect can vary depending on the pathophysiology of the basal ganglia disease but 
in general terms it can be classified as hypokinetic or hyperkinetic dysarthria. Despite 
the role of basal ganglia on speech, there is a marked discrepancy between the effect of 
medical and surgical treatments on limb and speech motor control. This is compounded 
by the complex nature of speech and communication in general, and the lack of animal 
models of speech motor control. The emergence of deep brain stimulation of basal 
ganglia structures gives us the opportunity to record systematically the effects on speech 
and attempt some assumptions on the role of basal ganglia on speech motor control. 
The aim of the present work was to examine the impact of bilateral subthalamic nucleus 
deep brain stimulation (STN-DBS) for Parkinson’s disease (PD) and globus pallidus 
internus (GPi-DBS) for dystonia on speech motor control. A consecutive series of PD 
and dystonia patients who underwent DBS was evaluated. Patients were studied in a 
prospective longitudinal manner with both clinical assessment of their speech 
intelligibility and acoustical analysis of their speech. The role of pre-operative clinical 
factors and electrical parameters of stimulation, mainly electrode positioning and 
voltage amplitude was systematically examined. In addition, for selected patients, 
tongue movements were studied using electropalatography. Aerodynamic aspects of 
speech were also studied. The impact of speech therapy was assessed in a subgroup of 
patients. 
The clinical evaluation of speech intelligibility one and three years post STN-DBS in 
PD patients showed a deterioration of speech, partly related to medially placed 
electrodes and high amplitude of stimulation. Pre-operative predictive factors included 
low speech intelligibility before surgery and longer disease duration. Articulation rather 
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than voice was most frequently affected with a distinct dysarthria type emerging, mainly 
hyperkinetic-dystonic, rather than hypokinetic. Traditionally effective therapy for PD 
dysarthria had little to no benefit following STN-DBS. 
Speech following GPi-DBS for dystonia did not significantly change after one year of 
stimulation. A subgroup of patients showed hypokinetic features, mainly reduced voice 
volume and fast rate of speech more typical of Parkinsonian speech. 
Speech changes in both STN-DBS and GPi-DBS were apparent after six months of 
stimulation. This progressive deterioration of speech and the critical role of the 
electrical parameters of stimulation suggest a long-term effect of electrical stimulation 
of basal ganglia on speech motor control.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Basal ganglia structure and function 
The basal ganglia consist of four main nuclei: the striatum, the globus pallidus, the 
subthalamic nucleus and the substantia nigra. Other nuclei, such as the central complex 
of the thalamus and the penduculopontine nucleus also play a major role in basal 
ganglia functioning.  
There are four determinants of basal ganglia functional properties: the anatomy of the 
four nuclei, the neuronal morphology, the dopaminergic control and their connectivity. 
1.1.1 Anatomy  
The striatum consists of two macroscopic nuclei, the caudate nucleus and the putamen. 
The caudate nucleus has a curved shape, with the rostral portion referred to as the head 
being far more voluminous than the body. The tail is very small in humans (Figure 1.1). 
 
Figure 1.1: Three-dimensional view of the caudate nuclei (blue) in relation to the STN 
(pink) from a postoperative MR acquisition in a patient with bilateral implantation of 
electrodes (grey) in the STN for the treatment of advanced PD using the atlas from 
Yelnik et al (2007). A, Anterior oblique view. B, Posterior oblique view. C, Zoom on the 
electrodes showing that their contacts are located inside the STN from Dormont, 2010. 
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The putamen, together with the globus pallidus, constitute the lenticular nucleus (Figure 
1.2). The shape of the lenticular nucleus is triangular when seen on axial sections but 
more elongated, like a banana (Yelnik, 2002) when seen on coronal sections.  
 
Figure 1.2: Representation of the major anatomical structures and fibre tracts 
associated with the subthalamic nucleus. AL = ansa lenticularis; CP = cerebral 
peduncle; FF = Fields of Forel; GPe = globus pallidus externus; GPi = globus pallidus 
internus; H1 = H1 Field of Forel (thalamic fasciculus); IC = internal capsule; LF = 
lenticular fasciculus (H2); PPN = pedunculopontine nucleus; Put = putamen; SN = 
substantia nigra; STN = subthalamic nucleus; Thal = thalamus 
 ZI = zona incerta. From Hamani et al (2004). 
 
The globus pallidus is subdivided into an external (GPe) and an internal (GPi) segment 
(Figure 1.3). The subthalamic nucleus (STN) is located under the thalamus and above 
the mesencephalon. Its shape is that of a biconvex lens (3x 5 x 12 mm in humans) 
which is obliquely oriented to the three anatomic planes. Thus the anterior pole of the 
STN is much more inferior (ventral) than the posterior pole. It is also much more medial 
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than the posterior pole (Figure 1.1). The substantia nigra is a mesencephalic structure 
that comprises two main subdivisions: the pars compacta (SNc) and the pars reticulata 
(SNr) (Figure 1.3).  
 
  
 
Figure 1.3: Superior view of a three-dimensional atlas model of the STN, Red Nucleus 
(RN), fct, al, fl, ft, substantia nigra pars reticulate (SNr), substantia nigra pars 
compacta (SNc), internal segment of the globus pallidus (GPi), and external segment of 
the globus pallidus (GPe), together with a DBS electrode placed in the posterodorsal 
area of the STN. From Astrom, 2010.  
 
1.1.2 Neuronal morphology   
Striatal neurons consist mainly of spiny neurons whose dendrites are densely covered 
with dendritic spines (Figure 1.4). They use GABA as their neurotransmitter, while 
afferent cortical neurons use glutamate. Cortical information is received on the spines of 
the spiny neurons, which are in turn submitted to the inhibitory control of the local 
circuit motorneurons, the disinhibitive control of the cholinergic neurons and the 
excitatory control of dopamine afferents.  
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Figure 1.4: Four main neuronal types of the basal ganglia as they appear after 
reconstruction from serial sections and camera lucida drawing. All neurons are shown 
at the same magnification. Note the long and sparsely ramified dendrites of pallidal 
neurons (GP) compared with the short but densely ramified dendrites of spiny striatal 
(ST), subthalamic (STN) and thalamocortical (Thal) neurons. From Yelnik, 2002. 
 
Pallidal and nigral neurons, which receive striatal input, have a different morphology 
than the striatal spiny neurons: their dendrites are long (up to 1 mm), thick, smooth and 
sparsely branched (Francois et al, 1984). They are covered with synaptic boutons 90% 
of which are coming from the striatum, 10% of which are coming from other sources 
including the STN and the PPN. Pallidal neurons are GABAergic neurons, which 
suggests they have an inhibitory effect on their thalamic target neurons (Penney et al, 
1981). They are 100 times fewer in number than the striatal neurons, which suggests a 
numeric convergence (Yelnik et al, 2008). Nigral neurons have the same dendrites as 
pallidal neurons. Anatomically the striatopallidal system is characterised by a volumic, 
numerical and geometrical convergence (see below). According to Yelnik (2008) the 
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GP could be viewed as a keyboard on which various behavioural repertoires could be 
coded from the simple movement of a single joint (which would be coded by a small 
number of pallidal neurons of the sensorimotor territory) to the most complex motor 
sequence involving the entire body and expressing an emotional content in a cognitive 
context (e.g. conversational speech, or movement of a dancer, or playing a musical 
instrument; this would involve a larger sample of neurons of the sensorimotor, 
associative and limbic territories). 
The subthalamic neurons have dendritic arborizations that are intermediate, in number 
of branching points and length of dendritic branches between those of striatal and 
pallidal neurons. They use glutamate as their neurotransmitter and have thus an 
excitatory effect on their pallidal and nigral targets. Neurons of the STN have the same 
branching pattern (number of branching points and length of dendritic branches) in rats, 
monkeys and humans. They are identical throughout the nucleus, which means that the 
nucleus is cytologically homogenous. In monkeys and humans the STN is a closed 
nucleus that receives and processes only afferences that are specifically devoted to it 
(Yelnik, 2008). For this reason it represents a target that is perfectly delimited, both 
anatomically and functionally. The STN has two major projection sites, the external 
globus pallidus and the output nuclei of the basal ganglia, internal globus pallidus and 
SNr. In the STN pallidal information is submitted to a volumic compression since the 
nucleus is five times smaller than the GPe (Yelnik, 2002). The GPe inhibits the STN, 
while this latter activates the former, making the pallidosubthalamic system a closed 
loop submitted to a autoinhibition process the role of which is not fully understood 
(Yelnik, 2008) (Figure 1.5).  
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Figure 1.5: A diagrammatic representation of the basal ganglia organisation. The 
basal ganglia receive information from three functional territories of the cerebral 
cortex, sensorimotor (green), associative (violet) and limbic (yellow), that are 
transmitted to separate regions of the striatum. Information is received by spiny-striatal 
neurons, which have small spherical dendritic arborizations (spheres), which preserve 
functional specificity. In the globus pallidus, neurons are 100 times less numerous and 
have flattened and large dendritic arborizations (rectangles), which makes transmission 
of striatal information onto pallidal neurons highly converging. In the subthalamic 
nucleus, information comes from the three functional territories of the globus pallidus, 
but also directly from motor cortices, which confers to this nucleus the role of a nexus 
in the circuit. From Yelnik, 2008. 
 
The role of the projection of the STN to the output nuclei is clearer: it provides a tonic 
excitatory permanent drive in these nuclei, which results in a permanent inhibition of 
the thalamocortical projection. However the way information is processed in the STN 
remains unclear: it is a small nucleus (3,000 times smaller than the cortex and with 
4,000 times smaller number of neurons), which implies that information coming from 
the sensorimotor, associative and limbic regions converge into a nucleus only a few mm 
large (Yelnik, 2002). The afferents from the GPe respect the functional division 
(Karachi, 2005). The STN receives two strikingly different inputs – one from the GPe, 
which is inhibitory and one from the cerebral cortex which is excitatory. (For the 
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functional implications of this dual system see section 1.4). Thus the STN can be 
viewed as a thermostat, whereby in the normal state with an appropriate level of activity 
it enables normal execution of cortical commands, neither too impulsive nor too slow. 
When hyperactive it slows down all cortical programmes, like in Parkinson akinesia, 
which can be released by its inactivation by lesion (Bergman et al, 1990) or stimulation 
(Limousin et al, 1995). At a territorial level the STN can process separately motor, 
associative and limbic information. At a neuronal scale a much finer organisation 
probably exists since it is possible to modify a behaviour with one particular contact but 
not with an adjacent contact, only 2 mm apart (Mallet, 2007).   
1.1.3 Dopaminergic control 
The dual model of direct and indirect pathways (Albin et al, 1989) is based on the 
observation that the striatum is not a uniform structure but a heterogeneous one, 
including the distribution of dopamine terminals. It was based on two concepts: the 
existence of subpopulations of striatal projection neurons and a differential effect of 
dopamine onto these two populations. Neurons that contained the neuropeptide 
substance P were supposed to project mainly upon the GPi and the SNr, the direct 
pathway, whereas those containing enkephalin would project to the GPe, the indirect 
pathway. Activation of the direct pathway has an excitatory effect on the 
thalamocortical projection, which facilitates movement; activation of the indirect 
pathway leads to an activation of the STN and then to an increased inhibition of the 
thalamocortical pathway. Dopamine had an excitatory role on the direct pathway and an 
inhibitory role on the indirect pathway, thus decreasing the inhibitory effect of the 
system and making possible the execution of movement. In the parkinsonian state the 
absence of dopamine results in the disinhibition of the output nuclei (GPi and SNr) and 
an increased inhibition of the thalamocortical projection, which leads to a reduction or 
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absence of movement (brady or akinesia). The model also suggests that the two 
populations of the striatal neurons bear different dopaminergic receptors (D1 receptors 
for the direct pathway and D2 for the indirect pathway) and that dopamine has an 
excitatory effect on the D1 receptors and an inhibitory effect on the D2 receptors. 
This model has received some criticism: it supposes that striatal neurons project to 
either the GPe or the GPi and not to both target nuclei. A single neuron tracing study 
has shown striatal neurons that project to GPe, GPi and SNr (Parent, 1995). Also a large 
number of pathways that may have a crucial control in normal and pathologic 
functioning of the circuit are not considered in the model: e.g. the pallidopallidal 
projection, the dopaminergic innervation of the STN (Francois et al, 2000), and globus 
pallidus (Jan et al, 2000) the afferent projection of the parafascicular nucleus and the 
PPN to the STN and the projections from the PPN to the basal ganglia. 
1.1.4 Connectivity and functional organisation 
Whilst our understanding of the morphological and biochemical properties of the basal 
ganglia system is increasing, its exact functioning in normal and pathological conditions 
remains quite enigmatic. This has led to various interpretations from which different 
models have been construed.  
1.1.4.1 The box and arrows models  
In the box and arrows model each nucleus of the basal ganglia is considered as a unique 
and homogenous structure, “the box” that communicates with the other nuclei by 
connections, characterised by their excitatory or inhibitory nature, the “arrows”.  
The dual circuit model was proposed by Albin et al (1989) to provide a simplified 
description of the basal ganglia circuits and the pathophysiology of both hypokinetic 
and hyperkinetic disorders. There is a direct pathway that has an excitatory effect and 
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thus a positive effect on movement and an indirect pathway that has an inhibitory effect 
on movement. The main information to the basal ganglia system comes from the cortex. 
Striatal information is transferred to the GPi and the SNr and then to the thalamus and 
from there to the frontal cortex, the supplementary motor area (SMA) for pallidal input 
and the dorsolateral prefrontal cortex (DLPF) for nigral input. This cortico-cortical loop 
passes through the direct pathway. The indirect pathway involves the GPe, then the 
STN and from there the GPi and the SNr. The central complex of the thalamus (centre 
median parafascicular complex) has strong links with the basal ganglia system in 
primates. The GPi projects to the central part of the complex (centre median nucleus), 
which projects back to the sensorimotor putamen. The SNr projects back to the medial 
part (the parafascicular nucleus), which projects back to the caudate nucleus. 
Mink (1996) put forward the triple-circuit model, adding a hyperdirect pathway, a most 
rapid cortico-subthalamopallidal projection that first inhibits all motor programmes in a 
reset-like fashion. Then the direct cortico-striapallidal pathway activates the motor 
sequence to be executed and finally the slow indirect cortico-stiato-subthalamopallidal 
pathway inhibits the motor sequence to terminate the execution (Nambu, 2002 and 
2004) (Figure 1.6). 
 28 
 
Figure 1.6: A schematic diagram of the cortico-STN-GPi/SNr “hyperdirect”, cortico-
striato-GPi/SNr “direct” and cortico-striato-GPe-STN-GPi/SNr “indirect” pathways. 
Open and filled arrows represent excitatory glutamatergic (glu) and inhibitory 
GABAergic (GABA) projections, respectively. Cx cerebral cortex; GPe external 
segment of the globus pallidus; GPi internal segment of the globus pallidus; SNr 
substantia nigra pars reticulata; STN subthalamic nucleus; 
Str striatum; Th thalamus (modified from Nambu et al, 2005). 
 
 
Alexander (1986) and Delong & Wichmann (2007) proposed the five-circuit model.  
It represents five different circuits from the frontal cortex, namely oculomotor, motor, 
dorsolateral, prefrontal, lateral orbitofrontal and anterior cingulated, which cross 
through the basal ganglia direct and indirect pathways. They also remain segregated up 
to their projection up to the frontal cortex from where they arise. This model supposes a 
parallel processing of cortical information and it has been challenged for the lack of 
integration between motor, oculomotor and nonmotor information in the basal ganglia. 
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1.1.4.2 The three functional territories 
Parent (1990) proposed a more functional subdivision of basal ganglia activity, namely 
the sensorimotor, associative and limbic territories (Figures 1.5, 1.7 and 1.8).  
 
Figure 1.7 Schematic diagram illustrating the main cortico-basal ganglia-
thalamocortical circuits within human brain. This figure shows a pseudo-anatomical 
arrangement of the motor, associative and limbic pathways. (a) Motor circuit. Neurons 
from the sensorimotor cortex project to the posterolateral putamen (Put). From the 
putamen there are two main projections topographically organised onto the 
posterolateral region of the target nuclei: (i) the direct circuit to the GPi and (ii) the 
indirect circuit connecting the posterior putamen to the globus pallidus pars externa 
(GPe), the STN and the GPi. The GPi is the primary output nucleus of the basal ganglia 
to the cortex via the ventrolateral thalamus. (b) Associative circuit. This circuit 
originates in the dorsolateral prefrontal and lateral orbitofrontal cortices, which 
project to the caudate nucleus (Cn) and anteromedial portion of the putamen. From the 
striatum (Cn + Put) it projects to the dorsomedial region of the GPi and anteromedial 
parts of the GPe and STN to converge onto the GPi and back to the cortex via the 
ventral anterior nuclei of the thalamus. (c) Limbic circuit. This loop starts in the 
hippocampus, amygdala and paralimbic and limbic cortices and projects to the ventral 
striatum (ventral portion of the caudate and putamen, including NAcc). The ventral 
striatum projects to the limbic portion of the GPe and medioventral STN and ventral 
GPi and to the cortex via the mediodorsal nucleus of the thalamus. From Krack et al, 
2010. 
The sensorimotor comprises the primary motor, the premotor cortices, supplementary 
motor area and the oculomotor area. It processes motor and somesthetic information. 
The associative territory comprises the prefrontal dorsolateral and lateral orbitofrontal 
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cortices as well as the temporal, parietal and occipital cortices. It processes cognitive 
information. The limbic territory comprises the anterior cingulated and medial 
orbitofrontal cortices, as well as the hypocampus. It processes emotional and 
motivational information. These three functional territories project to different parts of 
the basal ganglia nuclei: the sensorimotor territory to the dorsolateral portions, the 
medial territory to the ventromedial portions and the associative territory to the central 
intermediate portions. The validity of this model has been demonstrated in both primate 
research (Francois et al, 2004) and in human clinical research (Mallet, 2002; 2007). 
 
Figure 1.8: Schematic representation of the intrinsic organisation of the subthalamic 
nucleus (STN) according to the tripartite functional subdivision of the basal ganglia. 
From Hamani et al, 2004. 
 
1.1.4.3 The integrative properties of the basal ganglia (Yelnik, 2008) 
In contrast to the segregated parallel-circuit, the anatomical organisation of the basal 
ganglia exhibits a strong convergence at several levels: first the volumes of the 
successive nuclei that the circuits cross through are decreasing in dramatic proportions: 
cortex 500,000 mm3, striatum 10,000 mm3, pallidum 500 mm3, STN 150 mm3; hence 
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3,000 times less than the emitting cortex (Yelnik, 2002a and 2002b). Also the number 
of neurons in each of these nuclei also exhibits a dramatic decrease due to the decrease 
of both the volumes and the cell density (Parent, 1996; Levesque & Parent, 2005). The 
integrative properties of the basal ganglia have been considered in a model based on the 
anatomical properties of the dopaminergic pathways which do not form closed 
independent loops but rather provide ascending connections between the sensorimotor, 
associative and limbic striatal subdivisions (Yelnik, 2008; Flaherty & Graybiel, 1993) 
(Figure 1.5). 
1.2 Speech motor control in healthy adults and the role of basal ganglia 
Fluent articulation is perhaps man’s most complex motor skill. It involves the 
coordinated use of many muscles, such that speech sounds are produced at a rate of 
about 15 per second (Levelt, 1989). These muscles are distributed over three 
anatomically distinct structures: the respiratory, the laryngeal and the supralaryngeal. 
The respiratory system with the lungs as its central organ regulates the flow of air, the 
source of energy for speech production. The laryngeal structure, including the vocal 
folds, is responsible for the alternation between voicing and non-voicing. The 
supralaryngeal structure, the vocal tract, with the velum, the tongue, the jaw and the 
lips, as its major moving parts, exercises two functions in articulation. The first is to 
constrict or interrupt the airflow in particular ways so as to produce speech sounds and 
the second is to serve as a resonator, modulating the timbre of the successive speech 
sounds. The timbre depends in particular on the shape of the oral, pharyngeal and nasal 
cavities (Levelt, 1989, chapter 11, p 413).  
As compared to other areas of motor control, e.g. upper limb movement, rather sparse 
data of the cerebral organisation of speech motor control is available so far. This 
discrepancy is due, among other reasons, to the absence of an animal model of human 
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verbal communication and the biomechanical complexities of the vocal tract, together 
with restricted opportunities for kinematic and electormyographic (EMG) 
measurements (Ackermann, 2005, chapter 4). Prior to the introduction of brain imaging 
techniques, analyses of the neural network subserving speech had to rely on detailed 
perceptual descriptions of dysarthria in patients suffering from relatively focal lesions or 
degenerative disorders bound to a distinct functional component of the nervous system, 
e.g. PD or cerebellar atrophy. Some further data of speech motor control have been 
obtained by means of electrophysiological recordings during brain surgery. Functional 
brain imaging techniques such as PET and fMRI provide more detailed information on 
the neural correlates of speech motor control. However there are methodological 
difficulties in studying speech production, mainly because it involves mouth 
movements that can cause artifacts in the imaging signal as well as increasing head 
movement.   
1.2.1 Imaging data 
In the pioneering work carried out in the 1940s at the Montreal Neurological Institute, 
Penfield (1954) established a functional map of the sensorimotor areas along the central 
sulcus. In particular they found that electrical stimulation of the precentral gyrus (motor 
cortex) produced individualised movement. Stimulation of the lateral surface evoked 
movements of the lips, the tongue and the jaw. Imaging studies on speech production 
have shown activation mainly in motor and premotor cortex, the cerebellum, the 
supplementary motor area (SMA) the superior temporal gyri, the tempoparietal cortices, 
and the anterior insula with left lateralised activation in the putamen (Brown et al, 2009; 
Price 2010).  
With respect to the left anterior insula Brown and colleagues (2009) speculate that it is 
involved in generalised orofacial functions, including lip movement, tongue movement 
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and vocalisation. The fact that activation is not dependent on whether speech is overt 
(Riecker et al, 2002) or covert (Watkins et al, 2008) speech production and not reported 
to depend on number of syllables being produced (Papoutsi et al, 2009) is consistent 
with the previous claims from lesions studies (Dronkers et al, 1996) that the anterior 
insula is involved in the planning rather than the execution of speech sounds (for review 
see also Ackermann & Riecker, 2010). 
The initiation and execution of movement increases activation in bilateral 
premotor/motor cortex, the pre-SMA, and the left putamen. With respect to the function 
of the premotor cortex, Brown and colleagues (2009) distinguished the areas that 
control larynx movement (dorsal region) from those that involve tongue and lip 
movements (ventral region).  
The SMA is one of the few brain areas which when lesioned can give rise to mutism 
and stimulation in this area can lead to vocalisation in humans but not in monkeys 
(Jürgens, 2002). In the meta-analysis of 82 studies by Indefrey & Levelt (2004), they 
concluded that the SMA plays a role in motor planning, motor sequencing but its exact 
role in vocalisation is not well understood (Riecker et al, 2002; Price, 2010). 
The two areas found to be more involved with articulation of speech than non-speech 
orofacial movements are the anterior cingulate and bilateral head of caudate (Chang et 
al, 2009).  
Soros et al (2005) found that speech sounds of increasing complexity (monosyllabic 
consonant versus vowel and trisyllabic consonant versus vowel) are associated with an 
increased task demand and an increased recruitment of additional brain regions. Their 
experimental tasks included overt speech production of the vowel ah, the syllable /pa/ or 
/ta/ or /ka/, the /pataka/, and simple facial movement (kiss) using clustered MRI 
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acquisition. They found that more complex polysyllabic utterances were associated with 
additional activation in the bilateral cerebellum and the bilateral temporal cortex. 
Speaking a single vowel and performing a simple oral movement involved almost 
identical activation of the pyramidal and extrapyramidal tract (Figure 1.9). The 
production of more complex /pataka/ utterances involved activation in the left inferior 
frontal gyrus (Broca’s area), the left cerebellum (involved in timing), the left caudate 
nucleus (timing of sequential movements) and the bilateral superior and middle 
temporal gyri. 
 
Figure 1.9: The neural network of speech production. Schematic fibre tracts connecting 
those areas are represented by black arrows. Only main areas of activation and main 
fibre tracts are shown. The supplementary motor area (1) and the cingulated motor 
areas (2) are connected with the primary motor cortex (3). Several connections exist 
between the cortical and the subcortical motor system. Subcortical activation was found 
in the thalamus (4), the basal ganglia (not shown), the red nucleus (6) and in the vermal 
and paravermal cerebellum (5). In addition, the bilateral posterior superior temporal 
gyrus (7) was activated. The brain stem nuclei innervating the articulatory organs, such 
as the nucleus hypoglossus, were outside the field of view (8). From Soros et al (2006).  
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1.2.1.1. Role of basal ganglia on speech motor control in healthy adults 
The differential contribution of basal ganglia and cerebellum in timing of speech motor 
control has been investigated by Wildgruber et al (2001) using silent repetition of /ta/ at 
three different rates (2.5, 4.0 and 5.5 Hz). Lower rates (2.5 and 4.0 Hz) gave rise to 
higher magnitude of activation in the left putamen, whereas cerebellar activation was 
restricted for higher rates (5.5 Hz). The observed asymmetry of activation at the level of 
basal ganglia towards the left putamen is in good accordance with clinical observations 
of articulatory impairment and reduced voice volume after left-sided subcortical 
infarction (Alexander, 1987, Brain) as well as PET studies investigating repetition of 
single words. The decreased activation within the putamen during the fastest production 
rate might indicate this structure to be specifically involved in the control of articulatory 
movements during lower frequencies. The clinical observation of accelerated speech 
tempo in patients with dysfunction of the basal ganglia supports this assumption 
(Ackermann et al, 1993 & 1997). This was the opposite of the pattern of activation of 
the cerebellum: absence of cerebellar activation during slow syllable rate is in line with 
the clinical observation that maximum production rate does not seem to drop below 3 
Hz in patients suffering from ataxic dysarthria (Hertrich & Ackermann, 1997). Riecker 
et al (2005) repeated the same experiment but with overt speech production, 
synchronised to clic trains (from 2 Hz to 6 Hz) versus a passive listening task. Two 
different time series patterns were detected (Figure 1.10). Peak activation of the left 
SMA, left dorsolateral pre-frontal cortex (including Broca’s area), left anterior insula 
and right superior cerebellum emerged three to five seconds after the onset of acoustical 
stimulation; and by contrast the left sensorimotor cortex, left thalamus, left 
putamen/pallidum, left caudate nucleus and right inferior cerebellum achieved the 
maximum activity eight to nine seconds after the onset of speech production. The 
authors interpreted these data as two distinct cerebral networks subserving speech motor 
 36 
control – one for motor preparation and one for motor execution. It is of note that the 
left basal ganglia and left thalamus and inferior aspects of the right cerebellum were 
found to be involved in the motor execution of speech.  
 
Figure 1.10: Preparative and executive speech loop from quantitative functional 
connectivity analyses: computed correlation coefficients across the time series of the 
blood oxygen level-dependent (BOLD) signal within the volumes of interest. Only very 
high (_0.9, bold lines) and high correlations (0.75– 0.9, thin lines) are depicted. Low 
and intermediate correlations are not displayed. From Riecker et al, 2005, p 704. 
 
Watkins (2008) examined the brain activation during both overt and covert production 
of stutterers and found overactivity in the midbrain, at the level of substantia nigra, the 
pedunculopontine nucleus, red nucleus and subthalamic nucleus. The role of putamen in 
speech production becomes even more complex, when comparing phonation versus 
articulation and reading versus speaking. According to Brown et al (2009) there was no 
activity for the phonation task whereas there was a strong left hemispheric focus for 
speech. One could surmise that putamen is more important for articulation than 
phonation. However, clinical damage to the basal ganglia circuit gives rise to severe 
dysphonia (low vocal volume) (see section 1.4). The only therapy that seems to 
ameliorate voice and speech in PD, namely the Lee Silverman Voice Treatment  
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(Ramig et al, 2001) is based on phonation with benefit on articulation as a by-product. 
Activation in the putamen co-occurs with activation in the ventral thalamus, mainly in 
the syllable singing (Wildgruber et al, 1996).  
In summary neuroimaging studies of speech motor control (Bohland & Guenther, 2006; 
Riecker et al, 2008; Soros et al, 2006) using a variety of speech tasks have roughly 
converged on a “minimal network for overt speech production” including the 
“mesiofrontal areas, intrasylvian cortex, pre- and post-central gyrus, extending rostrally 
into posterior parts of the left inferior frontal convolution, basal ganglia, cerebellum and 
thalamus” (Riecker, 2008). However when it comes to speech versus singing, studies 
have found an opposite pattern of lateralisation in the sensorimotor cortex during speech 
production and production of tunes (i.e. “la” while singing a melody) with the former 
eliciting predominantly left-sided activity and the latter right-sided one (Wildgruber, 
1996). Similarly, Riecker et al (2000) and Callan et al (2006) found opposite laterality 
in the insula, motor cortex and cerebellum. That could explain the clinical observations 
of many aphasic right-handed patients with left inferior frontal lobe (Broca’s area) 
damage, having severe deficits in their ability to speak but being able to sing words 
without much effort (Hebert, 2003). Equally TMS to the left inferior frontal cortex in 
right-handed individuals causes speech arrest but singing even of the same words is 
relatively spared (Stewart 2001).  
1.2.2 Neural control of human vocalisation  
Apart from the linguistic/semantic versus motor control of speech, the elements of 
motor speech can be decomposed in yet another way, by isolating the neural substrates 
for phonation and differentiating these from those that regulate articulation. Animal 
studies suggest that in lower mammalian species, from rat, to cat, to monkey (Kuypers, 
1958; Larson, 1991) there exists a midline network of brain regions dedicated to 
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phonation, controlling the species-specific calls. It includes the anterior cingulate 
cortex, the periaquaductal grey (PAG) the nucleus retroambiguus and nucleus 
ambiguous (Jürgens, 2002). The main area of this circuit is the mesencephalic 
periaqueductal grey (PAG) which regulates activity of the lower brainstem that control 
vocal fold tension and respiration. The PAG itself is regulated by limbic-related regions 
of the forebrain and it encodes information about the emotional status and behaviour in 
a repertoire of vocal calls over which voluntary control – in non-human species – 
appears to be slight (Jürgens & Zwirner, 1996). In humans this system may be involved 
in emotional expression such as laughter or crying but appears to be less important for 
volitional expression, which appears to be more under cortical control. There are two 
competing hypotheses (Jürgens & Zwirner 1996; Jürgens, 2002); one suggests that only 
involuntary emotional vocalisations, such as laughter or crying, are controlled by the 
PAG whereas voluntary phonation during speech is under the control of an autonomous 
neocortical system; the other suggests that both these systems operate in concert during 
production of spoken language, with a hierarchical control maintained by neocortical 
motor systems. From the literature it seems that comparative animal versus human 
studies of anatomical connections provide evidence supporting the first hypothesis, 
whereas functional imaging studies support the second. Kuypers compared the 
corticobulbar pathways in humans (1958a) with those in monkeys (1958b) and found 
sparse labeling in the nucleus ambiguous after cortical injection of a tracer in a patient, 
suggesting that there are some direct corticobulbar projections from the motor cortex to 
the laryngeal motor neurons in the nucleus ambiguous in the humans. He found no 
evidence of a similar direct corticobulbar projection in the monkey and chimpanzee. 
This has been confirmed more recently by Simonyan & Jürgens (2003). They used 
electrical stimulation to identify the laryngeal motor cortex producing bilateral vocal 
fold closure in Rhesus monkeys and injected an anterograde tracer into the effective site 
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to label subcortical projections. Dense projections with ipsilateral predominance were 
found in the putamen and thalamus (in the ventral nuclei) with heavy bilateral 
projections to the brain stem nuclei in the nucleus tractus solitarius. In 2005 the same 
authors found dense projections into the laryngeal motor cortex from the ventrolateral 
thalamus in Rhesus monkeys, demonstrating dense reciprocal connections between the 
basal ganglia and the laryngeal motor cortex. These results support the conclusion that 
many of the laryngeal muscle functions for swallowing, cough respiration and 
vocalisation are controlled by subcortical connections for non-human primates and that 
direct corticobulbar projections to the nucleus ambiguus may be exclusively human. 
Although the study in four human brains of Kuypers has not been replicated, TMS 
studies of latencies of laryngeal muscle responses (12ms) support the possibility of 
direct projections from the cortex to the recurrent laryngeal nerve innervating the 
intrinsic laryngeal muscles (Ludlow et al, 1996). Clinically evidence of this dissociation 
can be seen in spasmodic dysphonia, where involuntary muscle spasms only interfere 
with voice production for speech and not during crying, laughing (Izdebski et al, 1984; 
Nash & Ludlow, 1996).  
Although anatomical connections provide evidence on regions of connectivity, only 
functional neuroimaging can provide information on active systems for laryngeal 
muscle control during respiration and voice production in humans. Schulz et al (2005) 
compared brain activation of voiced and whispered speech (using voiced narrative 
speech and an identical whispered narrative) in 20 healthy adults. They observed 
activation of the PAG and paramedian cortices only with voiced and not whispered 
speech, which provided evidence that, as in lower mammalian species, these midline 
regions may operate as an integrated system during human vocalisation. However since 
linguistic information was also conveyed with the narrative they observed coactivation 
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of additional regions during voiced speech: premotor regions including the SMA and 
subcortical projection areas in the basal ganglia and thalamus. Stimulation in the pre-
SMA has been reported to elicit vocalisations in humans (Fried et al, 1991) but not in 
lower species. It appears that there are no direct links with the PAG (Jürgens, 1984). 
Activity in the SMA is regulated to some degree by its interaction with the basal ganglia 
(Alexander et al, 1986; Parent et al, 1995). The putamen, where they found maximal 
increases in activation, is part of the motor circuit which conducts neural information 
from the striatum through to the ventral thalamus through to the SMA. This motor 
circuit might enable more precise voluntary control over the timing and sequencing of 
laryngeal, respiratory and articulatory activity during voiced speech. Thalamic 
activations were maximal in the region of the centromedian (CM) nucleus, a major 
source of input to the basal ganglia and with projections in the SMA and the PAG 
(Jürgens, 1984). The authors interpreted activation in the cerebellum and the perisylvian 
areas of the temporal lobe as related to self-monitoring and processing of own voice that 
makes possible the continuous online correction of laryngeal and oral articulatory 
movements. Thus basal ganglia and thalamic structures and premotor structures provide 
the degree of voluntary control over phonation in humans. In a more recent study of 34 
healthy adults, Chang et al (2009) compared the neural control of speech and non-
speech production (defined as “volitional vocal tract gestures, such as whistle, cry, sigh 
and cough) and found that they share the same network as speech and same left cortical 
laterality. They concluded that the brain regions involved in both speech and non-
speech gestures seem to support “a larger domain of vocal tract gestures requiring 
sensory-motor mapping” (p 321).  
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Figure 1.11: Key brain areas of the vocal circuit. Shaded boxes represent “primary” 
areas that are principal regions for the control of phonation in speaking and singing. 
White boxes represent “secondary” areas that are less reliably activated during 
phonation and that might be more important for articulation. See text for details.  
This is not meant to be a comprehensive connectivity diagram. The focus is placed 
 on the connectivity between these multiple areas and the primary motor/premotor 
cortex, rather than on connections among the other areas. Connectivity data is based 
principally on the afferent and efferent connections of the M1 larynx area of the Rhesus 
monkey, as described in (Simonyan & Jürgens, 2003,2005, Simonyan et al, 2008). The 
projection from the motor cortex to the cerebellum is via the pontine nuclei. As 
described in the text, lobule VIII of the cerebellum may turn out to be a primary area, 
but many imaging studies, especially PET studies, have not included this part of the 
cerebellum in their field of view. Abbreviations: SMA, supplementary motor area; 
CMA, cingulated motor area; pSTG, posterior part of the superior temporal gyrus; 
aSTG, anterior part of the superior temporal gyrus; Spt, cortex of the dorsal Sylvian 
fissure at the parietal-temporal junction. From Brown et al, 2009. 
 
Brown et al (2009) used fMRI to compare an overt speech task with tongue, lip 
movement and vowel phonation in an attempt to differentiate the activation areas for 
phonation to those for articulation (Figure 1.11). Their results showed that the strongest 
motor activation for speech was the somatotopic larynx area of the motor cortex, thus 
reflecting the significant contribution of phonation to speech production.  
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1.2.3 Neural control of facial muscles 
Hughlings Jackson first noted that the muscles of the lower face, and not those of the 
upper face, were adversely affected unilaterally following common localised brain 
trauma. In an attempt to explain this pattern of facial paralysis, Jackson suggested that 
unilateral movements like those performed by the arm, leg and lower face were more 
voluntary and it was this “voluntary” nature of these movements that formed the basis 
of their underlying vulnerability (Jackson as reported in Morecraft et al, 2004). It was 
further speculated that bilateral movements such as those commonly expressed by the 
upper face were retained, as they represent a more automatic class of movements. 
Recent experimental data (Morecraft, 2001) reveal the existence of multiple cortical 
facial representation of the primary motor cortex (M1), ventral lateral premotor cortex, 
supplementary motor cortex (M2), rostral cingulate motor cortex (M3) and caudal 
cingulate motor cortex (M4). These diverse cortical areas are part of limbic and 
prefrontal regions (M3 and M4), which suggests a role in emotional expression 
attention and cognition. Functional correlates of face/head regions of M2 may include 
the control of eye movements, speech (Paus, 1993) and laughter (Fried, 1998). Speech 
and laughter are distinctly human abilities and share the same musculature. Fried et al 
(1998) applied electrical stimulation in the anterior part of the anterior SMA of a patient 
undergoing monitoring by intracranial subdural electrodes to locate the focus of 
epileptic seizures. They identified a small area on the left superior frontal gyrus where 
stimulation consistently produced laughter, accompanied by a sensation of merriment or 
mirth. It was interesting that each trial was accompanied with a different explanation 
offered by the patient, attributing the laughter to whatever external stimulus was present 
at the moment. They concluded that speech and laughter are closely represented in the 
rostral part of the SMA, just anterior to the representation of manual activity. Clinically 
the recognition of multiple cortical facial representations is reflected in the dual control 
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of facial movements, such as the dissociation of voluntary (i.e. for speech) and 
emotional facial movements. The most common clinical profile is in patients presenting 
with impaired lower face voluntary movement with intact ability to overcome the 
paralysis when emotional facial expression is needed. In contrast, emotional facial 
paralysis (also described as amimia) has been reported to occur in patients with damage 
to the midline cortex, insula, thalamus striatocapsular region and pons and is 
characterised by a disturbance in smiling on one side of the face in the presence of 
complete voluntary control over the same set of facial muscles (Morecraft, 2004). In 
summary, cortical projections from the lateral facial representations (M1 and LPMC) 
and the caudal cingulated motor cortex (M4) might exert their influence primarily on 
contralateral lower facial muscles. Medial motor areas including the supplementary 
(M2) and rostral cingulated (M3) motor cortices may exert influence on the upper facial 
muscles, possibly bilaterally. Also the cingulated corticofacial projections may exert an 
influence on emotional facial expression. However despite the marked paucity of facial 
expression from diseases of basal ganglia there is limited literature on the role of 
subcortical structures in the control of facial muscles.   
1.3 Muscle control for speech 
The speech related muscles in humans appear to differ from analogous tissues in 
mammalian and non-mammalian species, as well as from limb muscles. This is the case 
of the inferior pharyngeal constrictor (Mu & Sanders, 2001), the vocalis muscle (Han et 
al, 1999) and the masseter muscle (Korfage et al, 2005a and 2005b). The muscle 
properties of the human craniofacial and laryngeal systems are suited to motor 
performances that are continuous, precise and highly coordinated. This can be true 
cross-culturally: Levelt et al (1989) have argued that the normal syllable rate in the 
world’s languages of five to six syllables per second is a consequence of the 
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biomechanics of the vocal tract, especially the movements of the mandible. Some of the 
muscles involved in speech have properties of fatigue resistance. Thus compared with 
limb and trunk muscles, the jaw muscles are highly unusual: in addition to the normal 
slow type I and fast type II fibres, they contain fibre types which are typical for cardiac 
muscle. Korfage et al (2000) reported that the temporalis, masseter and pterygoid 
muscles (mandibular elevators) have a large number of hybrid fibres, but mylohyoid, 
geniohyoid and digastric muscles (mandibular depressors) have fewer hybrid fibres. 
Hybrid fibres are thought to be those that are in transition from one fibre type to the 
other since they are predominantly found during disuse or during extreme usage of the 
muscle (Korfage, 2005). This relatively high quantity of hybrid fibres provides a 
mechanism that produces a very fine gradation of force and movement. 
1.3.1 Laryngeal muscles involved in the production of speech, swallowing, respiration 
and cough  
For each of these laryngeal functions different vocal fold movement is required. Voice 
is produced as the vocal folds are held in the midline of the glottis and airflow from the 
lungs causes increases in the subglottal air pressure for opening the vocal folds. As the 
vocal folds open, the airflow passes between the folds reducing the pressure between 
them (the Bernouilli effect) and the muscle tension in the vocal folds returns to the 
midline for closure, allowing the cyclic process to continue (Titze, 1994). Thus the 
speaker has to maintain adequate respiratory airflow during exhalation and use adequate 
muscle activity to keep the vocal folds in the midline for vibration to occur (Figure 
1.12). Speech requires a rapid and precise muscle control for voice onsets and offsets 
within a few milliseconds to make linguistic distinctions between voiced and unvoiced 
sounds such as /t/ and /d/. 
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Figure 1.12: This shows a normal larynx in the abducted or open position for 
breathing. Notice that it is very easy to see into the trachea. B, This is the larynx in the 
adducted position for phonation. Only the true vocal folds are opposed. C, This is a gag 
and shows the larynx in a protective position – notice that the false vocal folds have 
closed over the true vocal folds and the epiglottis and aryepiglottic folds are 
constricting in a sphincteric manner. T indicates true vocal folds; F, false vocal folds; 
A, arytenoids; AE, aryepiglottic folds; Ep, epiglottis (anterior); P, posterior pharyngeal 
wall; Eo, esophageal inlet. From: Meyer, 2009  
 
 
The laryngeal muscles are classified as either intrinsic (confined in the larynx) or 
extrinsic (attaching the larynx to other structures within the neck). Vocal fold 
movements are described as adductor (closing) or abductor (opening). 
 
Figure 1.13: Cartilaginous structures of the larynx. From: Meyer, 2009. 
 
Intrinsic laryngeal muscles are classified as either having an adductor action 
(thyroarytenoid (TA), lateral cricoarytenoid (LCA), interarytenoid (IA), or abductor 
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function (posterior cricoarytenoid (PCA). The cricothyroid (CT) muscle can elongate 
the vocal folds.  
The extrinsic laryngeal muscles are the thyrohyoid and the sternohyoid change the 
position of the larynx in the neck by raising or lowering the thyroid cartilage 
respectively. The thyrohyoid muscle raises the larynx during swallowing while the 
sternothyroid lowers voice pitch (Ludlow, 2005).  
In the laryngeal system, Han et al (1999) have identified a large population of slow 
tonic muscle fibres (STF) in the vocalis muscle compartment of the thyroarytenoid 
muscle. STF differ from most other muscle fibres in that they do not exhibit a twitch 
contraction but rather have contractions that are prolonged, precisely controlled and 
fatigue resistant. Because STF have not been observed in the vocal folds of other 
mammals, Han et al suggested that STF may be a unique specialisation for human 
speech (p 146). The physiological study of the laryngeal musculature in humans is 
challenging due to the difficulty in obtaining accurate EMG recordings from these 
inaccessible muscles. Most investigators use percutaneous insertions of hooked or 
needle electrodes. Placement is verified by using gestures that would elicit accurate 
location of the recording electrode (Hirano & Ohala, 1969). For example, a sniff will 
elicit increased activity in the PCA while throat clear will activate the TA muscle. These 
methodological difficulties may partly account for the differences in results between 
studies of swallowing, respiration, voice and speech. However individual differences in 
use of the laryngeal musculature to produce the same task are particularly evident 
during speech. In a study of four young healthy adults and five old ones Baker et al 
(2001) found a striking variability in the amount of muscle activation of the TA, CT and 
LCA muscles during three different loudness levels. Finnegan et al (1999, 2000) 
recorded from the laryngeal muscles while recording tracheal (subglottal) air pressure 
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during speech. They found a complex but independent interaction between variations in 
laryngeal muscle activity and tracheal pressures, demonstrating that speakers control the 
laryngeal muscles independently from subglottal air pressure to produce changes in 
voice intensity and fundamental frequency. This is possibly why breathing exercises 
have no effect on vocal loudness (Yorkston et al, 1996).  
1.3.2 Lingual and palatal muscles 
Lingual and palatal muscles have not been examined as extensively as jaw and 
laryngeal muscles. Sokoloff (2000) has identified motor units in the rat tongue that are 
fatigue resistant. In humans the production of most vowels depends on the positioning 
of the tongue body by means of the extrinsic muscles – in particular the genioglossus. 
Most consonants that involve the tongue in particular the alveolars, /t/, /d/, /s/, /z/) are 
articulated by means of the intrinsic muscles, which affect the shape rather than the 
body of the tongue. Thus the movements between vowels and consonants can be 
produced without interference (Levelt, 1989, Chapter 11, p 453). 
The palatal muscles also resemble facial muscles more than limb muscles: Stal & 
Lindman (2000) have studied the palatopharyngeus (PP), the uvular (U), levator veli 
palatini (LVP) and tensor veli palatini (TVP). PP and U were found to have some of the 
highest proportions of type II fibres ever reported in human muscles, while LVP and 
TVP contained primarily type I fibres. The authors concluded that PP and U are 
equipped for rapid movements whereas LVP and TVP are more adapted to slow and 
continuous contractions. The lingual and palatal muscles have shared respiratory-related 
activity. The tongue is central to a variety of reflexes and orofacial movements that 
contribute to complex motor responses in feeding, chewing, swallowing, speech and 
respiration. Intersystem coordination that links mandibular, lingual and laryngeal 
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movements to respiratory patterns serves speech well by ensuring efficient and well-
timed movement.  
This difference between the muscle fibre composition of speech versus limb muscles 
could partly account for the discrepancy between limb and speech motor response to 
medical and surgical interventions, especially in PD. Although it is not known exactly 
how the neural control of speech differs from that of the limbs, it may be important to 
consider both peripheral factors (e.g. differences in muscle fibre composition) and 
central factors (neural circuits controlling movement).  
1.4 Perceptual and acoustical characteristics of speech in Parkinson’s disease 
James Parkinson in his 1817 essay on the “shaking palsy” mentioned some 
distinguishing features of the disease. He reported that in the late stages of the disease 
patients’ words are “scarcely intelligible” and “that speech is very much interrupted”. In 
presenting the “pathognomonic symptoms” Parkinson listed “a propensity to bend the 
trunk forwards and to pass from a walking to a running pace”. He quoted an earlier 
observer Gaubius, “cases occur in which the muscles duly excited into action by the 
impulse of the will, do then, with an unbidden agility, and with the impetus not to be 
repressed, accelerate their motion, and run before the unwilling mind. It is a frequent 
fault of the muscles belonging to speech, nor yet of these alone: I have seen one who 
was able to run but not walk” (p 24). Parkinson himself added: “a similar affection of 
the speech, when the tongue thus outruns the mind is termed volubility”. He also quoted 
a Dr Maty who described the case of Count de Lordat: what began as a small 
impediment in uttering some words increased in severity until later “it was with 
difficulty he uttered a few words”; still later, “what words he could still utter were 
monosyllables, and these came out, after much struggle, in a violent expiration, and 
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with such low voice and indistinct articulation, as hardly to be understood but by those 
who were constantly with him. He fetched his breath rather hard.”  
More modern discussions of Parkinsonism uniformly describe speech changes as an 
integral part of the syndrome. For the era before levodopa, descriptions are quite 
similar: Walshe (1955) mentions “the loss of inflections in the voice, the weakness of 
phonation, and the blurring of articulation”. De Jong (1967) calls the speech problem 
bradylalia and lists its characteristics as weakness of voice, dysprosody, lack of 
inflection, indistinctness of articulation, hesitations, stoppages and bursts of speed”. 
Nielsen (1958) describes the phenomenon of repetitious speech known as palilalia: 
“palilalia is a repetitive disturbance encountered in parkinsonism and encephalitis (as 
representatives of the organic causes) and in schizophrenia. This condition is 
characterised by a repetition of sentences or fractions of sentences.”  
At the beginning, the main purpose of studying the physiological support for speech in 
PD seemed to be to investigate the motor rather than the motivational/linguistic aspects 
of speech impairment in PD in order to inform therapy. Thus, on one hand, Zimmerman 
(1959, as reported in Canter, 1965a, p 48) stresses that the primary goal of speech 
therapy should be to increase motivation so that the patient would make maximum use 
of his abilities. On the other hand, through the pioneering work starting with Canter in 
1963, and culminating with Darley Aronson Brown (1969), the physiologic basis of the 
speech deficit in PD was established.  
Perhaps the most comprehensive descriptions of the dysarthria of parkinsonism is 
presented by Selby (1968): “in the great majority of cases of paralysis agitans, disorders 
of speech become obvious as the disease advances. The shades of inflection to 
emphasise a point disappear, the volume of the voice is reduced, pronunciation of 
consonants is defective and the sentence often ends in a mumble. From a monotonous, 
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soft voice without variation in pitch there is a gradual progression of dysarthria until the 
patient’s diction might become neither audible nor intelligible. Whereas the general 
slowness of movement finds its expression also in the rate of speech in some cases, 
others talk fast, running words into each other, as if they wanted to conserve their 
energies and get it over and done with. A few exhibit progressive acceleration of words 
toward the end of the sentence similar to the festination of gait” (p 188). In a large 
series of patients Selby (1968) found speech to be impaired in most patients, although 
almost half considered their speech to be unimpaired. Darley et al (1969) in their 
seminal work on motor speech disorders examined the perceptual characteristics of 
various types of dysarthrias. They determined the salient pitch, loudness, respiration, 
prosody and articulation characteristics as well as overall general impressions for each 
of the dysarthria classifications. The authors served as listeners and ranked the 
perceptual prominence of 38 speech characteristics after listening to speech samples 
from 212 patients of various aetiologies. The parkinsonian group consisted of 32 
unmedicated patients. The characteristics associated with hypokinetic dysarthria were 
monopitch, reduced stress, mono-loudness, imprecise consonants and inappropriate 
silences. Other perceptual characteristics were short rushes of speech and a harsh voice 
quality. We will review the pertinent characteristics of dysarthria in PD based on the 
three anatomically distinct yet functionally linked components – the subsystems of 
respiration, phonation and articulation and prosody. 
1.4.1 Respiration 
Several features of the total picture of hypokinetic dysarthria, namely decreased 
loudness, short phrases, fast rate, could be partly linked to the respiratory impairment. 
Methodologically the studies could be classified according to whether they examine 
non-speech breathing function, mainly measures of vital capacity, or speech breathing 
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functions, mainly chest wall kinematics (Hixon et al, 1973), mean flow rate (evaluation 
of the phonatory function by dividing the total volume of air used by the duration of 
phonation: lt/sec), phonation quotient (the greatest vital capacity divided by the max 
phonation time: ml/sec) and voice efficiency measurements, (oral pressure, equal to the 
subglottal air pressure during the articulation of an unvoiced plosive where the lips are 
closed and the vocal folds are fully opened e.g. /p/: cm H2O) (Yiu et al, 2004).  
Some aspects of non-speech breathing function, mainly the vital capacity, have been 
found to be abnormal in PD. Laszewski (1956, as reported in DAB, 1969, p 180) 
reported that in most cases of PD there is a marked decrease in vital capacity with little 
measurable thoracic excursion during either inhalation or exhalation. She attributed 
parkinsonian speech impairment more to rigidity of the articulatory muscles than to 
restriction of vital capacity. Equally, reduced amplitude of chest wall movements during 
breathing, irregularities in breathing patterns and increased respiratory rates have been 
documented (Solomon & Hixon, 1993). 
Generalisation of non-speech breathing characteristics to breathing for speech is 
difficult because the total range of speech capacity is not needed for speech production 
(Kent et al, 1987), and there are other systems involved in the production of speech that 
interact with breathing (Netsell, 1975). Two primary methodologies have been used in 
studying the speech breathing mechanism. The first method evaluates features of the 
airstream (e.g. air pressure, airflow) and the second examines measures of chest wall 
movements or kinematics. 
1.4.1.1 Chest wall kinematics 
Direct measurements of speech breathing via assessment of chest wall kinematics have 
been employed infrequently in studies of PD. The technique involves measuring 
movement of the rib cage and the abdomen from the surface (Hixon et al, 1973). 
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Murdoch et al (1989) measured chest wall kinematics in 19 PD patients and 19 healthy 
controls. Rib cage and abdominal circumference was assessed using strain gauge belt 
pneumographs. However their method of attaching the belt above the umbilicus raised 
some criticism of their results (Solomon & Hixon, 1993). Solomon & Hixon (1993) 
examined speech breathing in people with PD using kinematic, spirometric, acoustic 
and pressure data in 14 patients and 14 healthy controls, during resting, reading aloud 
and monologue at the middle and the end of their drug cycle. There were no significant 
differences between the data from the two drug cycles. During resting tidal breathing, 
PD patients had a faster breathing rate and smaller relative contribution of the rib cage 
to lung volume change than did normal controls. Patients with PD produced fewer 
words per breath group and tended to have faster interpause speech rate than did the 
controls. Oral pressure was lower for patients with PD but estimated tracheal pressure 
did not differ between the two groups. The authors concluded that there is “inadequate 
valving of the air stream for patients with PD”. Huber et al (2004) reported increased 
reliance on the abdomen for changing lung volume compared to controls as well as 
increased variability in respiratory movements compared to controls. Equally, Vercueil 
et al (1999) studied the breathing pattern in 11 patients with PD on- and off-levodopa. 
They found abnormal rib cage/ abdomen plots in four out of six patients, suggesting 
normal diaphragmatic activity, but impaired activity in other intercostal muscles. 
1.4.1.2 Studies of air stream 
Lower than normal air pressure during consonant production has been demonstrated in 
people with PD (Netsell et al, 1975). Oral pressure can be a good estimate of the driving 
pressure delivered to the larynx and upper airway structures for sound generation. 
However the influence of the oral structures on the air stream makes it difficult to 
determine whether the lower than expected oral pressure seen in patients with PD is due 
  
 53 
to the respiratory system or to the laryngeal or upper airway valving. Solomon & Hixon 
(1993) reported oral pressure to be lower in patients with PD but estimated tracheal 
pressure to be equal to this in the controls. This difference suggests that in PD poor oral 
closure and/or velopharyngeal valving problems affects measures of oral pressure, thus 
it is not a good indicator of respiratory impairment (Bunton, 2005). DePandis et al 
(2002) examined the Forced Vital Capacity (FVC) and Forced Expiratory Volume in 
one second (FEV1) in 12 PD patients during on- and off-medication. They found 
reduced FEV1 and FVC in both medication states but more severe in the off state. They 
concluded that the respiratory dysfunction in those patients is due to abnormal activity 
of respiratory muscles, resulting directly from their state of rigidity and reduced range 
of movement. Similarly Weiner et al (2002) found reduced respiratory muscle strength 
and endurance more during off- medication as measured by FVC and FEV1.  
Regarding airflow during speech there are contradictory reports and few normative data. 
Warren and Wood (1969, as reported in Bunton, 2005) report 0.040 lt per syllable for 
men and 0.053 lt per syllable for women. Mueller (1971, as reported in Bunton, 2005, p 
332) found no difference from controls in a sustained phonation task. Bunton (2005) 
analysed speech production per the breath groups in seven PD patients using a free 
monologue. She used chest wall kinematics and linguistic and acoustic analysis. She 
concluded that there was a great variability between PD speakers: “three out of seven 
PD speakers initiated speech at low starting lung volumes and continued speaking 
below the end expiratory level (EEL). This subgroup ended breath groups at 
agrammatical boundaries” (p 331). Intraoral air pressure has been reported to vary as a 
function of linguistic variables, age (Hiss et al, 2001) and to a lesser extent, gender 
(Stathopoulos, 1986). However Hiss et al (2001) studied the intraoral air pressure in 60 
adults of three different age groups, males and females, using /ipipi/. They found no 
 54 
statistically significant difference of age or gender. The mean intraoral air pressure 
across age and gender was 6.20cm H2O (0.08 standard error). Intraoral air pressure has 
not been investigated in PD (see also Chapter 7).   
Indirect measures of respiratory function concern deficits in phonation, articulation and 
phrasing. Thus some studies imply respiratory capacity from measures of voice, mainly 
maximum phonation time (MPT) and ability to vary intensity. PD speakers have been 
found to have overall lower intensity levels (Ramig et al, 2001) difficulty in maintaining 
intensity level (Ho et al, 2001) and deficits regulating intensity in response to external 
cues (Ho et al, 1999). Sadagopan et al (2007) studied the effects of implicit and explicit 
cues in increasing vocal loudness on respiratory support in PD patients and they found 
that speaking in background noise resulted in the largest increase in loudness with the 
most efficient respiratory patterns, rather than a more explicit cue (i.e. speak at 10 dB 
SPL above your comfortable loudness or speak at double your comfortable loudness). 
They concluded that PD dysarthria is not related to disease-related physiologic 
limitations in increasing loudness since they can produce normal loudness with cueing. 
In a recent study De Letter et al (2007) investigated the effects of levodopa medication 
on vital capacity, sustained vowel phonation (SVP) and phonation quotient and the 
speech intelligibility (as measured by the Words subtest of the AIDS, Yorkston et al, 
1981). They found reduced vital capacity in 18/25 patients at the off-medication 
condition and 15/25 at the on-medication condition. Phonation quotient and SVP were 
within normal limits. All three respiratory parameters, as well as intelligibility, 
improved with levodopa. However there was no correlation between the respiratory 
measures and speech intelligibility.  
This lack of correlation between respiratory parameters and articulatory/laryngeal 
measures has been discussed in the literature in terms of overlapping neural control and 
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muscular coordination. Thus because the larynx plays a vital role in regulating airflow 
during metabolic respiration, it shares some neural structures with the control of both 
respiratory and laryngeal muscles, namely neurons in the nucleus ambiguous and the 
nucleus retroambiguus with their axons projecting via the recurrent laryngeal nerve to 
the intrinsic muscles of the larynx (Dromey, 1998). Even though rest breathing with its 
medullary rhythm generation differs from speech breathing (Sakamoto et al, 1996), the 
central nervous system facilitates integration of these separately descending neural 
drives at the level of spinal motorneuron. This allows the same respiratory muscles to be 
driven automatically by the brain stem or to be enlisted by the cortex for the more 
specialised requirements of spoken communication. Despite this shared neural control 
for respiration and laryngeal activity, little is known about the coordination of 
respiration and articulation. Given the therapy modification techniques based on 
respiratory control, it would be of clinical interest to understand whether working 
respiratory variables such as airflow and air pressure could affect articulation. Davis et 
al (1996) concluded that “the fine and rapid changes in orofacial muscle activity 
associated with the production of speech consonants are highly coordinated with but 
also independent of the patterned laryngorespiratory activities” (p 34). Dromey et al 
(1998) examined the effect of lung volume on phonatory and articulatory variables in 
five men and five women using the phrase “I sell a sapapple again”. They used five lung 
volume conditions: speaking normally; speaking after exhaling most of the air of the 
lungs (“immediately after taking a very deep breath”); speaking at the end of expiratory 
level (EEL) (“after a sigh without taking any air first”); speaking at a low lung volume 
(LV) (“after breathing out most of your air first”); and speaking at maximum LV while 
speaking normally (“immediately after taking a very deep breath but concentrating on 
saying the sentence as normal as possible”) (p 494). They first measured vital capacity 
with a spirometer and then they used plethysmograph bands around the rib cage (but 
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secured on participants’ clothing), to calculate the percentage of VC used for speech. 
They then correlated these measures with measures of phonatory activity (mean SPL, 
mean F0 and lip displacement in mm from /p/ to /ae/ and from /ae/ to /p/ as calculated 
by a strain-gauge cantilever system (Barlow et al, 1983). They found that the sentence 
was spoken faster in the lowest LV condition. Sound Pressure Level (SPL) was 
increased at the high LV condition. There was no effect of LV on lower lip 
displacement and upper lip velocities generally decreased for anything but normal lip 
velocities. Thus there doesn’t seem to be a clear relationship between respiratory and 
articulatory control unlike the positive relationship of respiratory and laryngeal 
parameters (see also McClean & Tasko, 2002). This is reflected in the results from PD 
patients’ therapy studies, where breathing exercises have little to no effect on 
articulatory parameters of speech (Ramig, 1998).  
1.4.2 Phonation 
Phonation abnormality is one of the main symptoms of the disease. Logemann (1978) 
attempted to characterise the voice and speech abnormalities in 200 PD patients 
representing all stages of the disease. Two expert listeners performed the phonetic 
analysis during reading of a paragraph and conversation. They reported that 89% of the 
patients had abnormal voice and 45% had abnormal articulation. Of the patients with 
voice abnormality 45% had only voice whereas the others had an additional articulatory 
disorder. They concluded that the progression of dysfunction begins with voice and 
gradually extends to include the articulation and other aspects of speech. Sapir et al 
(2001) repeated the same speech protocol for 41 medicated PD patients and correlated 
disease severity (as measured by the Unified Parkinson’s Disease Rating Scale, motor 
part III-UPDRS-III), depression, age and gender variables. They found 85.6% 
prevalence of voice and speech abnormalities. Abnormal voice was present even with 
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short duration or low UPDRS-III scores. Patients with high UPDRS-III scores tended to 
have significantly more voice and speech abnormalities, primarily related to 
abnormalities in articulation and prosody. There was no significant correlation between 
age, gender and depression scores. 
The main study areas of phonation problems in people with PD concern four areas: 
studies on fundamental frequency (F0) and vocal intensity, studies on voice quality, 
studies on laryngeal motor control and studies on laryngeal structure and vocal fold 
function (as suggested by Darley et al 1969, and Duffy, 2005). 
 
Figure 1.14: Bowing of vocal folds from Parkinson’s disease. A, Notice the spindle 
shaped defect in the closure of the true vocal folds. B, The vocal folds are injected 
bilaterally with collagen. From: Meyer (2009).  
 
1.4.2.1 Fundamental frequency and vocal intensity 
Fundamental frequency (F0) can vary across the course of a syllable and can contribute 
to vowel identification in dysarthric speech (Bunton, 2006). Vowel identification is 
thought to be dependent on the location of the first three formant frequencies (F1, F2, 
F3). Fundamental frequency (F0) is believed to primarily influence perception of 
speaker-specific qualities (e.g. age, sex).  
Canter (1963), investigated the voice characteristics of 17 people with PD, unmedicated 
and 17 age-matched controls. He found that although vocal intensity was not 
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significantly lower than the controls (only 1.6dB on average) the average pitch levels 
were higher in the patient group and “the parkinsonian subjects were found to be 
deviant with respect to the range of fundamental vocal frequencies used in the reading 
of the sample material” (p 226). Thus the median F0 for Canter’s 17 patients was 126 
Hz compared to 106 Hz for age-matched controls. Similarly Doyle et al (1995) found 
higher F0 for 12 PD patients off medication, in sustained vowel production. On the other 
hand, Metter & Hanson (1986) found F0 to fall mostly within the normal range of their 
seven PD patients although they noted a tendency for the F0 to increase with increased 
disease severity. This tendency for the F0 to be increased is in contrast to the perceptual 
findings of Darley and colleagues (1969) who found a tendency for pitch to be 
perceived generally as lower in PD. According to Duffy (2005) the reasons for this 
discrepancy between acoustic and perceptual data on this dimension are not very clear. 
It may be that there is a considerable intersubject variability or that monopitch, 
monoloudness and reduced loudness could lead to perceptions of lower pitch. Hence 
Duffy advises against using F0 and pitch levels as a sensitive distinguishing feature of 
hypokinetic dysarthria. Additionally work in the area of synthetic speech and by Bunton 
(2006) in PD speech has shown that even though flattening of F0 does not affect vowel 
identification in normal controls, modification of the F0 for PD speakers affected the 
accuracy with which speakers identified certain vowels. This resulted in reduced 
intelligibility in PD patients. This result supports the perception of monopitch in PD 
dysarthria and the perceptual contribution of F0 variation to sentence-level intelligibility 
(see also Laures & Weismer, 1999: reduced sentence intelligibility by synthetically 
flattening F0 in two normal speakers). 
In PD speech measures of F0 and intensity variability are much more revealing: 
findings consistently demonstrate a reduction of pitch and loudness variability in PD 
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patients (Duffy, 1995). As Canter (1965b) noted, he was unable to measure DDK 
measures in some of his patients due to “flattened intensity peaks” during DDK tasks. 
One factor that varies in the literature is the selection of appropriate speech and non-
speech tasks, that are sensitive to the disease. Although decreased vocal intensity is a 
common finding (Fox et al, 1997; Dromey, 2003; Ho et al, 1999; Schulz, 2000) it is 
not consistently replicated in acoustic or perceptual studies (Canter, 1963; Metter & 
Hanson, 1986; Ludlow & Bassich 1984). Ho et al (1999) found that speakers with PD 
had reduced conversational loudness at various distances from the listeners but they 
could increase the loudness as distance increased. These results were interpreted as a 
reflection of normal loudness regulation but within a context of a damaged “motor set” 
for loudness, analogous to the reduced limb movement associated with PD. It is also 
interesting that PD patients overestimated the speakers’ loudness as distance 
increased, thus raising the possibility that perceptual deficits played a role in their 
ability to set loudness for themselves. The same group (Ho et al 2001, 2002a) 
investigated intensity decay (the tendency of the voice to trail off) and found that 
patients with PD have consistently larger intensity decay than healthy speakers in 
sustained vowels and reading text. In a later study (Ho et al, 2002b) the same group 
found that PD patients had difficulty maintaining vocal intensity while performing a 
concurrent visual-motor task, which indicates that maintenance of vocal intensity 
requires greater attention for patients with PD. This implies that complex tasks may be 
more sensitive than others to the impaired motor control, either because they are less 
automatic or because they demand more attention. Rosen et al (2006) examined 
intensity decline (measured in dB/sec) across tasks, sustained phonation and syllable 
repetitions (termed “quasi-speech”) and isolated sentences and conversation (termed 
“speech”) in 20 medicated male patients with PD, and compared them to six healthy 
controls. The task that yielded the greater amount of intensity decay was the DDK 
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rates, and there were no differences between PD and controls in sentence and 
conversation tasks with regards to maintaining intensity. Thus they concluded that 
rapid intensity decline is not a robust feature of PD dysarthria, but they noted a large 
intersubject variability. They thus replicated previous results by Ho and colleagues of 
no significant difference in intensity decline between patients and controls. However 
the same group (Rosen et al, 2005) published the results from the acoustic analysis of 
conversational speech in 20 PD patients compared to 20 controls. They analysed 
speech-pause ratio, intensity variation, median and max formant slope, formant range 
and range of the spectral envelope. Their aim was to identify which measures were 
sensitive to PD speech. They defined acoustic contrastivity as the “degree of 
spectrotemporal variation in the acoustic signal of speech. The variability of acoustic 
characteristics, such as formants, intensity and spectral shapes contributes to our 
ability to produce distinguishable speech sounds (…) thus it is not surprising that 
reduced variation in prosody, resonances and spectral envelopes has been shown to be 
associated with perceived severity or reduced speech intelligibility” (p 396). They 
found that intensity variation and spectral range in both sentence repetition and 
conversational speech can consistently distinguish PD speech from normal control.  
In contrast to the reduced variability of F0 and intensity in connected speech, studies 
have shown that PD speakers tend to have abnormally large standard deviations (SD) of 
F0 in sustained vowel phonation and that this is correlated with perceptual judgements 
of dysphonia (Zwirner, 1991, 1992). Larson et al (1994) found abnormally high long-
term amplitude perturbation in two speakers with PD which they assigned to slow 
innervation fluctuations to laryngeal abductory and adductory muscles1
                                                 
1 Also high SD of F0  in our data was linked with dysphonia. 
. A promising 
new measure for capturing some of the abnormalities perceived in PD speech, 
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especially in connected speech, may lie in long-term average spectrum (LTAS) 
measures, which capture the shape of the distribution of energy in the acoustic 
spectrum. Dromey (2003) compared dysarthric speakers with PD to age-matched 
controls and found that LTAS measures distinguished the two groups on vowel 
prolongation, reading and monologue tasks, when other acoustic measures such as SPL 
level and variability of F0 did not. Duffy (2005, p 200) comments that this suggests that 
some of the prominent qualitative deficits perceived in PD speech may be more readily 
detectable by the spectrum of voice rather than the “simpler” measures of frequency and 
intensity variability. 
1.4.2.2 Voice quality and voice motor control 
There are few acoustic investigations of voice quality, mainly due to the inherent 
methodological difficulties of correlating perceptual and acoustical data (Bunton, 2007). 
Lehiste (1965) as reported in Duffy (1995, p 178) found spectrographic evidence of 
laryngealisation (slow or irregular vocal fold activity or biphasic phonation) and 
breathiness in parkinsonian speakers. Ludlow & Bassich (1984) found abnormal 
average amplitude perturbations (shimmer) that were correlated with perceptual 
measures of breathiness; they noted that this abnormality could be related to vocal fold 
bowing, with subsequent increased airflow turbulence and intensity variations. However 
Kent (1993) found that measures of jitter and shimmer fail to discriminate PD males 
from healthy males. He concluded that there would be reason to question the sensitivity 
of acoustic perturbation measures (such as jitter and shimmer) to voice function in 
dysarthria, at least for the general purposes of identifying abnormality and classifying 
clinical groups.  
The area that links perceptual and acoustical measures most is that of the onset and 
offset of voicing. Voice Onset Time (VOT) is defined as the duration of time from 
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articulatory release of a consonant to the onset of voicing of the following vowel 
(Goberman & Blomgren, 2006). So far, examination of VOT in PD speech as yielded 
varied results: there have been reports of increased VOT in PD patients compared to 
age-matched controls (Forrest et al 1989; Ozsancak et al, 1997) attributed to difficulties 
initiating movement, i.e. bradykinesia, at the level of the larynx (Forrest et al, 1989). 
Bunton & Weismer (2002) found no clear differences between PD patients and normal 
geriatric controls. And finally Flint et al (1992) and Weismer (1984) reported decreased 
VOT in PD speech, attributed to the rigidity of the laryngeal musculature causing a 
reduction in vocal fold opening. Recently, Goberman & Blomgren (2008) investigated 
the acoustical correlates of the perception of laryngeal tension at the initiation of 
voicing, or else the difficulty with offset of voicing before and after a voiceless 
consonant. They found that PD patients stop vocal fold vibration through vocal fold 
adduction (without adding tension). This tension was lowest for patients off-medication 
and highest for age-matched participants and patients on-medication. They assign this 
laryngeal tension to laryngeal rigidity in PD speech. In summary the VOT literature in 
PD speech shows deficits with the onset of voicing but the direction of this difference is 
still undetermined. This is perhaps illustrated by the fact that the same researcher made 
two opposing conclusions: Weismer (1984) showed a decrease in VOT and five years 
later an increase (Forrest et al, 1989). Goberman & Blomgren (2008) examined the 
VOT and voice offset times in nine PD patients on- and off-medication, compared to 
eight controls. They studied the phrase “one finds” by analyzing the F0 before and after 
the voiceless consonant. They found a great variability especially at the off-medication 
state, with patients overall having difficulty with rapid onset of voicing, not 
significantly improved with medication. They assigned these deficits in either 
articulatory (accuracy of phoneme production) or phonatory (tension and abduction of 
vocal folds) or aerodynamic (decrease airflow rate) variables in speech but not the result 
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of timing deficits. Apart from acoustical examination of voice onset and offset, a 
number of studies have examined similar measures physiologically. Gallena et al (2001) 
performed EMG analysis of laryngeal muscle activity during the offset and onset of 
voicing in PD patients. They found increased laryngeal muscle activity (i.e. tension), 
which was reduced with medication. Earlier, in a comprehensive telescopic 
cinelaryngoscopy study of 32 unselected patients, Hanson et al (1984) studied the 
laryngeal abnormalities of PD speech: of the 32 patients only two had normal voices 
and no voice complaints and were free of “abnormal phonatory posturing”. The 
remaining 30 patients exhibited vocal cord bowing during phonation, represented by a 
significant glottic gap. This increased glottic gap was correlated with perceived 
breathiness and reduced intensity (Figure 1.13). Tremulousness of the arytenoids 
cartilages was apparent during quiet breathing in some patients but the perception of 
voice tremor was more closely related to the secondary effects of head tremor. 
Laryngeal structure asymmetries were apparent in many patients, in terms of vocal fold 
length, degree of bowing and ventricular fold movements. The authors noted that the 
vocal folds appeared solid, in spite of bowing, in contrast to the hypotonicity that may 
be present in lower motor neuron paralysis. They concluded that the abnormalities in 
phonatory postures are related to muscle rigidity. Similarly Jiang et al (1999) used 
electroglottographic analysis and found that PD patients had increased laryngeal 
rigidity, improved with medication.    
1.4.3 Articulation and resonance 
Plowman-Price (2009) analysed the speech of 16 PD patients on- and off-medication 
and applied the 35 perceptual dimensions of Darley et al (1969). They found that 
reduced intelligibility was most strongly correlated with imprecise articulation (sound 
imprecision), followed by mono-loudness and mono-pitch.   
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Studies on articulation in PD speech can be grouped according to the methodology they 
use (acoustic analysis, EMG, microbeam, force transducer), the area of articulation 
motor control they investigate (muscle function, rate of movement with DDKs) or the 
articulatory organ they examine (tongue, lips, jaw). They provide support for the 
perception of imprecise articulation, rate abnormalities and the reduction in range of 
articulatory movement.  
Articulatory imprecision is usually termed articulatory “undershoot”. The failure to 
completely reach articulatory targets or sustain contacts for sufficient durations has the 
perceived effect of reduced acoustic contrast and detail, and it contributes to imprecise 
articulation (Weismer, 1984). This undershooting could be explained by reduced range 
of movement or rigidity.   
1.4.3.1 Lips 
Leanderson et al (1972) examined the articulatory EMG activity of lip muscles in 12 PD 
Swedish patients and compared with normal speakers and the effects of levodopa using 
needle electrodes (see also Leanderson (1971), where he describes the needle EMG 
method for the first time). He found increased resting activity between utterances, 
which progressed to a sustained hypertonic background activity. He found no signs of 
reciprocal inhibition of labial muscles when patients were off-medication. levodopa 
medication was followed by a reduction of background activity and reestablishment of 
reciprocal activation. He concluded that there was an obvious relationship between this 
disturbed activity pattern and misarticulation of bilabial consonants, as well as rigidity. 
These conclusions have been confirmed by Forrest et al (1989) and Hirose (1981), who 
used an X-ray microbeam system together with the EMG measures from the anterior 
digastric and mentalis muscles in two patients. Similarly, Caligiuri (1989 as reported in 
Goberman, 2002b, p 250) examined labial stiffness, displacement and velocity in five 
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PD patients. Recordings were made of the syllable /va/ before taking levodopa and at 
the beginning, half-way point and end of the drug cycle. The investigator found that PD 
patients showed increased labial stiffness, which decreased immediately after taking 
medication. Amplitude and velocity of labial movements also improved immediately 
after medication. Labial velocity and stiffness continued to improve throughout the drug 
cycle, while labial amplitude did not change. Caligiuri (1989) acknowledged a 
limitation to this study, in that the labial changes reported may not necessarily reflect on 
speech intelligibility. Netsell et al (1975) used the term acceleration and weakness to 
describe the underlying neuromuscular mechanisms responsible for the articulatory 
undershoot that they studied in 22 PD medicated patients using lip surface EMG 
aerodynamics and audio recordings. Hunker et al (1982) suggested that such persistent 
abnormal muscle contractions – reflecting difficulties with reciprocal adjustments of 
antagonistic muscles or a loss of reciprocal suppression between functionally 
antagonistic muscular pairs – may represent the physiological basis of rigidity and 
hypokinesia (see also Leanderson, 1972).  
1.4.3.2 Tongue 
In examining articulation in PD a number of researchers have reported that stop 
consonants (p,t,k,g,b,d) were imprecise and produced as fricatives (Logemann, 1981; 
Weismer, 1984). Logemann (1978) studied the frequency and co-occurrence of speech 
deficits in 200 medicated patients with PD and reported that five main groups of 
misarticulations: 45% of patients presented with laryngeal dysfunction as their only 
vocal tract symptom, 13.5% presented with laryngeal and back of the tongue 
involvement (k,g sounds), 17% of patients presented with laryngeal, back tongue and 
tongue blade dysfunction (k,g,s,z), 5.5% presented with additional lip involvement and 
finally 9% presented with additional tongue tip involvement. This consistent pattern 
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was interpreted as a result of the incomplete contact of the articulators, i.e. an 
articulatory undershoot phenomenon. Tongue muscle weakness has rarely been detected 
during neurologic examination of people with PD (Yanagawa et al, 1990). Solomon et 
al (2000) examined tongue strength endurance and stability during a sustained 
submaximal effort using a pressure transducer that senses pressure exerted on an air-
filled bulb. Patients were asked to talk for 10 minutes and then the effortful tongue 
endurance tasks were performed. Tongue endurance was found to be significantly lower 
in the PD patients rather than the controls. However there was no significant correlation 
between tongue strength and endurance, interpause speech rate, articulatory precision 
and overall speech impairment. They thus question the influence of modest degrees of 
tongue weakness and fatigue on perceptual speech deficits. Ackermann & Zeigler 
(1991) compared the intensity of stop consonant production in 12 PD patients and they 
found that whereas normal speakers showed a decreased intensity at the moment of stop 
closure (i.e. oral closure) the PD patients did not show any decrease in intensity, 
therefore complete closure may not have been achieved. This may be another example 
of reduced amplitude of articulatory movement leading to an inability to close off the 
oral cavity.  
Rate is the other area that has received a lot of attention due to the increased rate often 
perceived in PD speech. It can be measured as words per minute (with normal of 180 
wpm, Yorkston, 1981) or syllables per second. Canter et al (1967) showed a great 
variability across patients ranging from abnormally slow to abnormally fast. Another 
method of evaluating articulatory skills and rate in particular is the oral diadochokinetic 
tasks (DDK), i.e. the production of syllable trains containing consonant-vowel 
combinations with bilabial, alveolar and velar places of articulation 
/papapa/tatata/kakaka/ following the instruction “repeat the syllables…as fast as 
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possible in a single breath”. They are used to examine the patient’s ability to make 
rapidly alternating articulatory movements. Patients with cerebellar atrophy, 
Friedreich’s ataxia, spastic dysarthria or Huntington’s chorea show decreased syllabic 
rates (Ludlow et al, 1987; Ackermann et al, 1995a). In contrast the performance of most 
PD patients is similar to the normal subjects (Ackermann, 1991, 1997). The explanation 
of this phenomenon is that PD patients may produce normal syllabic movements at the 
expense of movement amplitude (Ackermann et al, 1997). Hence Caligiuri (1989) 
compared sequences of repetitions of the syllable /va/ at 3 to 5 Hz and at 5 to 7 Hz and 
found hypokinesia, i.e. reduced range of movement with faster oral diadochokinesis in 
the PD patients. Ackermann et al (1995b) reported similar results for 17 patients, who 
used articulatory undershoot to successfully compensate for bradykinesia; however the 
more severe patients were unable to fully compensate and produced abnormally slow 
speech. This trade off between tempo and articulatory precision is made possible by the 
fact that reduced articulatory precision may still be compatible with the requirements 
for intelligible speech. In this respect speech is different from other motor acts like 
grasping or finger tapping where a similar trade off cannot be made without 
compromising the requirements of the task.  
1.4.4 Speech intelligibility and people with PD 
Speech intelligibility is of paramount concern in both the evaluation and management of 
dysarthria. The definition of speech intelligibility for this study is “the degree to which a 
speaker’s message can be recovered by the listener” (Kent et al, 1989, p 483). Current 
clinical methods for measuring speech intelligibility reflect the interaction between a 
speaker and a listener under given communication conditions. Factors that can influence 
intelligibility measures include: a) severity of the intelligibility impairment (Yorkston & 
Beukelman, 1978b), b) speech rate (Yorkston & Beukelman, 1981; Canter, 1965c), c) 
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type of speech stimulus, d) scoring method (Beukelman & Yorkston, 1980), e) 
predictability of stimuli (Duffy & Giolas, 1974), f) listener familiarity with the speech 
disorder and/or individual speaker (Beukelman & Yorkston, 1980; Platt et al, 1980). 
Studies of clear versus conversational style speech offer insight into speech production 
changes that speakers make when asked to produce speech clearly. Specifically, clear 
speech was characterised by decreased articulation rates and increased frequency and 
length of pauses (Bradlow et al, 2003; Goberman, 2005; Canter, 1969). Bradlow (2003) 
compared speakers who differed in intelligibility and found that a highly intelligible 
speaker would have a relatively wide range of fundamental frequency, a relatively 
expanded vowel space, precise articulation of the point vowels (/i/ /a/ /u/) and high 
precision in intersegmental timing. Dysarthric speech analysis of the relative 
contribution of speech subsystems (voice, quality, articulation, nasality and prosody) 
showed that articulation was the strongest contributor on speech intelligibility (DeBodt 
et al, 2002). Barreto & Ortiz (2009) reviewed the methods of measuring speech 
intelligibility. Because speech intelligibility is defined as the amount of speech 
understood from the acoustic signal alone, most current clinical measurement tools for 
speech intelligibility allow listeners access to only signal-dependent information. The 
most common measurement protocol for intelligibility involves audiotape-recording the 
speaker and then asking the listener to transcribe words and or sentences (Tikofsky & 
Tikofsky 1964; Yorkston & Beukelman, 1980). The resultant intelligibility score is the 
percentage of words correctly transcribed or selected. Information other than that 
provided by the acoustic signal is referred to as signal-independent. Hustad et al (2003) 
have described three types of communicative knowledge that may be used by listeners 
to decode a spoken message. They include: a) linguistic knowledge, which defines a 
listener’s expectations for semantics, syntax and phonology, b) paralinguistic 
knowledge, such as that related to gestures, facial expression and speech related 
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movements, and c) experiential knowledge, which refers to shared knowledge of culture 
and experiences between the listener and the speaker. Keintz et al (2007) investigated 
the influence of visual information on speech intelligibility for eight PD patients with 
dysarthria. Twenty listeners transcribed sentences while watching and listening to 
videotapes of the speakers (audio-visual mode) and while only listening to the speakers 
(auditory-only mode). They found that auditory-visual scores were significantly higher 
than auditory-only scores for three speakers with the lowest intelligibility scores. Kent 
et al (1994) have suggested that each speaker has a range of potential intelligibility that 
is influenced by factors related to the speaker, the listener and the conditions in which 
communication takes place. They suggested that given that visual cues are commonly 
available to listeners in most everyday situations, it may be appropriate to include visual 
information when evaluating a patient’s intelligibility and when managing a 
communication disorder.  
Goberman (2005) studied the strategies patients with PD use when they are instructed to 
use clear speech (i.e. “to speak as clearly as possible”) compared to conversational 
speech (i.e. “to speak in a manner similar to ordinary conversation”). They found that 
people with PD use the same strategies as non-impaired speakers, namely decreased 
articulation rate, increased mean fundamental frequency, and increased speaking F0 SD 
compared to conversational speech. However they doubt how much these strategies 
could be generalised outside the clinical setting.  
The strategy of rate manipulation (i.e. speaking at a slower or faster rate) has been 
further tested. Tjaden & Wilding (2004) compared the effects of rate and loudness 
manipulations on speech intelligibility of 12 people with PD. Ten listeners scaled 
intelligibility for reading passages. Intelligibility for people with PD improved with the 
loud condition as opposed to the slow condition. Rate manipulation and its effects on 
 70 
speech intelligibility were studied earlier by Hammen et al, (1994). They examined the 
difference between paced temporal alteration, i.e. the slowing down of speech rate by 
60%, and synthetically altered speech, i.e. modifying the rate of speech samples using 
digital signal processing, in six PD patients. They found that the greater impact on 
speech intelligibility was achieved with the paced alteration, i.e. slowing down the 
habitual speaking rate, rather than synthetically altered speech rate. Loudness 
manipulations have been used more successfully to improve speech intelligibility in 
people with PD, hence the success of treatments based on increase loudness, such as the 
Lee Silverman Voice Treatment (LSVT, Ramig et al, 2001). Dromey & Ramig (1998) 
found that for talkers with normal speech, loud speech is characterised by greater 
displacement and velocity of jaw and lip movements than normal speech. Physiological 
changes associated with people with PD using loud speech include increased tongue 
strength and endurance, increased lip displacement and velocity (Dromey, 2000), and 
greater stability of lip movement patterns (Kleinow et al, 2001). Acoustic changes such 
as increases in vowel duration, decreased in fricative duration and increased in formant 
transition duration and extent (Dromey et al, 1998), increased in vowel space area 
(Bunton, 2006; Sapir et al, 2007) and reduced rate of speech with increased 
distinctiveness between stop consonants (Tjaden & Wilding, 2004) have also been 
described. Recently Neel (2009) examined the effects of loud speech and amplification 
on people with PD and found that loud speech resulted in greater intelligibility 
improvement than amplification, mainly due to phonatory changes (as measured by 
improvements in fundamental frequency and spectral tilt) and not so much articulatory 
ones (measured as articulatory rate and pause time). In terms of amplification, Neel 
(2009) findings agreed with the scarce evidence regarding their efficacy for people with 
PD. Sarno (1968) was the first to observe that amplification may improve 
communication for “occasional cases” of speakers with PD, but that in her experience 
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amplification “exaggerates” the dysarthria. Equally Greene & Watson (1968) reported 
their clinical experience that benefit is gained from amplification only when reduced 
vocal volume is the only symptom present, but there is no benefit when the speaker has 
slurred articulation. Adams (1997) commented that despite widespread use of voice 
amplification for people with PD little data is available on their effectiveness.  The 
prevalence of speech intelligibility problems in the parkinsonian population has been 
estimated at 70-90% in five studies that used various methodologies. The most recent 
one is by Miller (2007) and it is the only one using a diagnostic test (the Assessment of 
Intelligibility of the Dysarthric Speaker, AIDS, Yorkston et al, 1984) in a large sample 
(N=125) of PD patients off-medication with controls and 99 naïve listeners. They found 
that 70% of people with PD fell below the control mean of unaffected speakers, of 
which 51% by more than one standard deviation. Thirty-eight percent placed speech 
changes amongst their top four concerns regarding their PD. Intelligibility level did not 
correlate significantly with age or disease duration and only weakly with stage and 
severity of PD. They found no significant differences between tremor dominant versus 
balance/gait disorder motor phenotypes of PD. Previous surveys gave similar estimates 
of speech and voice problems in PD. Logemann et al, (1978) was the first to assess 200 
PD patients by two expert listeners listening to tapes of their conversational speech and 
reading samples. By examining the co-occurrence of speech deficit a progression of 
impairment was hypothesised beginning with voice followed by articulation, 
progressing from posterior tongue involvement to lip involvement. Ho et al (1998) 
replicated the study and had similar findings. Hartelius (1994) surveyed a large sample 
of patients with PD and Multiple Sclerosis (MS) and found that 70% of PD patients had 
experienced impairment of speech and voice after the onset of the disease (compared to 
40% of people with MS) and 41% had some swallowing problems. Of those affected 
patients only 3% had received some form of speech therapy. Coates & Bakheit (1997) 
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assessed 48 patients using a modified version of the AIDS, rated by a single Speech and 
Language Therapist (SLT). They found that two-thirds of patients had reduced speech 
intelligibility. They also examined the impact on their lifestyle and they found that none 
of the patients reported that their speech difficulties interfered with their lives. This 
study was later criticised for its methodology.  
The issue of the impact of reduced intelligibility on the lives of people with PD has 
occupied relatively few studies. Miller et al (2006) performed a qualitative study with 
interviews of 37 people with PD and four impact themes emerged: i) interaction with 
others, ii) problems with conversations, iii) feelings about intelligibility and iv) voice. 
They also identified four corresponding coping themes a) helping others understand,  
b) managing conversations, c) monitoring and adjusting and d) physical changes. Of 
interest is the passive approach that people with PD adopt when they need to manage 
conversations, i.e. not speaking unless directly addressed. When it comes to hospital 
care or other vital communication people with PD ask their relatives to be present:  
“I don’t speak unless I have to as I’m frightened I don’t get my words out, and if I go to 
the hospital my wife comes and does all the talking”. In conclusion speech and language 
changes in PD impact upon individual and family life long before frank impairment on 
intelligibility is apparent.  
The same group (Walshe et al, 2008) tried to compare speaker and listener reception of 
the intelligibility of dysarthric speech and in particular to examine the relationship 
between speaker perceptions of intelligibility and formal clinical intelligibility ratings. 
They compared the intelligibility ratings between 20 people with dysarthria, 10 SLTs 
and 20 naïve listeners and found no significant difference between the three listener 
groups. They also compared the ratings of patients’ own speech compared to those of 
the SLTs and the naïve listeners and they found no relationship between the two. 
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1.4.5 Prosody 
According to Pell et al (2006) prosody refers to an equilibrium between temporal 
(duration, pause) dynamic (intensity) and melodic aspects (pitch) of speech.  
A combination of these features allows speakers to communicate their emotions and 
attitudes to listeners. Disturbances in the rate of speech, pitch variation and intensity in 
PD patients may alter listeners’ perceptions of the social and linguistic competence of 
the speaker with PD in a negative manner (McNamara & Durso, 2003). Listeners judge 
people with PD to be more “cold, anxious, unhappy and less likeable” than healthy 
adults, based on impressions from their speaking voices (Pitcairn et al, 1990). Thus 
prosody is the intersection between the acoustic and the perceptual aspects of speech. 
Acoustic analysis of intensity and pitch variation, speech rate and speech intelligibility 
may be used towards characterising prosodic aspects of speech. Skodda (2009) 
investigated the progression of dysprosody in 50 patients with PD over at least seven 
months (mean 25 months) using syllable rate, pause rate, frequency variation. They 
found no correlation between these prosodic aspects of speech and disease duration or 
UPDRS motor score. In a previous study (Skodda, 2008) the same group calculated the 
speech rate and pause time in 121 patients with PD and compared that to 70 healthy 
controls. They found no significant difference in overall articulatory rate, but the PD 
patients had higher speech acceleration at the end of the sentence than did the controls.  
De Letter et al (2007) investigated the effects of levodopa on prosody and 
comprehensibility in 10 PD patients, using non-instrumental, perceptual rating of the 
speech samples by four speech and language therapists. They used a 100 mm, 10 point 
scale on four aspects of speech production: variations in pitch, variations in loudness, 
variations in reading rate and comprehensibility. They found a significant improvement 
in pitch variation, loudness variation and comprehensibility. However Goberman et al 
(2005) found no significant changes in pitch variation after levodopa intake, possibly 
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due to the different methodology and stage of disease. Prosody was rated as the most 
severely affected speech subsystem in Darley’s et al (1969) seminal investigations.  
In those studies three raters performed perceptual assessments of speech of 212 
neurologically impaired patients as they read the “Grandfather Passage”. They used a 36 
speech dimensions and two general dimensions (intelligibility and bizarreness) using a 
seven-point scale. The classification of hypokinetic dysarthria of the 32 PD patients was 
based on the monotony of pitch and loudness, reduced stress and imprecise consonants 
speech dimensions.  
These results were recently replicated by Plowman-Prine et al (2009) with the same 
methodology in 16 PD patients on- and off-medication. They found monopitch, 
monoloudness, reduced stress and imprecise consonants to be the most prominent 
speech dimension. Neither intelligibility nor the affected speech dimensions changed 
significantly with medication, as opposed to the significant improvement in the motor 
scores.    
Perhaps most eloquently Kent & Rosenbeck (1982) have provided a useful summary of 
the acoustic “signature” of hypokinetic dysarthria. They labelled the pattern in which 
the contour across syllables within utterances is flattened or indistinct as fused. This 
fused or altered profile is characterised by 1) small and gradual F0 and intensity 
variations within and between syllables, 2) continuous voicing, 3) reduced variations in 
syllable durations, 4) syllable reduction, 5) indistinct boundaries between syllables 
because of faulty consonant articulation and 6) spread of nasalization across consecutive 
syllables. In summary these features represent a reduced ability to use the full range of 
pitch, intensity, articulatory and durational options that are used in normal speakers.    
Mobes et al (2008) conducted an interesting study on emotional speech in PD using 
prosodic measures of pitch and intensity variation. They compared 16 PD patients and 
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16 healthy controls in the following tasks: 1. intensity and pitch range (max and min 
values of loudness and fundamental frequency) of non-emotional speech (phonatory 
capacity), 2. intensity and pitch range when saying “Anna” in emotional intonation 
(neutral, sad and happy), and 3. intensity and pitch range when imitating a professional 
speaker. They found no differences in the phonation capacity and the imitation task 
between groups, but a significantly reduced pitch and intensity range in the production 
task. These patients had mild motor symptoms as measured by the UPDRS and no 
dysarthria. They interpreted these results as a result of a difficulty in emotional 
processing but they did not provide further arguments. The inability to internally self-
cue a behaviour has also been postulated.  
1.4.5.1 Perception of emotional prosody  
Scott and colleagues (1984) were among the first to investigate the perception of 
emotional prosody in PD, an area that has received scant interest. They reported that  
PD patients were able to discriminate sentences with non-emotional prosodic contrast 
(e.g. I can run, versus I can run) but were impaired in judging the meaning and certain 
emotional features of those sentences (similar results from Pell et al (1996). There may 
be at least two confounding factors when analyzing emotional processing either through 
recognition of facial expression or prosody: the effect of higher cognitive processes in 
the comprehension of emotional aspects of speech has been shown by Benke et al 
(1998). Depression is another factor that could be implicated as a confounding variable. 
However there is increasing evidence that emotional processing of both facial 
expression and prosody can be affected in PD. In 1998 Breitenstein et al published their 
data on the emotional perception of 32 patients with focal cortical lesions and 14 
patients with PD. They found that only patients with advanced PD and those with focal 
damage to the right frontal lobe differed significantly from controls in both facial 
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expression and affective prosody recognition. They thus conclude that there is an 
involvement of the fronto-striatal circuitry in emotional processing. Velez et al, (2008) 
found that PD patients with depression had heightened perception of negative emotions 
(indifference and anger). Contrarily, recently Dara et al (2008) found the opposite i.e. 
reduced sensitivity to negative emotions. They compared 16 non-demented PD patients 
to 17 healthy controls and they found that the PD group was significantly impaired in 
categorizing emotional prosody, especially for expressions of anger, disgust and fear. 
Similarly Ariatti et al (2008) used the Facial Emotion Recognition Battery and the 
Emotional Prosody Recognition Battery and they found that PD patients (n=27) had 
significant impairment in selecting, recognising and matching facial effects, in 
particular sad and fearful faces. Bach (2008) using fMRI found activation of the basal 
ganglia and the right anterior cingulated cortex in response to explicit processing of 
emotional versus neutral sentences. Additionally, Paulmann (2008) found impaired 
explicit recognition of emotional processing in a group of patients with focal basal 
ganglia lesions. In 1998 Scott et al presented a case study of a lady with lesion confined 
to the amygdala complex through stereotactic neurosurgery for her epilepsy. She had 
severely affected recognition of fear and sadness despite normal hearing. These studies 
argue that basal ganglia provide a critical mechanism for reinforcing the behavioural 
significance of prosodic/emotional aspects of speech. However the above observations 
have not been tested clinically: indeed Yoshimura et al (2005) conclude that 
“corticostriatal connections may be variably affected by a lack of dopamine or by 
pathological changes in the amygdala, but somatosensory recruitment may overcome 
the mild cognitive emotional deficits that may be present in PD patients”. 
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1.4.6 Correlation of speech with motor symptoms 
Speech response to medical and surgical treatments in PD rarely follows the pattern of 
improvement of the other limb motor symptoms (Pinto et al, 2004), despite the fact that 
speech is affected in the majority of PD patients at some stage of the disease process 
(Logemann, 1978). This has led investigators to examine the pattern of change of motor 
and speech symptoms and assign the latter to non-dopaminergic basal ganglia lesions. 
Midi et al (2008) evaluated the changes in perceptual and acoustic parameters of voice 
in patients with PD and the relationship with UPDRS motor score. They found only few 
significant correlations between UPDRS subcomponents and speech measures, mainly 
with diadochokinetic (DDK) tasks: they found no association between finger tapping 
DDK rate as well as a negative correlation between DDK and rigidity, indicating a 
lower speech DDK rate with increased severity of rigidity. Goberman (2005) studied 
nine PD patients and Gamboa (1997) 41 patients and found the same lack of association 
between speech and motor symptoms (see also Plowman-Prine, 2009, as cited above). 
On the other hand, Sapir et al (2001) found a positive correlation between higher 
UPDRS scores (i.e. worse motor functioning) and disease duration with voice and 
speech abnormalities in 42 PD patients. These voice abnormalities did not correlate with 
age, depression or gender.  
Another interesting motor area is that of festination and freezing of gait, i.e. the 
tendency to speed up and lose normal amplitude during quick, repetitive movements 
(gait, speech and tapping). Gait festination was described as a propensity to lean 
forward while taking rapid small steps whereas freezing of gait refers to sudden motor 
block. Moreau et al (2007) correlated oral festination with gait and freezing in 40 
patients recruited according to their gait disorder, off-medication. They used an 
orofacial DDK task the repetition of the syllable /pa/ at different frequencies (from 1 to 
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7.5 Hz) and patients were asked to synchronise their performance with a metronome. 
Jaw movements were recorded using an optoelectronic movement analysis system.  
They found a high correlation between oral festination and gait but not freezing. Oral 
festination was not correlated with the severity of dysarthria and it was present in 45% 
of their sample.  
A task similar to speech, in terms of linguistic expression, can be handwriting with a 
typical symptom of micrographia in PD. Micrographia resembles hypokinetic speech in 
that small movement excursions compensate for the inability to execute high velocity 
strokes (Ackermann, 1991). Poluha et al (1998) examined the effects of medication on 
handwriting and speech in 10 PD patients. The handwriting measures include /l/ and /e/ 
upstroke duration and size, whereas the speech measures included duration of the 
vowels /i/, /u/, /ae/ and /o/. Levodopa improved significantly handwriting upstroke 
duration but not size. Speech measures did not show any significant change across 
levodopa cycle.  
Perhaps the most interesting comparative study of motor effects of PD on speech and 
movement is that of the finger spelling of deaf signers with Parkinson’s disease. Since 
movements of the articulators in sign, unlike speech, are directly observable, one can 
investigate signing not only as a linguistic behaviour but also as a motor behaviour. 
Brentari et al (1995) contrasted aphasic and parkinsonian signing and found the 
equivalent of a phonetic impairment in the PD signers manifested as a disturbance in the 
temporal organisation and coordination of hand shape and movement, with no 
disruption in the underlying representation and syllabification processes of the language 
as in the aphasic signers. They also describe the equivalent of monotone speech, in the 
lack of difference between hand shape changes that occur as syllable peaks and those 
that occur during the transitional movements between signs. The underlying strategy is 
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that of lessened motor programming load. It is also in accordance with earlier results 
from Benecke et al (1987) who showed that PD patients exhibit a longer inter-onset 
latency for preparation of the second of the three movements within a sequence.  
Tyrone and colleagues (1999) examined the production of the ASL finger spelling, a 
more sequential and rapid motor behaviour than signing, with a linguistic structure. 
They found that signers with PD showed segmentation of individual segments of finger 
spelling sequence (holding them for longer), blended adjacent segments into a single 
segment (sequential blending). The movements for the independent articulators for 
finger spelling (thumb, fingers and wrist) were markedly further apart in time and they 
had fewer wrist movements. They assigned these deficits to lack of interarticulator 
coordinator. One could however argue that they are merely symptoms of bradykinesia 
and rigidity. The similarities of parkinsonian signing and speaking point towards a 
common underlying neural deficit affecting all movement of articulators which is not 
confined to the oral area. There are no imaging studies on deaf signers with PD. If sign 
language stands at the intersection of how the brain controls arm/hand movement and 
how it controls language expression, then the interest would be in investigating the 
effect of stimulation on non-linguistic hand movement (i.e. joystick) and linguistic hand 
movement (signing) and speech. That could elucidate the role of basal ganglia and 
perhaps point to an oromotor speech specific neural network.    
1.4.7 Patient perceptions and complaints 
Patients with PD frequently report that others tell them that their voice is quiet or weak, 
and they often deny or minimize such changes themselves (Duffy, 2005). Complaints 
that rate is too fast or that words are indistinct are common. They also report that it can 
be hard to get speech started and that they have hesitations or stutter.  
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Patients’ perception of their speech problems is directly linked to sensory processing of 
their own speech, and particularly their speech volume. Fox et al (1997) showed that PD 
patients were able to rate their speech and volume more severely impaired than healthy 
controls. In other studies though, specifically focusing on volume, patients consistently 
perceived their speech when reading and in conversation to be louder than the actual 
volume (Ho et al, 2000). This suggests that the voice disorder experienced by PD 
patients may be compounded by an impaired perception of its true characteristics. There 
have been two types of cueing the implicit and explicit. Ho et al (1999) investigated the 
effect of implicit cueing for loudness using background noise (“the Lombard effect”) as 
well as the provision of instantaneous auditory feedback at various intensities (the 
reverse “Lombard effect”). They found that PD patients had overall reduced intensity 
and reduced ability to modulate their volume using implicit cueing. Under explicit 
instructions to increase their volume they were able to do so but they were still below 
the control levels. This difficulty in maintaining the amplitude of movement without 
constant explicit cueing had been investigated in the early 1980s with the provision  
of a portable auditory feedback device. Thus Rubow et al (1985) published their 
“microcomputer-based wearable biofeedback device to improve transfer of treatment in 
parkinsonian dysarthria” which gave visual feedback on intensity following treatment. 
There was little further research in the technology in this biofeedback area, despite the 
promising results and the sound scientific argument. There has been more interest in 
Delayed Auditory Feedback (DAF) devices mainly for palilalia (or festinating speech). 
This technique is not equally effective on all patients and it is still unclear who can be 
helped (Downie et al, 1981). 
However, despite the difficulty in self-perception of speech loudness, patients with PD 
seem to have intact perception of the communication and speech intelligibility changes 
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associated with PD (Miller, 2008, 2006) when this is compared to their carers’ 
perception. 
1.4.8 Neural control of speech in Parkinson’s disease  
There are four published studies of functional imaging and the neural correlates of 
parkinsonian speech. Pinto and colleagues (2004) used H2 15O PET to measure the 
effects of subthalamic nucleus (STN) stimulation on speech production and silent 
articulation of one sentence. Patients when on- and off-stimulation showed lack of 
involvement of the right orofacial primary motor area (M1) and the cerebellum, and 
increased regional cerebral blood flow (rCBF) in the SMA, dorsolateral prefrontal 
cortex (DLPFC), right superior premotor and left insula. Stimulation normalised the 
pattern of rCBF to that of the healthy controls, mainly for the M1, the SMA and the 
cerebellum, concurrently with improvement in speech.  
Liotti and colleagues (2003) used the same PET technique and both paragraph reading 
and sustained phonation tasks to investigate the effects of a speech treatment, the Lee 
Silverman Voice Treatment (LSVT) on PD patients with medication on. Results showed 
an increase in rCBF post LSVT compared to pre-LSVT in the right caudate, right 
putamen, right anterior insula and right DLPFC in the phonation and reading tasks.  
In contrast there were CBF decreases in all motor and pre-motor areas, including right 
orofacial M1, SMA and left Broca’s area. The response in the primary motor cortex and 
cerebellum appears variable with both decreases (Pinto et al, 2004) and increases (Liotti 
et al, 2003) reported. The authors of these studies interpreted these findings as pre-
treatment abnormalities. Another difference is the abnormal hyperactivity in bilateral 
DLPFC during speech tasks that was reversed following STN-DBS (Pinto et al, 2004). 
They concluded that the combined hyperactivity of the DLPFC and the rostral SMA is a 
compensatory phenomenon due to the disease process, which becomes normalized with 
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STN-DBS. In the Liotti study the opposite was observed: hyperactivity of the DLPFC 
was noted only post-treatment. Therefore the authors concluded that activation of 
DLPFC post LSVT-LOUD undergoes normalisation similar to the limb motor system in 
PD, due to the re-establishment of the basal ganglia-thalamic inputs to the prefrontal 
cortex. However DLPFC activation is not observed during speech in normal controls2
Rektorova et al (2007) used fMRI to assess the response to the overt reading of 
emotionally neutral sentences in medically treated female patients (N=9) with mild to 
moderate PD and compared them to eight age and sex matched healthy controls. They 
found increased activity in the left orofacial sensorimotor cortex (SM1), which was 
involved in all aspects of speech (including initiation, duration, speech loudness and 
prosody)
. 
Thus the only common area in the two studies was the increased activation of the SMA 
when patients are without medical or surgical treatment or before behavioural treatment 
and the increase in the right orofacial sensorimotor cortex (SM1) after the STN 
stimulation and when reading in patients before LSVT, on-medication. The differences 
in medication status and disease-speech severity should be considered when interpreting 
these findings. 
3
                                                 
2 A challenging hypothesis would be: DLPFC activation is used as a compensatory 
strategy for speech in PD patients. STN-DBS reduces the need for DLPFC activation 
only in patients where speech is improved by stimulation. LSVT increases activation as 
it improves speech. So there is a competing activation of the DLPFC when it comes to 
speech post STN-DBS and LSVT. 
. However between group analysis revealed higher signal in the right orofacial 
SM1 for the PD patients. They speculated that this might be a compensatory strategy for 
the impaired recruitment of subcortical structures or indeed the result of medical 
treatment, as it contradicts earlier finding by Pinto et al (2004) on decreased right SM1 
activity in PD patients when off-medication and off-stimulation. 
3 See also Dias et al (2006): one session of high frequency rTMS in the left orofacial 
SM1 may lead to improvement of fundamental frequency and voice intensity in PD 
patients. 
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It is of note that the quality of speech of their sample is described as similar to that of 
the control group (i.e. very mild dysarthria). In the above studies the observed 
activations during PD speech do not parallel the activation associated during hand 
movements: Haslinger et al (2001) reported increased SM1 overactivity in advanced PD 
patients when off-medication while studying simple or complex motor tasks. 
Sachin et al (2008) studied 22 PD patients off-medication using fMRI and compared the 
results with 18 PSP patients and 10 healthy controls. They found PD patients to have 
the least consistency of activated areas. They found increased activation in the SMA  
(as in Pinto et al, 2004) and in the pre frontal cortex, namely the DLPFC and the insula 
(as in Pinto 2004 and Narayana 2009, see below).  
In a case study, Narayana et al (2009) used PET to investigate changes in neural 
activation during paragraph reading in a medicated PD patient with speech deterioration 
following bilateral STN-DBS. They compared activation and speech effects of left and 
right stimulation alone. They concluded that speech production was worst during left 
STN stimulation compared to no stimulation. This was accompanied with increased 
activity in the left dorsal premotor cortex (PMd). Then they used rTMS to “lesion” the 
PMd with patient off stimulation and they observed perceptually similar speech, 
characterized by decreased speech intelligibility. Activation of the PMd in normal 
speech has been reported before (Schultz et al, 2005), as well as in stuttering (Brown et 
al, 2005). Lesion studies indicate that PMd is important for speech programming 
(Watkins & Dronkers, 2002). In contrast studies on limb motor control and STN-DBS 
report decrease of activation in the left PMd when DBS is on (Haslinger, 2005). Pinto et 
al reported abnormal activation in PMd during speech, normalised with STN-DBS. In 
Narayana (2009) speech disruption seen during STN-DBS as well as TMS on the PMd 
was interpreted as a “direct result of disynchronisation of ongoing activity in the left 
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PMd” (p 158). Aravamathun et al (2007) used MR tractography to map the connections 
between STN and cortex. They found that STN regions connected to the cortex (i.e. 
motor cortex, SMA, PMd) are located in close proximity and are more lateral and 
anterior to the STN regions connected to the thalamus and basal ganglia. Thus motor 
cortical regions (M1, SMA and PMd) all connect to the most superior portion of the 
STN while associative regions are connected to the inferior and medial portions of the 
STN, as in the STN topography of non-human primates (Hamani, 2004). The STN 
regions connected to the GP, midcerebellum, SN, and PPN were located in the inferior 
and medial STN. However the STN region connected to the thalamus was distinctly 
segregated, located superior and posterior to the STN regions connected to other 
subcortical regions. Therefore DBS can directly stimulate areas in the STN connected to 
the premotor cortices and the primary hand, limb and trunk areas. So while improving 
motor function by “lesioning” the connections of the STN to the motor cortex, DBS 
might incidentally “lesion” its connections to the premotor area, needed for speech. This 
could also explain the variability in speech response seen in STN-DBS patients.   
1.4.9 Effects of medication on speech in PD 
Initial reports on the effects of levodopa on speech noted the less dramatic effect than 
on physical symptoms. Rigrodsky & Morrison (1970) first examined the effects of 
optimum dose levodopa on reading and spontaneous speaking in consecutive patients 
and in a double-blind fashion. They found no significant difference but a trend towards 
improvement during levodopa therapy with a considerable individual variation. They 
pointed out the need for a more long-term study with appropriate tasks. Interestingly 
Mawdsley & Gamsu (1971) found the opposite, i.e. that speech of six patients became 
more intelligible after treatment with levodopa. They also noted that “there is a 
suggestion that needs further study, that in those patients with the postencephalic 
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disease and in those who have undergone stereotactic thalamotomy, levodopa is less 
effective in improving speech” (p 316). They followed on from that to propose a 
hypothesis on the relative contribution of the malfunction of the striatum, which leads to 
reduced kinesthetic information from the speech organs and consequently to what is 
perceived as prolonged phonation. “Restoration of the inhibitory striatal action by 
activation of dopaminergic neurons restores a more rapid selection of the cues for the 
next stage of motor activation thus shortening the phonation time of individual words 
and lengthening the pauses” (p 316). Marsden & Parkes (1976) observed the co-
occurrence of peak-dose akinesia with dysphonia, and without tremor or rigidity. 
Subsequently, Critchley (1976) in a letter to the Lancet describes his experience of a 
similar discrepancy between motor improvement and speech deterioration without 
dyskinesias. Leandersen et al (1971, 1972) demonstrated through EMG of the lips that 
coordination of labio-oral musculature improved with levodopa. Similarly, in a double-
blind study by Nakano et al (1973) parkinsonian patients treated with levodopa showed 
a significant improvement in movement and coordination of labial muscles. Logemann 
(1973, as reported in Wolfe et al, 1975), had commented that although near normal 
motor state can be achieved through levodopa therapy, speech may not be helped. 
Wolfe et al (1975) found that out of 17 patients nine achieved minimal or poor 
improvement, with only two patients showing 50% or more improvement. They also 
found that age and duration of the disease did not reliably predict the speech response 
result replicated recently by Sapir et al (2001) and Skodda et al (2008). This variability 
in response has since been documented in all levels of speech motor control and overall 
speech intelligibility. Perhaps the area where medication has more beneficial effect is 
that of lip movement (Leanderson, 1971, 1972; Nakano, 1973; Caligiuri, 1989). At the 
laryngeal level, levodopa can have a beneficial effect (Mawdsley, 1971; Jiang et al, 
1999; Sanabria, 2001; Galena, 2001; Goberman, 2002). Larson et al (1994) conducted 
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the most detailed recording study on two patients with drug-related dyskinesias. They 
recorded voice and EGG signal during two full-day sessions one week apart. During 
each day, data were collected every hour for 10 consecutive hours. They found no 
systematic and consistent relationship between drug cycle fluctuations and phonatory 
measures.  
Recently Plowman-Prine (2009) examined drug related fluctuations in speech using the 
Darley et al (1972) scale (henceforth “DAB scale”) and found no significant differences 
in any speech dimension, despite beneficial effect on movement. De Letter et al (2007a-
Clin Neurology and Neurosurgery, and 2007b- Clinical Linguistics and Phonetics) 
examined the effect of levodopa on respiration (thoracic mobility) and word 
intelligibility as well as prosody in 10 patients with advanced PD. They found 
medication results in improvement of thoracic mobility but not normalisation and 
improvement in intelligibility not correlated to the respiratory change. They also found 
improvement of variability in pitch and loudness after medication intake, which had a 
beneficial effect on comprehensibility as scored by four SLTs. 
Studies on the effects of apomorphine on speech are limited (Kompoliti, 2000) and they 
showed that although non-speech motor functions may improve overall speech 
intelligibility doesn’t. It is thus apparent that the effects of medication on speech are not 
as dramatic as those on movement, despite the symptomatology of tremor, rigidity and 
akinesia that seemingly affects the oral musculature and the possible alleviation of these 
symptoms by medical treatment.  
  
 87 
1.4.10 Effects of deep brain stimulation on speech in PD 
1.4.10.1 Initial studies on electrical stimulation and lesions of deep brain structures and 
speech 
In 1908 Sir Victor Horsley (1857-1914) and Robert Henri Clarke (1850-1926) applied 
the stereotactic instrument and electricity to study cerebellar structures and functions in 
monkeys (Horsley & Clarke, 1908). In 1947 Spiegel & Wycis became the first to apply 
Clarke’s idea for human stereotaxis by performing a thalamotomy in a depressed man 
(Spiegel et al, 1947). Stimulation of deep cerebral structures was used initially to guide 
lesioning procedures in the early years of surgical treatment of PD. This development of 
basal ganglia lesioning and then stimulation procedures gave rise to an interest in the 
role of thalamus and basal ganglia on speech. Very early in the course of stereotactic 
neurosurgery it was observed that “improvement in speech should not be the prime goal 
in selecting patients for surgical treatment of parkinsonism. Rather patients should be 
selected on a basis of the degree of incapacitation due to rigidity and tremor. They 
should be informed that whereas 70% of patients obtain material alleviation of tremor 
and rigidity following operation on the globus pallidus, less than 20% experience a 
similar degree of improvement in speech” (Buck & Cooper, 1956, p 122). Initially the 
role of the thalamus in speech motor control was explored through stimulation and 
lesioning procedures. Guiot (Guiot et al, 1961) was the first to describe speech 
phenomena in the course of stereotactic procedures, in each of the three areas, thalamus, 
internal capsule and pallidum, traversed by the needle for stimulation, before destroying 
the selected region. The point stimulated was situated in the ventrolateral nucleus of the 
thalamus near the thalamocapsular boundary. He described two distinct speech 
modifications, one was total arrest and the other was speech acceleration, coupled with 
“progressive weakening of the voice and an enunciation which ends in a kind of 
incomprehensible jumbling of several figures or the last figure uttered” (p 367). He 
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hypothesised that diffusion of the current mainly in the internal capsule was the cause of 
these speech phenomena. He also noted “stimulation by a volley of impulses can excite 
a number of positive responses which vary according to individual patients and of 
which the origin may be quite remote from the point stimulated” (p 367). However he 
also observed that the speech modifications might not be a purely motor phenomenon, 
but a psychomotor one. Van Buren (1975) and Hassler (Hassler et al, 1960) described 
similar observations from stimulation in the head of the caudate nucleus, the pallidum 
and the frontal limb of the internal capsule.  
 
In 1969, Samra and colleagues (Samra et al, 1969) reported their experience from the 
surgical treatment of 6,000 individuals who underwent thalamic surgery for the relief of 
parkinsonian tremor and rigidity. They were routinely referred for language and speech 
evaluations before and after surgery. Speech overall deteriorated in 35% of unilateral 
and 75% of bilateral surgeries. It was not clear however why some patients developed 
language and speech difficulties and others did not. The surgical target was the 
ventrolateral nucleus of the thalamus in all cases. Results from the correlation of the site 
of the lesion from 27 brains of deceased parkinsonian patients – out of the initial 6,000 
– and any language and speech deficit that may have resulted from thalamic surgery 
showed that partial involvement of the subthalamic nucleus, the red nucleus or even the 
internal capsule could be tolerated so long as the pyramidal tract remained intact. 
Language deficits seemed related to left thalamic unilateral surgery but no definite 
relationship was found between laterality of surgery and motor speech deficits. There 
was no relationship between the site or size of lesion and postoperative speech deficits. 
They conclude that “the motor processes associated with “speech” – mainly rate and 
rhythm of articulation – might be related more directly and exclusively to motor cortex-
ventrolateral thalamus modulation than to thalamic influences in general” (pp 538-539). 
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Bell (1968) on the other hand could not find any relationship between the pre and 
postoperative speech deficits in PD dysarthria and concluded that the speech 
deterioration following thalamic surgery is due to lesions in the internal capsule.  
 
Schaltenbrand (1975) summarised his observations from thalamic stimulation using a 
bipolar electrode on the tip of a stereotactic needle and stimulation of 32 Hz and 8 volts 
and 10-20 µsec pulse width. He described mainly silencing and slowing of speech with 
thalamic stimulation, monosyllabic yells and exclamations, some stammering, repetition 
of syllables and words and “compulsory speech”. He concluded that the function of the 
thalamus cannot be that of initiating speech but of releasing and silencing preformed 
patterns, therefore of timing and time giving. He warns against the production of large 
lesions in this area since the effects on speech can be lasting.  
 
In summary, the debate of the role of thalamus in speech production started with the 
interest of the pioneers of stereotactic neurosurgery on the overall effects of their 
treatments. The exact role of the thalamus in speech deterioration following surgery for 
the alleviation of parkinsonian rigidity and tremor was debated due to the variability and 
high occurrence of speech deficits. The role of and the involvement of the internal 
capsule in the postoperative speech problems was a topic of debate.  
 
1.4.10.2 Effects of STN-DBS on speech in PD 
After the introduction of levodopa in the late 1960’s, stereotactic surgery for PD went 
into a worldwide hibernation (Hariz, 2003). Following the initial satisfactory response 
to levodopa many patients develop motor fluctuations that are difficult to control. The 
patients alternate between a state of severe parkinsonism (the “off-medication” period) 
and a state of improved mobility (the “on-medication” state) when movement is often 
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impaired by dyskinesias. In 1991, Benabid and colleagues (Benabid et al, 1991) 
published the long-term results of thalamic DBS with emphasis on its reversibility and 
adaptability compared to destructive lesions. Thalamic stimulation is effective mainly 
for tremor and therefore is useful to only a small proportion of people with PD 
(Limousin et al, 1998). Advances in the knowledge of basal ganglia pathophysiology 
and neurosurgical procedures have led to the development of high frequency stimulation 
in the GPi (Siegfried & Lippitz, 1994) and the STN (Limousin et al, 1998; Limousin et 
al, 1995) as a treatment of choice for the majority of parkinsonian signs.  
 
Studies on the effects of STN-DBS on speech, using clinical scales, have shown a 
variable response to stimulation (Limousin et al, 1998). Hariz and colleagues (2000) 
illustrate the barrier speech deterioration can become towards fully utilising the motor 
benefits from the procedure. They described a patient following one year of STN 
stimulation and good motor effect, with worsening of pre-operative dysphonia and 
drooling. They concluded that “improvement in motor function may not be sufficient 
alone to improve the overall disability of a patient in whom cognitive decline and 
speech problems are present pre-operatively” (p 138). In recent reports of long-term 
follow-up, using the UPDRS-III scale, dysarthria has been reported as a common 
stimulation-induced side effect of STN-DBS with a prevalence ranging from 4% to 17% 
(Deuschl et al, 2006). Speech is the only function not improved following five years of 
STN stimulation (Deuschl, 2006; Krack et al, 2003) with some patients reporting 
unequivocal worsening of speech over time and after surgery, and displaying a 
progression of speech difficulties that was not modifiable with adjustment of medication 
and stimulation (Kleiner-Fisman et al, 2004). At six months after bilateral STN-DBS 
Herzog and colleagues (2003) reported a 4% incidence of speech problems in their 
results from 48 consecutive patients. At one year, Tir et al (2007) reported a 12% 
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incidence of speech problems, only for patients with disease duration longer than 12 
years. Thobois et al (2002) reports a 5% incidence in 18 patients and Herzog et al 
(2003) a 6% in 32 patients. Higher incidence is reported by Pahwa et al (2003) with 
28%, and Volkmann and colleagues (2001) who noted a 56% incidence of speech 
problems in 16 patients. Some groups do not report any speech problems following 
STN-DBS (Jaggi et al, 2004; Romito et al, 2003; Vesper et al, 2002). At three and five 
years the reported incidence of speech problems tends to increase: Schupbach (2006) 
reported a 35% incidence at five years of STN-DBS and Gan et al (2007) reported a 
52% incidence in 36 patients at three years. The highest incidence is reported by 
Piboolnurak (2007) with 69.7% (23 patients in 33). Krack et al (2003) and Rodriguez-
Oros (2005) reported a progressive deterioration of speech over five years’ follow-up, 
particularly for the on-medication/on-stimulation condition. 
 
However initial reports, using electrophysiological measures of speech, showed a 
marked improvement of non-speech oral motor tasks with STN-DBS. Gentil and 
colleagues (Gentil et al, 1999) studied the oral force control of ten selected patients 
using load sensitive devices to measure the compression forces generated by the upper 
and lower lip and tongue. STN stimulation improved speech as measured with the 
UPDRS-III speech item 18, and increased the maximal strength, accuracy and precision 
of the articulatory organs. The same group reported the beneficial effects of stimulation 
on acoustical data of 26 PD patients. They found longer duration of sustained vowels, 
shorter duration of sentences, more variable fundamental frequency in sentences and 
more stable fundamental frequency in vowels. Relative intensity was unchanged (Gentil 
et al, 2001, 2003). These studies were on selected patients and selected non-speech 
motor tasks with no reference to speech intelligibility. They also compare the off- and 
on-stimulation conditions without reference to the pre-operative state.     
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Dromey and colleagues (2000) measured the STN stimulation effects on acoustical 
variables of speech in seven consecutive patients compared to their pre-operative state. 
They found modest increases in vocal intensity and in fundamental frequency variability 
in the on-medication condition. They also note the wide variability in speech response, 
with decline in functional communication in some patients and great disparity between 
the motor and speech outcomes. Rousseaux and colleagues (Rousseaux et al, 2004) 
were the first to assess speech intelligibility and compare the results with perceptual 
indices of voice and articulatory quality in seven patients. They observed reduced 
intelligibility in the on-stimulation and on-medication condition for two patients who 
also exhibited increased facial and trunk dyskinesias, whilst the rest remained the same. 
At a group level the non-significant decrease in speech intelligibility was not associated 
with oromotor difficulties, or with the pre-operative speech level or surgical parameters.  
 
Pinto and colleagues (Pinto et al, 2005) illustrated this variability in four case studies. 
Response to STN stimulation varied from improvement with medication and 
stimulation to deterioration with increased voltage intensity. They also noted that 
“motor speech subcomponents can improve like other limb motor aspect but that 
complex coordination of all speech anatomical substrates is not responsive to STN 
stimulation” (p 1507). They conclude that diffusion of the current outside the target may 
be responsible for speech deterioration. 
 
Laterality of stimulation and its effects on speech have been investigated. Santens and 
colleagues (2003) analysed the effects of left and right STN separately on different 
perceptual aspects of speech in seven patients. All patients reported subjective decrease 
of the speech intelligibility following bilateral STN stimulation. There was a significant 
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deterioration of prosody, articulation and intelligibility when stimulating the left STN 
compared to the right STN alone. Wang and colleagues (2006) investigated the effect of 
unilateral STN-DBS on speech in 20 PD patients, 10 operated on the left STN and 10 
on the right. They presented the results from articulatory accuracy and syllable rate of 
diadochokinetic tasks. Left STN stimulation decreased articulatory accuracy and 
speaking rate.  
 
One case report (Burghaus et al, 2006) so far describes a PD patient treated with 
bilateral STN-DBS and with severe deterioration of his childhood stuttering under 
effective stimulation. Positron emission tomography (PET) of regional cerebral blood 
flow (rCBF) in stimulation on and off conditions showed overactivation of cerebral and 
cerebellar motor systems in line with other studies on brain activation during stuttering. 
The abnormal rCBF pattern was increased in the stimulation- on condition and was 
associated with a marked worsening of stuttering. 
 
Klostermann et al (2007) have investigated the effect of STN-DBS on acoustic 
measures of speech and speech intelligibility in 19 patients on medication and on-  
and off-stimulation. They conclude that speech intelligibility declines, despite an 
improvement in glottic tremor, increased sustained phonation time and faster rate of 
reading. They hypothesise that the discrepancy is due to the nature of the voice 
measures and the difficulty in measuring prosodic changes of connected speech. This 
dissociation between improvement in acoustic parameters related to glottal vibration 
and voice tremor and lack of effect on speech intelligibility is discussed in a study by 
D’Alatri et al (2008). They assessed 12 selected patients two to five years post bilateral 
STN-DBS in all medication and stimulation conditions. They analysed sustained 
phonation, one set sentence for intonation and diadochokinesis for rate control. 
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Perceptual speech evaluation was conducted using the UPDRS-III speech item. 
Similarly Putzer at al (2008) studied the effect of STN-DBS in nine consecutive  
patients on- and off-stimulation with no pre-operative data. They collected EGG 
(electroglottograph) data together with acoustic recording of syllable repetition 
/pa/ta/ka/ as fast as possible. They observed a varied response in both the phonation and 
supraglottal system of speech. No data on speech intelligibility is given. 
 
1.4.10.3 Effects of GPi-DBS on speech in Parkinson’s disease  
Speech difficulties following GPi-DBS have been infrequently reported. Initially, Gross 
and colleagues (Gross et al, 1997) reported improvement in speech following one year 
GPi stimulation in six patients as measured by the Unified Parkinson’s Disease Rating 
Scale-motor part III (Fahn et al, 1987). Ghika and colleagues (Ghika et al, 1998) 
reported dysarthria as a side effect that was controlled by modulation of stimulation. 
They do not however give any more details of the nature of this modulation. Lyons et al 
(2002) reported dysarthria in six out of nine patients. Volkmann et al (2004) followed-
up 11 patients with GPi-DBS who did not have a significant speech change after five 
years of stimulation. 
 
Solomon and colleagues (2000) examined the effects of pallidal stimulation on 
aerodynamic and intelligibility data. They measured airflow and air pressure during 
slow syllable repetitions and speech intelligibility before surgery on- and off-
medication, and six months and 12 months after. There is a variable response to speech 
intelligibility. Speech improved in one patient, through the alleviation of painful 
oromandibular dyskinesias, and deteriorated in the other two. They also concluded that 
it is laryngeal rather than respiratory dysfunction that contributes to the speech 
impairment. Maruska and colleagues (2000) described the changes in speech 
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intelligibility of four patients on- and off-medication and on- and off-stimulation. 
Stimulation and medication were beneficial to speech intelligibility. Increase of 
intelligibility was coupled with decreases in the numbers of errors, increases in speaking 
rate and loudness.  
 
1.4.10.4 Comparison of GPi and STN effects on speech 
Krack et al (1998) compared the effects of STN and GPi DBS on speech and reported 
two out of five GPi patients having speech problems but no STN-DBS patients. 
Burchiel et al (1999) reported only one out of five STN-DBS patients having transient 
speech problem. In a multicentre study of bilateral DBS with four-years’ follow-up 
Rodriguez-Oroz and colleagues (2005) report that speech and postural stability showed 
significant worsening for both the GPi and the STN group, but more commonly for the 
STN group. Volkman and colleagues (2001) compared one year results of bilateral DBS 
of the STN and the GPi and found equal improvement in the motor symptoms apart 
from a significant worsening of speech and swallowing items only in the STN patients 
(nine out of 16 STN-DBS patients (56.3%). A recent large multicentre study on adverse 
events following deep brain stimulation (Hariz et al, 2008) compared adverse events 
following four years of STN versus GPi stimulation. They reported nine out of 49 
patients with STN-DBS (18.5%) to have speech problems compared to one out of 20 
(5%) with GPi-DBS. Similarly Moro et al (2010) reported the effects of five years of 
GPi versus STN-DBS and found 10 out of 35 (28.5%) STN patients with speech 
problems compared to two out of 16 (12%) GPi patients. 
 
1.4.10.5 Treatment of speech problems arising from surgical treatment 
Neurosurgeons were strongly involved in earlier studies with peri-operative 
observations and descriptions of long-term results of their operations on speech. Cooper 
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(Cooper et al, 1968) founded the multidisciplinary approach to management of surgical 
patients with emphasis on vocational rehabilitation. The aim of the two-to-four weeks’ 
postoperative rehabilitation was to restore vocational function. Most parkinsonian 
patients who underwent surgery were given speech therapy. The postoperative 
techniques were directed towards the difficulties of voice volume. “Since difficulties in 
volume are paramount we emphasize strengthening of the voice. One of these methods 
is essentially a “boosting” technique and involves various means of using the entire 
body to support the tone of voice” (p 1215). In order to ensure generalisation, family 
and friends of the patient are “instructed not to respond to the patient unless he speaks 
with sufficient volume. This is sometimes a tedious and frustrating task but experience 
has shown that only constant attention to his own voice and constant awareness of his 
difficulties can produce the desired results.” The programme involves techniques for 
rate control through reading and singing, but mainly free conversation in groups of six 
to eight and individual sessions. The intensity and the voice focus of these techniques 
remind one of the Lee Silverman Voice Treatment (LSVT) (Ramig et al, 2001). There 
are no recent studies on the treatment of speech problems following bilateral STN-DBS 
(see also Chapter 6).  
 
1.5 Dystonia  
Dystonia has been defined as a “syndrome of sustained muscle contractions, frequently 
causing twisting and repetitive movements, or abnormal postures” (Fahn at al, 1998).  
It is characterised by excessive movement which leads to involuntary movements and 
abnormal postures. Depending on the affected body site dystonia may affect speech 
musculature and motor speech production. Oppenheim first used the term dystonia in 
1911 when he described a childhood-onset syndrome that he called dystonia 
musculorum deformans. Almost a century later, many different types of dystonia are 
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been described and the classification is continuously updated. Although a detailed 
discussion of the numerous forms and types of dystonia goes beyond the scope of this 
chapter, a description of the types that can affect speech in a direct or indirect way will 
be attempted. 
 
1.5.1 Definition and classification 
Marsden and his colleagues (1976), based on clustered clinical phenomenology, 
described three basic approaches to classification: age at onset, body regions or 
distribution affected and etiology. 
 
They stressed that the age at onset is the single most important feature in determining 
outcome. The earlier the age at onset the more likely symptoms will be severe, with 
dystonia spreading to involve multiple regions. In terms of speech muscles early-onset 
dystonia (onset before 26 years of age as described by Jarman et al, 1998) usually first 
involves a leg or arm and less commonly starts with the neck or vocal folds (Hallett, 
1998). Conversely, late-onset (onset after 26 years of age) primary dystonia commonly 
affects the neck or cranial muscles and less frequently involves an arm at onset. It also 
tends to remain localised as focal or segmental dystonia.  
 
In terms of distribution, focal dystonia tends to involve a single body area, frequently 
affecting motor speech production: blepharospasm (upper face), oromandibular (jaw 
opening or jaw closing), vocal cords (spasmodic dysphonia) and neck area (spasmodic 
torticollis). 
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In segmental dystonia two or more continuous areas are affected, namely cranial  
(face, jaw, tongue and vocal cords), cranial and cervical, or axial (neck and trunk).  
In multifocal two or more non-contiguous regions are involved either as hemidystonia 
(ipsilateral arm and leg) or as generalised, when it affects both legs and trunk and at 
least one more region (Bressman, 2004). However, establishing discrete groups for age 
at onset and affected body distributions cannot fully reflect the complex relationship 
between muscles involved at onset and spread of symptoms and cause (Greene, 1995). 
 
1.5.2 Pathophysiology of dystonia and implications for speech 
Historically the causes of dystonia have been divided into two main groups: idiopathic 
(or primary) and symptomatic (or secondary) (Fahn, 1998). 
 
Primary dystonia includes early onset dystonia with onset in a limb and a tendency to 
generalise, and late-onset dystonia which most commonly occurs in focal 
(blepharospasm, oromandibular dystonia, cervical dystonia, laryngeal dystonia and arm 
dystonia) or segmental forms. Primary dystonia is the most common cause of dystonia 
with prevalence estimates from two to 50 cases per million for early onset and from 30 
to 7,320 per million for late onset dystonia (Defazio et al, 2004). Primary dystonia is 
thought to be partly genetic in origin, mainly because of its aggregation within certain 
families and the identification of specific genetic loci. Ozelius (2004) reports at least 13 
different loci identified for various forms of inherited dystonia. DYT1 was the first gene 
mapped. Focal dystonias, most commonly cranial and cervical dystonia, can affect the 
most commonly performed, automatic and unconscious motor acts – blinking, 
mimicking, voice performing, speaking, turning or tilting of the head.  
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Possible underlying mechanisms of these multiple motor abnormalities have 
implications both for interpreting the clinical presentation and for treatment planning. 
Basal ganglia are involved in the control of surround inhibition as evidenced by studies 
on bradykinesia and dystonia. Yoshida et al (2003) in a study in patients with 
oromandibular dystonia showed that novel and unfamiliar lateral jaw movements 
strongly reduce movement related potentials in central and parietal areas compared to 
normal subjects, whereas familiar mouth closing movements do not. They thus suggest 
that execution of familiar movement in the cranial area (for muscles involved in speech 
and mastication) might predominantly involve subcortical mechanisms.  
 
Basal ganglia have been involved in sensorimotor integration, the continuous 
modulation of motor tasks based on on-line sensory input. For patients with cranial and 
cervical dystonia the most striking evidence of impaired sensorimotor integration is the 
use of the “sensory trick” (or geste antagoniste). Sensory tricks can be observed in up to 
70% of patients with cervical dystonia (Deuschl et al, 1992). It is defined as a tactile or 
proprioceptive sensory input applied to a nearby body part which improves the 
abnormal posture. Although traditional opinion regarded the “sensory trick” as a sort of 
psychological manoeuvre to distract attention, later physiological and PET studies 
showed that it could actually modify EMG recruitment (Schramm et al, 2004) by 
inducing a perceptual dysbalance between primary and secondary motor and sensory 
areas (Naumann et al, 2000).  
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1.5 3 Speech disorders associated with primary and secondary dystonia 
1.5.3.1 Primary dystonia and speech 
The typical features associated with DYT1 dystonia are early limb onset and spread to 
the trunk, which rarely affects craniofacial muscles (Jarman, 1999). 
  
The clinical presentation of the DYT6 locus is mixed with an early age of onset and 
progression to involve multiple body regions, mainly orofacial (Ozelius, 2004). DYT13 
is also characterised by prominent cervical-cranial and upper limp involvement with 
early onset, similar to the DYT6 dystonia but with less significant laryngeal and leg 
involvement.  
 
Adult onset primary dystonia usually remains focal or spreads only to one contiguous 
body region. In a meta-analysis of published studies to date O’Riordan and colleagues 
(2004) investigated age as the single factor in determining the phenotype of primary 
dystonia. They report that in a total of 13 studies on spasmodic dysphonia the mean age 
at onset was 43 years, compared to 55 years for the 21 studies on 
blepharospasm/oromandibular dystonia. They thus concluded that with increasing age 
there is a caudal-to-rostral shift of the site of onset in the order: leg-onset dystonia, 
writer’s cramp, cervical dystonia, spasmodic dysphonia and 
blepharospasm/oromandibular dystonia. The authors speculate that this spread of 
symptoms from the limbs to the face area may reflect a somatotropic organisation  
of the putamen. 
 
Cervical dystonia, also known as spasmodic torticollis, is the most common focal 
dystonia (Defazio, 2004). It usually begins between the ages of 30 and 50 years, often 
with initial neck stiffness and restricted head mobility. Abnormal head postures follow, 
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sometimes associated with head tremor, neck and shoulder pain. Speech can be affected 
at a later stage, and swallowing abnormalities at the pharyngeal level can also occur. 
 
Blepharospasm, a focal dystonia whose main feature is involuntary eye closure, is the 
most common cranial dystonia. Symptoms usually begin with excess eye blinking and 
sore eyes and develop into periods of complete eye closure that can be triggered by 
bright light, reading, watching TV or stressful situations. Suppression of unwanted eye 
closure is possible in some patients by touching the periorbital area or some other points 
of the face (Valls-Sole & Montero, 2004). Blepharospasm may be accompanied by 
oromandibular dystonia (OMD), in which case the condition is referred to as Meige’s 
syndrome.  
 
OMD can also occur as an adverse effect of chronic administration of certain drugs, 
known as tardive dystonia, or as an accompanied manifestation of neurodegenerative 
disease or focal or brainstem lesions (Tolosa, 1988). The most common form of 
presentation of OMD is that of an adult with idiopathic focal dystonia. The patients 
show bizarre, irregular, somewhat chaotic movements of the jaw, lips, platysma and 
sometimes tongue. These disturbed perioral movements can interfere with basic 
functions, such as chewing and swallowing as well as speech, with the consequence of 
social embarrassment. Yoshida et al (2002) studied 44 patients with OMD and the effect 
of local injection of ethanol and lidocaine. They distinguished four groups, according to 
the pattern of incisal movement and involuntary contraction: spastic group, in which the 
patients showed spastic contraction but no remarkable movement, rhythmic group in 
which the patients showed rhythmic or involuntarily repeated muscle contractions, 
dyskinetic group in which the patients showed oral dyskinesia or hyperkinetic jaw 
movement and task-specific group in which the involuntary contraction appeared only 
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at the time of speech or mastication, with no symptoms at rest. Difficulty in speech was 
the major complaint, followed by tenderness and pain of muscle. Difficulty in 
swallowing and communicating are the main factors influencing quality of life in OMD 
patients (Bhattacharyya & Tatsy, 2001). Dystonia is rarely life-threatening; however 
there have been reports of respiratory failure due to involvement of the larynx (Hamzei 
et al, 2003). The pathophysiology of OMD is still unknown and despite the wealth of 
studies on blepharospasm there is a paucity of studies on OMD.  
 
1.5.3.2 Secondary dystonia and speech 
Secondary dystonia is a large and diverse group of disorders with many causes, 
including acquired brain lesions, heredodegenerative disorders and drug-induced 
dystonia. Speech and swallowing mechanism can be affected to a greater or lesser 
degree depending on the site of the lesion and the age of onset. From the 
heredodegenerative disorders the ones involving speech are Huntington’s disease, 
Wilson’s disease and Pantothenate kinase-associated neurodegeneration, formerly 
known as Hallervorden-Spatz syndrome. Primary Focal Lingual Dystonia is a rare form 
of focal dystonia affecting the tongue muscles and induced by speaking. There have 
been four cases reported in the literature so far: two with tongue protrusion and two 
with tongue retraction, all induced by speaking and with symptoms not present during 
mastication and swallowing. These cases all responded well to anticholinergic therapy 
and sensory tricks (Papapetropoulos & Singer, 2005; Baik et al, 2004). 
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1.5.4 Examination findings 
1.5.4.1 Non-speech oral mechanism   
In terms of non-speech oral mechanism, examination can show normal strength, size 
and symmetry at rest, with dystonic movements triggered only by speech (Duffy, 2005). 
Blepharospasm and temporomandibular movements may be present intermittently. The 
main non-speech oromotor examination finding is slow and sustained co-contractions of 
the muscles of the lips, jaw, mouth-tongue and neck and respiratory muscles that can 
interfere with voluntary control of movement and presentation at rest. Use of sensory 
tricks are common, mainly use of a pipe, or a stick for mouth-closing dystonia and 
pressure or light touch at the jaw or neck. 
 
1.5.4.2 Examination findings: speech     
Two main studies summarize observations from dystonic speech examination, namely 
the Darley et al (1975) and Golper et al (1983). Depending on the pathophysiology and 
main presentation of dystonia, nearly all aspects of movement during speech can be 
disturbed. Dystonic movements may alter direction and rhythm of movement with 
generally slow rate and impact on precision. Fatigue is another factor influencing 
repetitive movements.  
 
The most prominent feature of the dysarthria in dystonia is the variable presentation of 
deviant speech characteristics, both between patients and within the same patient with 
dystonia. This variability is more prevalent in the phonatory and articulatory 
subcomponents of speech. Speakers often try to compensate or avoid the involuntary 
co-contraction of a neck-facial muscle which results in irregular, slower rate speech 
with imprecise consonants, unexpected pauses and disordered prosody of speech.  
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More specifically, phonation may be affected depending on the degree of cervical 
dystonia and spasmodic dysphonia. Harsh or strained and strangled voice quality with 
excess loudness variations and voice stoppages are often observed (Duffy, 2005). These 
difficulties lead to short phrases with occasional audible inspiration, probably due to 
involuntary vocal fold adduction during inhalation. This is a feature rarely encountered 
in other dysarthria types (Darley et al 1975). In the most detailed study of speech in 
people with cervical dystonia La Pointe et al (1994) report reduced intelligibility despite 
the overall impression of “functional and intelligible speech even if subtly different 
along some parameters”. In general speech in people with cervical dystonia may be 
perceived as slowly initiated, with short phrases, reduced pitch variability and reduced 
in rate.   
 
Articulation is particularly affected in patients with OMD, with or without 
blepharospasm. Imprecise consonants and distorted vowels are the effect of involuntary 
jaw, lips and tongue movements and of various efforts to compensate. Patients with 
predominantly jaw-opening dystonia present with more sensory tricks and spread of 
symptoms in different regions than those with predominantly jaw-closing dystonia 
(Singer et al, 2006). The combination of articulatory and phonatory distortions leads to 
prosodic disorders and the overall impression of slow and effortful speech. 
  
1.5.4.3 Investigating speech in patients with dystonia 
The variability in the clinical presentation of speech in dystonia and the dynamic nature 
of its progression warrant multiple sources of information gathering. Duffy (2005) 
stresses the importance of “careful visual observation of the patient during speaking”,  
in order to describe the speech difficulties at every level and the likely triggers of co-
contractions and sensory tricks. Videotaping can facilitate observations of movements 
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of the trunk and neck, especially when their influence on speech may not be 
immediately obvious. It also serves as a record of changes through time in the disease 
process and the treatment effects.  
 
Due to the variable presentation of respiratory-phonatory-articulatory features of speech 
in dystonia there is no expected acoustic and perceptual profile with very few studies of 
limited and diverse population. Respiratory dynamics in six patients with generalized 
dystonia have been investigated by LaBlanche & Rutherford (1991) using respiratory 
inductive plethysmography to assess breathing rate, periodicity of the breathing pattern 
and inspiratory lung volume. They found faster breathing rate, less rhythmic breathing 
pattern and decreased lung volume. LaPointe et al (1994) in their study of 70 patients 
with cervical dystonia found reduced speech DDK rates, reduced maximum phonation 
reduced phonation reaction time and reduced pitch variability.  
 
In terms of observational scales Yoshida et al (2002) use a 4-point rating scale for OMD 
for mastication, speech, pain and discomfort. The speech subcomponent ranges from 
inaudible (over 50%) to normal. Equally, the most widely used scale for dystonia Fahn-
Marsden rating scale (Burke et al, 1985) groups together in one item (SS) both 
swallowing and different speech abnormalities (spasmodic dysphonia and dysarthria) 
which limits its sensitivity and specificity. 
 
There is a need for more descriptive data following medical or surgical interventions in 
order to appreciate the changes and to maximise the benefits of such procedures. 
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1.5.5 Treatment of communication disorders in dystonia 
Dystonia can affect muscles of the face, neck and trunk areas and consequently affect 
communication and swallowing. Depending on the affected body site dystonia may 
affect speech musculature and motor speech production. The face is a very active part of 
the body involved in many spontaneous movements such as blinking, swallowing and 
expression of emotions.  
 
Treatment of communication disorders of people with dystonia can be a challenge for 
the speech clinician not only due to the wide variability of the disease presentation, the 
sometimes unpredictable progression to other body parts, and the effect of 
environmental factors on the dystonia but also the effect of other medical and surgical 
treatments on the disease. 
  
Timing of intervention largely depends on diagnosis and referral to the speech clinician 
rather than evidence. Medical and surgical treatments throughout the disease course can 
also be a significant factor on communication intervention. Speech management could 
be deferred until after the planned intervention, but often the provision of an 
Augmentative and Alternative Communication Aid can facilitate the treatment process 
and decision making.   
 
Dystonic symptoms can vary depending on environmental and personal factors such as 
anxiety, pain, fatigue and stress, all of which can exacerbate the symptoms of dystonia. 
The general principle of every communication intervention of considering the 
environment and the people where communication takes place applies to treatment of 
dystonia. Family, employment and social support can be positive factors in any 
intervention. 
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1.5.5.1 Behavioural management 
The role of the speech clinician when working with patients with dystonia is to observe 
and describe as accurately as possible the changes induced by the treatment in the whole 
body. This is best achieved by videotaping before and after intervention. Speech being 
so variable in different dystonia types, it requires a multitude of speech and non-speech 
tasks. Subjective accounts of change are also valuable. The aim of any communication 
intervention should be to maximise the benefit of the procedure for communication.  
 
When working with OMD and lingual dystonia the speech clinician needs to consider 
the fact that these focal dystonias are usually task-specific. The abnormal, involuntary 
and sustained co-contractions of the facial, jaw and tongue muscles occur when the 
patient wants to speak and/or chew and swallow. Breathing and voice can also be 
affected, with tight and strained phonation or some vocalisation. It is thus very difficult 
to apply a set of drills or repetitive exercises of non-speech motor tasks in the hope of 
generalising into speech. Additionally writing can be impaired especially in cases of 
primary generalised dystonia with early onset and limb progression.  
 
Disease progression usually means deterioration of function. Patients have to adapt to a 
continually changing and unpredictably moving body. Because of the variable effect of 
pharmacological and surgical function and the effects of correct posture and sitting, 
working in a multidisciplinary setting is paramount for maximum effect in dystonia 
intervention.  
 
 108 
Dwarkin (1996) investigated the impact of a bite block or other acceptable object in the 
mouth to limit the involuntary movements during speech, which had a resultant 
improvement in articulation and intelligibility (Dwarkin et al, 1996).  
 
Equally sensory tricks for oromandibular dystonia, blepharospasm and other facial 
dystonia can inhibit involuntary movements and facilitate speech. It is worth exploring 
different sensory tricks with patients who haven’t discovered their own. Another area 
with very limited evidence (Duffy, 2005) is the use of EMG biofeedback for the 
treatment of orofacial dystonia.   
 
McGuire et al (1988) report on the rehabilitation of three patients with “dystonia 
musculorum deformans”. Communication work consisted of maximising their hand 
function for use of a communication board. They stress the need for a total team 
approach. 
 
Similarly Shahar et al (1987) report on the rehabilitation of communication impairment 
of three patients with dystonia using Augmentative and Alternative Communication 
(AAC). It is also stressed that every AAC method requires support and training of the 
family/social setting and a relaxing environment. 
 
1.5.5.2 Pharmacological treatment in dystonia and effects on speech 
The symptomatic treatment of dystonia has markedly improved, particularly since the 
introduction of Botulinum Toxin. Many patients with dystonia require a combination of 
several medications and treatments. Thus anticholinergic therapy has been found to be 
useful in the treatment of generalised and segmental dystonia (Greene et al, 1988). Oral 
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Baclofen may be helpful in the treatment of OMD (Jankovic, 2004). Intrathecal 
Baclofen can be used in cervical and truncal dystonia. 
  
Botulinum Toxin has been a major advance in the treatment of dystonia.  
It was first introduced in 1981 by Scott to correct strabismus and he later began using  
it for blepharospasm. It acts presynaptically at peripheral nerve terminals to prevent 
calcium-dependent release of acetylcholine (Fahn & Marsden, 1998) and thus 
weakening the hyperactive muscle fibres involved in the involuntary movement.  
It is useful in the treatment of focal dystonias, cranial and cervical. Numerous reports 
have shown the efficacy of Botulinum Toxin in treating dystonia (and it can be regarded 
as a first line of treatment for primary cranial (but not oromandibular) or cervical 
dystonia, (Albanese, 2006). OMD is the most challenging of the focal dystonias to treat 
with Botulinum Toxin, which can possibly complicate swallowing problems. The 
masseter muscles are injected in patients with jaw-closing dystonia and the lateral 
pterygoid or submental muscles which can occasionally cause rhinolalia or nasal 
regurgitation (Yoshida et al, 2002). These are groups of muscles directly involved in 
mastication. In cases of OMD that do not respond to Botulinum Toxin, either due to 
antibodies or weakness of the muscles, Yoshida et al (2003) have reported a method of 
blocking muscle afferents using a local injection of lidocaine and ethanol. They reported 
significant improvement in patients with the spastic type of OMD but not those with the 
hyperkinetic/dyskinetic type. Complications include tenderness, stiffness or swelling of 
the injected muscle, limited mouth opening and dysphagia. 
  
Similarly patients with cervical dystonia can expect improvement in function of their 
head and neck movements and pain. However there have been only a few longitudinal 
studies of Botulinum Toxin injections in cervical dystonia (Jankovic, 2004 as reported 
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in Duffy 2005). Patients with longstanding dystonia have been found to respond less 
than those treated relatively early in their disease process. Complications such as 
swallowing problems and neck weakness are probably related to local spread of activity 
into adjacent muscles. 
 
The response of lingual dystonia to Botulinum Toxin is more variable, with a high risk 
of dysphagia (up to 50%) and aspiration pneumonia. The tongue is solely composed of 
muscle and thus plays an important and delicate role in chewing, speaking and 
swallowing. Therefore it is hard to control the task-specific dystonic muscle contraction 
of tongue by local injections of Botulinum Toxin.  
 
Spasmodic dysphonia is a primary task specific focal dysphonia affecting the laryngeal 
muscles during speech (Ludlow C, 2009). Adductor spasmodic dysphonia (ADSD) 
affects close to 90% of spasmodic dysphonia patients and it is characterised by voice 
breaks during vowels during speech due to intermittent hyperadduction of the vocla 
folds (Parnes et al, 1978). Abductor spasmodic dysphonia (ABSD) is relatively rare and 
involves intermittent voiceless voice breaks due to prolonged voiceless consonants 
before initiation of the following vowel (Edgar et al, 2001). Treatment of spasmodic 
dysphonia with botulinum toxin has been the subject of two evidence-based reviews:  
Watts and colleagues (2008) concluded that botulinum toxin injection is an effective 
treatment for spasmodic dysphonia. However, Simpson and colleagues (2008) 
concluded that botulinum toxin injection is probably effective for the treatment of 
ADSD but that there is insufficient evidence for the use of botulinum toxin injection for 
ABSD. 
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In summary, pharmacological therapy in focal dystonia is centred on Botulinum Toxin. 
Swallowing problems can arise as a complication of injections in the cranial and 
cervical muscles treated. A thorough assessment before and after treatment, preferably 
with videotaping, can assist the speech clinician in measuring change and maximising 
the benefit from the treatment. Advice and careful monitoring of swallowing and speech 
complications following treatment is warranted.  
 
1.5.5.3 Surgical treatment  
Peripheral denervation therapy and Botulinum Toxin injections cannot be used to treat 
segmental and generalised dystonias because of the greater number of muscles 
involved. Bilateral stereotactic Deep Brain Stimulation of the Globus Pallidus internum 
(GPi-DBS) is most commonly performed. 
 
Victor Horsley in 1909 was the first to carry out ablative lesions of brain tissue in an 
attempt to treat hyperkinetic disorders. He excised the motor cortex in a boy with hemi-
athetosis, dramatically relieving the involuntary movements. This work was a milestone 
in understanding motor physiology and anatomy. Stereotactic surgery in animals was 
developed around the same period by Horsley & Clark. Several decades after (1946) 
Spiegel and his colleagues were the first to apply the principles of stereotactic surgery 
to humans. Cooper (1969) then developed the idea of carrying out chemopalidectomies 
in patients with dystonia based on the observation that a relief of a fixed dystonic 
flexion of a Parkinson’s disease patient can improve with stereotactic lesions of the 
pallidum. He operated on approximately 226 and he reported some benefit in 70% of his 
patients. He agreed that this type of surgery is more effective for limb dystonia than 
axial dystonia and that dysarthria occurred in 11% of patients with unilateral lesions and 
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56% of bilateral lesions. Dysphonia has been reported to occur in 18% of cases by 
Cooper and 33% of cases by Ojemann (1982). 
 
The first GPi-DBS for dystonia was attempted in 1996 by Coubes (2004) for an eight-
year old girl, based on the established efficacy of the technique for the treatment of 
levodopa-induced dyskinesia in patients with Parkinson’s disease. In 2004, Coubes 
reported the results of 31 patients with primary torsion dystonia bilaterally implanted in 
the GPi with improvement of 79±19%. Children displayed greater improvement in 
clinical scores than adult patients.  
 
However although limb and trunk dystonia is improved by DBS the benefit on speech 
intelligibility is more critical and less predictable (Vidailhet & Pollak, 2005b). These 
differential effects of neurostimulation should be considered when selecting patients for 
surgery. Speech may not be directly affected by GPi-DBS but improvement of other 
involuntary movements mainly of the trunk for breathing control and of limbs may 
provide more flexibility in the choice of communication modality. For patients with 
anarthria due to severe dystonia the option of a communication aid using their improved 
hand function or head control is a significant gain to their quality of life. Additionally 
frequent reassessments of overall function and possibilities of augmenting 
communication are warranted following GPi-DBS due to the observed progressive 
improvement of the dystonia, following more than two years after surgery.  
 
1.5.5.3.1 Primary generalised dystonia  
Two large studies have confirmed the beneficial effect of GPi-DBS for patients with 
primary generalised dystonia: Vidailhet et al (2005b) studied 22 patients and found a 
54% improvement at the BFM movement score and a 44% at the BFM disability score 
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at 12 months with chronic stimulation relative to baseline. Motor improvement occurred 
in most segments of the body (neck, trunk and limbs) with the exception of facial 
movement and speech, which remained unchanged. This improvement was maintained 
at 36 months (Vidailhet et al, 2007). In 2006, Kupsch et al reported the results from a 
randomised control trial in primary dystonia, with 40 patients, comparing 20 who 
received sham stimulation (off-stimulation) with 20 who received stimulation, at three 
months, and then the whole group versus baseline at six months. At three months, 
stimulation led to an improvement of 39% in movement and 38% in disability, both 
superior to the ones from sham stimulation. Speech and swallowing was the only item 
in the BFM scale that didn’t change significantly. Dysarthria was the most common 
adverse event occurring in five patients (12%) and manifesting as slurred but 
understandable speech. The most beneficial results with pallidal DBS were reported in 
children with DYT-1 positive generalised dystonia. Coubes et al (2000) described a 
mean 90% improvement in the BFM motor scores at one year follow-up (also Cif et al, 
2003; Tisch et al, 2007). Tisch et al reported the development of delayed-onset akinesia 
with gait slowing, difficulty rising from chair and turning in bed in two out of 15 DYT-
1 positive patients. In terms of speech, Isaias (2009) reported the long-term effects (up 
to four years) of 30 consecutive patients with speech and swallowing abnormalities 
being the least responsive to DBS and with one-quarter of symptomatic patients 
showing no improvement or worsening. They commented that this might be due to the 
inadequacy of the BFMDRS scale which lumps together in one item (SS) both 
swallowing and different speech abnormalities (spasmodic dysphonia and dysarthria). 
“the SS symptoms should be further evaluated in dedicated studies” (p 469). Allert et al 
(2010) have recently reported a case of a patient with generalised dystonia, and Vim 
DBS mainly to treat dystonic tremor who developed reversible stuttering following the 
replacement of the battery. The fluency disorder disappeared after adjustments. 
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1.5.5.3.2 Cervical dystonia  
Idiopathic cranial-cervical dystonia (CD) is an adult-onset segmental dystonia affecting 
orbicularis oris, facial, oromandibular and cervical musculature (Ostrem et al, 2007). It 
is the most frequent dystonic movement disorder, hence DBS may be of special interest 
in this group. Bilateral pallidal stimulation produces both symptomatic and functional 
improvement including marked long-term relief of pain in patients with complex CD 
(Krauss, 1999, 2002). Krauss et al (2002) reported a gradual improvement of CD over 
time as reported on the modified Toronto Western Spasmodic Torticollis Rating Scale 
(TWSTRS) of 63%, and 69% improvement in the disability score and 50% 
improvement in the pain score. Similarly Yianni et al (2003) reported similar 
amelioration for severity (64%), disability (60%) at 19 months follow-up. Kiss et al 
(2007) reported the results from the Canadian multicentre study in 10 patients with 
severe cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale 
(TWISTRS). They reported 43% improvement over one year of stimulation and 59% in 
disability scores. The reported that two patients had mild difficulties with swallowing 
and two patients had mild improvement but they do not discuss any details. Ostrem et al 
(2007) were the first to report worsening in non-dystonic body regions with stimulation 
in four out of their six CD patients treated with bilateral GPi-DBS. Speech and 
swallowing were the only subscores of the BFMDRS that did not improve significantly. 
The same group recently reported induction of bradykinesia in 10 out of 11 CD patients, 
despite of significant improvement in dystonia. They used a questionnaire to rate 
changes in various upper and lower limb motor activities e.g. handwriting, dressing, 
walking, buttoning shirts and they correlated with lead placement. They found no 
correlation with leads nearer the internal capsule. Furthermore patients who received 
most benefit from the treatment tended to have more difficulty with stimulation-induced 
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bradykinesia, indicating a common neural circuit mediating the antidystonic effect 
rather than a spread to neighbouring structures. In terms of speech there are two case 
reports in the literature so far suggesting the induction of dysarthria and dysfluency: 
Nebel (2009) reported on two patients, one with DYT-1 positive and one with CD both 
of which developed stuttering after GPi-DBS under conditions that optimally 
suppressed the dystonic symptoms, which suggests a shared neural control pathway. 
The description of speech difficulties in Case 2 (DYT-1) resembles hypokinetic-
parkinsonian speech more so than stuttering (“dysarthria was characterised by a very 
soft voice, imprecise articulation, and very small amplitudes of articulatory movements. 
His fluency was disturbed by blocks, iterations and intermittent rushes of unintelligible 
utterances. By using a pacing board he could slow down his speech, increase speech 
volume and improve intelligibility” p 168). A recent case study of hypophonia amongst 
other parkinsonian symptoms was reported by Zauber et al, (2009), in a patient with 
craniocervical dystonia. There have been no reports of electrical parameters and their 
effects on speech/hypophonia in relation to CD and GPi-DBS (Moro et al, 2009).  
 
1.5.5.3.3 Oromandibular/orofacial 
Woerhrle (2009) et al published their results on 14 consecutive patients with segmental 
dystonia, 12 primary, with segmental dystonia affecting larynx, oromandibular and 
cervical muscles. They reported a mean relative improvement of 57% with the effect of 
DBS being more pronounced for the extremities and less pronounced in axial and facial 
regions. They also report that dysarthria was limiting the therapeutic voltage amplitude 
in four patients.  
 
However despite the improvement in segmental dystonia, it is not clear which parts of 
the facial musculature improve most and what is the functional impact on speech and 
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swallowing. A long-term follow-up of 11 segmental dystonia patients (Sensi et al, 2009) 
shows that dysarthria can still be a stimulation-related side effect despite overall 
improvement in the orofacial dystonia. They report that there was a delayed positive 
effect on speech at three year follow-up “of around 60% that was more evident in the 
most anarthric patients where language was not intelligible”. So the controversy 
between improvement in segmental dystonia involving head and face and possible 
stimulation-related deterioration of speech points towards a threshold of stimulation 
above which dysarthria is a side effect and below which dystonia is not well controlled. 
This threshold and any predictive factors associated are worth investigating. 
 
1.5.5.3.4 Secondary dystonia 
DBS for the treatment of secondary dystonia appears to be much more complex than 
that of primary dystonia. Vidailhet et al (2009) have recently reported on the treatment 
of cerebral palsy (CP). The dystonia-choreoathetosis forms of CP with basal ganglia 
dysfunction are mainly due to neonatal hypoxic ischaemic encephalopathy in term or 
near term infants (Bax et al, JAMA, 2006). The group conducted a multicentre 
prospective pilot study in 13 adults with dystonia-choroathetosis CP improvement in the 
BFMDRS scale of 24% as well as improvement in functional disability and pain. They 
do note however the inherent difficulties of this population, namely the heterogeneity 
due to the injury in a developing brain and the complex movement disorder.   
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CHAPTER 2: GENERAL METHODS 
2.1 Participants 
The work presented in this thesis is derived from a consecutive series of 54 PD patients 
and 25 dystonia patients, who were all studied clinically before and after deep brain 
stimulation surgery. 
2.1.1 PD patients 
For the first 32 consecutive PD patients data were collected before, one month, six 
months, one year and three years (N=15) after the operation. For the following 22 
patients data were collected before and one year after the operation (total of 54 PD 
patients with before-one year post data). A group of 12 non-operated PD patients, 
randomised for medical treatment as part of a larger study (PD-SURG) were also 
studied as control participants to the surgical PD group. A subgroup of the PD patients 
underwent further studies, using aerodynamic recordings (N=12) and 
electropalatography (N=2). 
2.1.2 Dystonia patients 
Twenty five patients with dystonia were assessed before and 12 months after bilateral 
GPi-DBS. The aetiology of dystonia was as follows: eleven were primary generalised 
(six DYT-1 positive, five DYT-1 negative), seven were cervical/cranial dystonia, two 
myoclonic dystonia, one tardivedystonia plus Tourette’s, one hemidystonia, two 
dystonia following stroke and one dystonia following a post-anoxic episode. Data for 
the dystonia patients were collected before and one year after surgery.  
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The description of the participants included in each study is outlined in the methods 
section of each chapter. All participants gave written informed consent and the studies 
were approved by the joint Ethics Research Committee of the National Hospital for 
Neurology and Neurosurgery, and the Institute of Neurology.  
2.2 Surgical procedure 
2.2.1 Bilateral STN-DBS for PD patients 
Surgery was usually performed under local anaesthesia, in the off-medication condition, 
to allow clinical evaluation during electrode placement. If the patient was unable to 
tolerate prolonged periods off-medication, surgery was performed under general 
anaesthesia (N=7). The STN was visualised in each patient using specifically selected 
pre-operative stereotactic MRI sequences (Ashkan et al, 2007; Hariz et al, 2003) 
following attachment of a Leksell frame (Elekta Instrument AB, Stockholm, Sweden). 
Our standard technique is that two experienced neurosurgeons independently select the 
optimal target within the STN and then compare co-ordinates that are calculated both 
manually on enlarged film copies, and using commercially available planning software 
(FrameLink, Medtronic, Minneapolis). This is performed to ensure that optimal target 
selection is reviewed in detail for every patient and the possibility of human error or 
miscalculation is minimised. A trajectory was calculated during planning to avoid sulci 
and the ventricular system as this has been shown to reduce complications and improve 
targeting accuracy (Elias et al, 2009; Zrinzo et al, 2009). In addition, the trajectory was 
modified to maximise the number of quadripolar electrode contacts within the three-
dimensional structure of the nucleus. Impedance monitoring was performed while 
introducing a 1.5 or 2.2 mm blunt-tip radiofrequency (RF) electrode to the target 
(Leksell RF electrodes, Elekta, Stockholm). After withdrawal of the RF electrode, a 
quadripolar DBS electrode (Model 3389 DBS lead, Medtronic®, Minneapolis) was 
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soft-passed down the same track. In those patients undergoing surgery under local 
anaesthesia, symptoms were assessed for the presence of a micro-lesion introduction 
effect. Monopolar stimulation through the contacts of the DBS electrode was then 
sequentially performed to assess for additional therapeutic effect and/or the presence of 
side effects such as dysarthria, oculomotor, sensory or capsular responses (~10 minutes 
per side).  
 
Immediately following implantation of the DBS leads, all patients had a stereotactic 
MRI scan with the frame still on the head to confirm the electrode positions before 
implantation of the pulse generator. The perpendicular scalar (Euclidean) distance 
between the intended MRI target and the actual position of the implanted electrode was 
calculated on the post-operative MRI for each patient.   
 
2.2.2 Bilateral GPi-DBS for dystonia patients 
The surgery for dystonia patients is carried out under general anaesthesia following the 
MRI guided technique described above (2.A). By convention the electrode for the right 
hemibody (left brain) is connected to channel 1 (contacts 0, 1, 2, 3) and the left 
hemibody (right brain) to channel 2 (contacts 4, 5, 6, 7). 
2.3 Clinical evaluation 
2.3.1 Study design: prospective longitudinal assessment 
In all patients clinical evaluations were performed before and serially after surgery: 
postoperative evaluations were undertaken at the following time points: one month, six 
months, one year and three years. The clinical scoring of motor symptoms was carried 
out by a neurologist. The collection of the speech data was performed by the author. 
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The clinical scoring of speech intelligibility was carried out by a trained SLT, native 
speaker, independent of the study according to the instructions of the speech 
intelligibility assessment (see methods below) and as directed by the author. The 
acoustical analysis of the speech samples was carried out by the author. The 
aerodynamic data were analysed by the author. The Electropalatography (EPG) analysis 
was carried out jointly by Dr M. Hartinger and the author, under the guidance of Prof 
W. Hardcastle at Edinburgh University. 
2.3.2 Clinical scoring of motor symptoms for dystonia: Burke-Fahn-Marsden dystonia 
rating scale (BFM) 
The BFM was used for the evaluation of motor symptoms of the dystonia patients 
(Burke et al, 1985). The BFM is divided into two parts, the movement scale and the 
disability scale. The BFM movement score ranges from 0 to 120 and is the sum of body 
region items for the eyes, face/mouth, speech/swallow, neck arms trunk and legs. The 
arms and legs are scored separately for right and left sides; the other regions carry a 
single score. For each body region the score is derived from the product of a provoking 
factor (0 to 4) and a severity factor (0 to 4), multiplied by a weighing factor, where zero 
represents no dystonia. The provoking factor ranges from dystonia present with a 
specific action =1 to present at rest =4 while the severity factor ranges from slight =1 to 
severe =4. A severity factor of 4 corresponds to no useful grip of the hand or inability to 
walk. The weighing factor for eye, mouth and neck regions is 0.5 reflecting their lesser 
impact on disability and 1 for the remaining regions.  
The total disability score ranges from 0 to 30 and is the sum of scores for seven 
functional items: speech, handwriting, feeding, swallowing, hygiene, dressing and 
walking. All disability score items are rated (0 to 4) except walking which is (0 to 6). 
The BFM is the most widely used dystonia scale in studies of GPi-DBS for dystonia 
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(Cif et al, 2003; Yianni et al, 2003; Coubes et al, 2004; Vidailhet et al, 2005; Kupsch et 
al, 2006). It has however been criticised for having a single item dedicated to both 
speech and swallowing, which may not reflect accurately the effects of various 
treatments of dystonic movements associated with speech and swallowing.  
2.3.3 Clinical scoring of motor symptoms for PD: Unified Parkinson’s Disease Rating  
The UPDRS is the most widely used scale for measuring symptoms and signs of 
patients with PD in clinical practice (Siderowf et al, 2002). The UPDRS consists of 42 
items in four sections assessing (I) mentation and mood (4 items), (II) activities of daily 
living based on historical information (13 items), (III) motor function based on clinical 
examination (14 items) and (IV) complications in patients on dopaminergic therapy 
based on historical information (11 items). Each of the 14 items of the motor part (III) is 
given a rate between 0 – no abnormality and 4 – severe abnormality. Some of the items 
(symptoms) are rated for the different body parts, for example tremor at rest (item 20) is 
rated for the head and neck, right and left upper and lower limbs respectively. As a 
consequence, the maximum score (all items rated as severe) is 108. Maximum points for 
the different parkinsonian symptoms are as follows: speech (4), facial expression (4), 
tremor (28), rigidity (20), akinesia (32), axial symptoms and gait (20). High internal 
consistency (Martinez-Martin et al, 1994), inter-rater reliability (Richards et al, 1994) 
and test-retest reliability (Siderowf, 2002) have been shown for the part III UPDRS, not 
though for the speech and facial expression item (Richards, 1994). 
2.4 Speech recording set up 
The speech lab at the Unit of Functional Neurosurgery was set up according to the 
guidelines of the National centre for Voice and speech. The room was sound-treated and 
the ambient noise of no more than 50 dB at the centre of the room. All efforts were 
made to minimise noise from the computers, and the room does not have air 
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conditioning or other source of noise (according to Titze, (1995, p 29); given that 120 
Hz is very close to the average normal male speaking F0 special care should be given to 
the removal of noise sources in the room that create a 60 Hz hum and its associated 
harmonics). The equipment comprised:  
• a Shure SM48 unidirectional dynamic microphone with a wide frequency 
response of 55 to 14,000 Hz 
•  The Computerised Speech Lab (CSL), Kay Pentax 4150, with its recording 
software 
• A B&K class I Sound Level Meter (SLM), model 2100, calibrated  
• A Sony HD camcorder and a tripod 
• Chair without wheels and no arms 
• A DAT machine for recordings outside the speech lab 
• The Aerophone II, Kay Pentax for aerodynamic recordings  
• EPG software for analysis of EPG data (not acquisition) and the dongle 
• Backup of all files though the back up system of Sobell department.  
2.4.1. Set-up and computerised acquisition 
The recordings of all speech samples were made according to the recommendations 
from the Workshop on Acoustic Voice Analysis (Titze, 1995, NCVS) and Kent et al, 
1999. All recordings were made in a sound-treated room about 4m x 3m x 2m with the 
participants seated on a chair with no arms. The audio signal was picked up by a Shure 
SM 48 dynamic microphone kept at a constant distance of 15 cm from the mouth in an 
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off-axis positioning (45 to 65 degrees from the mouth axis) to avoid respiratory sounds. 
We did not use a head mounted microphone for two reasons: 1. patient comfort: some 
of the immediate post-operative recordings were done with the head bandages still on. 
Winholz & Titze (1997) advise that the microphone cable of the head mounted 
microphone should have a strain relief to eliminate motion noise that can be conducted 
through the cable, which would have been uncomfortable for newly operated patients. 2. 
There is a possibility of electromagnetic interference because the electrical output of the 
microphone is unbalanced from the microphone to the connector (at the time of starting 
our recordings Medtronic advised against the use of head mounted microphones). 3. 
The effect of aerodynamic artefacts with consonants and rapid voice onset-offset at 
close mouth-to-microphone distances awaits further study: Winholz & Titze (1997) do 
not recommend the head mounted microphone for connected speech tasks. The 
sampling frequency was at 22 kHz. For the aerodynamics and EPG data acquisition the 
methodology is described in the relevant chapters. 
2.4.2 Calibration for loudness data  
Measurement of speech intensity (and its subjective correlate loudness) can be made 
directly by placing a sound level meter at a specified distance from the speaker’s mouth 
(Ramig et al, 2001), or by indirectly converting the microphone signal to a decibel (dB) 
level (e.g. Winholz & Titze, 1997). The purpose of the calibration procedure is to obtain 
a decibel equivalent for the output voltage of the microphone. We used a steady 
vocalisation of the patient instead of an external sound source for ease of reference. 
Patient was positioned at 15 cm from the recording microphone and the calibrated 
sound level meter (SLM) (they are mounted alongside on the stand, at the same distance 
form the patient, see figure 2.1). The distance was checked periodically to ensure 
stability. This signal (patient vocalisation) was used during the computerised data 
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measurement to obtain calibrated intensity measurements of the speakers’ voices. The 
level shown on the sound level meter was then announced and recorded onto the CSL to 
allow a conversion of the CSL dB values to dB SPL (Dromey et al, 2002). The analysis 
is then based on the difference between the known reference value of the sound source 
(patient vocalisation) as recorded in the calibrated sound level meter and the processed 
value of the calibration tone (Winholz & Titze, 1997). 
 
Figure 2.1. Photograph of calibration method for collection of loudness data. From 
Asplund A, How loud was it? A calibration system for voice recording in clinical and 
research situation. 
2.5 Speech tasks 
Following the calibration method the patients were instructed to “take a deep breath and 
say /aaaa/ for as long and as loud as you can”. They were instructed to say the /aaa/ 
three times. Then they were instructed to read aloud the sentences from the Assessment 
of Intelligibility of the Dysarthric Speech (Yorkston et al, 1988). The sentences are 
printed in a single A4 page with font size 18 from the computerised version of the test. 
Then patients were asked to “talk for one minute about anything they want to talk 
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about” and they were given a topic (e.g. “what did you have for breakfast?”, “how did 
you come here?”, “how has it been since the operation?” etc), only if they could find 
nothing to talk about themselves. The sequence of instructions was the same for each 
speaker. The 15 cm mouth-to-microphone distance was checked periodically. At no 
time were tasks modelled by the experimenter because it was felt that this could 
influence the speaker’s performance.  
2.6 Speech acoustic analysis  
The contemporary understanding of vocal tract acoustics is based on the linear time-
invariant source-filter model (Fant, 1970). The source-filter concept proposes that 
acoustic energy generated by a sound-source is passed through a frequency dependent 
transmission system. The task of speech analysis therefore is to identify the sound 
source and to describe the corresponding filter function. There are three major sources 
to be considered: 1. laryngeal voicing source for the vowels, 2. turbulence noise source 
for the fricatives, and 3. transient source for the release of stop consonants.  
Acoustic analyses may be classified broadly as time-domain, frequency-domain and 
time-frequency domain analyses. A waveform or an energy envelope is time-domain 
analysis; a Fast Fourier Transform (FFT) spectrum or Linear Predictive Coding (LPC) 
spectrum is frequency-domain analysis. A spectogram is a time-frequency domain 
analysis (Kent 1993, Vocal tract acoustics). Another way to interpret speech data is 
according to their function: deterministic data focus on individual spectral-temporal 
features that relate to an aspect of speech production. For example, formant-frequency 
values pertaining to a particular vowel may be used to infer features of lingual 
articulation during that segment. Thus the objective of deterministic analysis is to infer 
some property of speech from individual events in the acoustic record. Stochastic data 
are statistical features typically collected over long samples. The Long Term Average 
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Spectrum (LTAS) may be used to characterise the overall energy patterns for a 
particular speaking task. The LTAS may not say anything about a specific event of 
speech but it describes the average energy calculated for a relatively long duration of 
the sample. It is similar to a histogram of vocal fundamental frequency (F0) determined 
from a long sample of speech which does not indicate how F0 varies with individual 
segments such as vowels and consonants but it portrays the distribution of values over a 
defined sample. Thus the assumption for using the LTAS is that the influence of various 
vocal tract resonances on spectral shape will average out across the sample (typically 
more than 40 seconds) yielding a measure that approximates the overall source 
contribution (Kreiman, 2007).  
2.6.1 Trimming of data files 
All data files (from sustained phonation, speech intelligibility and monologue) were 
inspected for non-speech vocal sounds such as loud cough or laughing that could 
interfere with speech intensity measurements. These were carefully trimmed so as not to 
remove any speech sounds as well. 
2.6.2 Loudness analysis for phonation and connected speech 
In order to calculate the mean sound pressure level of the sustained phonation the 
middle four seconds of the second trial were anlysed, using the CSL, energy contour. 
For the analysis of connected speech the maximum value was taken and the mean was 
calculated from the voiced peaks. 
2.6.3 Calculation of long-term average spectra  
The CSL LTAS algorithm was used for the analysis of the mean and standard deviation 
of both read sentences and connected speech samples. For the LTAS analysis the 
window length was 8192 points and the statistical moments were calculated 
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automatically by CSL for the entire frequency range of 0 to 22 kHz.  
 
2.7 Auditory-perceptual evaluation of voice quality 
Darley et al (1975, 1969) performed the seminal investigations that defined perceptual 
features of dysarthrias. In those studies three raters performed perceptual assessments of 
the speech of 212 neurologically impaired patients as they read the “Grandfather 
passage”. Thirty six individual speech dimensions and two general dimensions 
(intelligibility and bizarreness) were assessed on a seven-point scale. Of the sample 32 
patients had IPD and were classified as demonstrating a hypokinetic dysarthria. This 
dysarthria classification was based upon the most striking perceptual phenomena that 
consisted of monotony of pitch and loudness, reduced stress and imprecise consonants. 
In addition the single speech dimension of imprecise consonants was most highly 
correlated with the overall dimensions of intelligibility and bizarreness. Though nearly 
four decades have ensued, the Darley et al classification system of dysarthria has 
remained relatively intact (Kent et al, 2001) and is widely used by clinicians for 
diagnosis and treatment planning. Recently Plowman-Prine (2009) and colleagues have 
replicated this early work in 16 IPD patients on- and off-medication. They grouped the 
35 speech dimensions listed by Darley et al (1975) under six speech clusters. Our study 
follows the same methodology. The AIDS intelligibility sentences were used for rating 
both the speech intelligibility and the perceptual dimensions. Each speech dimension 
was assessed on a seven-point interval scale, where “one” represented the greatest 
deviation from normalcy and “seven” represented normalcy. So a score of 42 denotes 
“normal” sounding speech and a score closer to 0 denotes a greatest deviation. 
Perceptual analysis was performed independently in the same quiet speech lab, and with 
the same equipment so as to minimize variability across raters and listening tasks. The 
rater was blinded as to the patient and the stimulation/medication status as well as the 
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time of assessment. Speech samples were played using the CSL with Sennheiser HD500 
headphones. Assessment of overall intelligibility was determined at the beginning, so as 
to eliminate familiarity effects from re-reviewing a given sample. Thus the rater listened 
to 220 speech samples of the AIDS sentences (four samples for each of the 55 patients, 
two pre-operative ones and two at one year). Each sample could be looped for a 
maximum of six times in succession, one for each dimension. The rater completed the 
assessment in six 5-five hour sessions (total of 30 hours to complete the evaluation). 
Mean speech ratings were calculated individually for each of the 35 speech dimensions 
and collectively for the six speech clusters across medication/stimulation states. 
2.7.1 Rating speech intelligibility 
Intelligibility is a measure of the effectiveness of speech and it is usually expressed as 
the percentage of a message that is understood correctly. Intelligibility of speech 
depends both on audibility and clarity. Comprehensibility is defined as “contextual 
intelligibility” or intelligibility when contextual information is present in different 
forms, such as semantic cues, syntactic cues, orthographic cues and gestures (Yorkston 
et al, 1996). Improved intelligibility is often a primary goal of speech therapy (Yorkston 
et al, 1999). Ways to assess intelligibility vary. Scaling methods include equal 
appearing interval scale (EAIS) (e.g. UPDRS), Visual Analogue Scale (VAS); 
transcription is when the listener transcribes the words produced by the talker. Scoring 
is typically done by counting the number of words correctly transcribed. However when 
applied in conversation it must be assumed that the talker’s intent is known. There are 
Single Word Identification Tests and Sentence Intelligibility Test (e.g. Assessment of 
Intelligibility of the Dysarthric Speaker, Yorkston & Beukelman, 1981). The AIDS is 
the most widely used intelligibility assessment (Duffy, 2005) and it is based on the 
transcription of random sentences of varied length from five to 15 words (total words 
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110). Sentence samples are generated by randomly selecting one sentence (for the short 
version we used in this study) from a master pool of 100 sentences of each length from 
the computerised version of the test (Sentence Intelligibility Test). All of the sentences 
were selected from adult level reading material and have the following characteristics: 
1) phrases and sentences containing five to 15 words with contractions counted as 
single word, 
2) words chosen from the 30,000 most frequently occurring (Thorndike & Lodge, 
1944), 
3) phrases and sentences containing no quotations, parentheses, proper names, 
hyphenated words or numbers larger than 10. 
In our study we followed the instructions in the AIDS manual, namely that “the number 
of judges required for reliable results depends on the purposes of the intelligibility 
measurements. If the purpose is the monitoring of change in an individual dysarthric 
speaker over time, a single judge is sufficient, provided that the judge is the same 
individual each time” (pp 5-6). 
There is no consensus in the literature as to how many raters are needed for 
intelligibility or whether experience with dysarthric speech makes a difference. 
Hammen et al (1994) provided a guide, which seems ideal. They used a 5 x 5 Latin 
square (Listeners x Sentences) for each of their subjects, with the five conditions 
counterbalanced under the rows and the columns of the square (as suggested in Edwards 
1985, Experimental design in psychological research. New York: Harper and Row). 
Thus, for five sentences of each of five conditions spoken by six patients one would 
need 30 listeners. The advantage of this design is that a reduced number of listeners are 
required to obtain measures of intelligibility. Because each listener is presented a 
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different sentence for each condition, the problem of listener familiarity confounding 
the intelligibility measure is avoided. This design would also eliminate the need to 
determine the reliability of the listeners using correlation methods. Therefore relative 
homogeneity of the variables assigned to the rows and columns (i.e. listeners and 
sentences) is assumed. However this design has not been replicated since. The majority 
of the studies on speech intelligibility in PD have from five patients (Neel, 2009) to 10 
(De Letter et al, 2007; De Letter et al, 2005; Yunusova, 2005; Tornqvist, 2005; Keinz et 
al, 2007; Goberman & Elmer, 2005) and they recruit from three expert listeners (De 
Letter, 2007) to 60 (Yunusova, 2005). Miller et al (2008) had 104 PD patients and 45 
carers to assess self perception of speech changes. For a previous study looking at the 
prevalence of intelligibility problems Miller et al (2007) had 125 patients rated by 99 
unfamiliar listeners.  
The methodology for the studies on aerodynamic measures and electropalatography are 
described in the relevant chapters. 
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CHAPTER 3: LONGITUDINAL STUDY OF THE EFFECTS 
OF STN-DBS ON SPEECH IN CONSECUTIVE SERIES OF 
PATIENTS.  
3.1 Summary   
Studies on speech outcome following bilateral STN-DBS have focused on selected 
patients and selected speech tasks with lack of pre-operative data. Similarly there was 
no detailed description of perceptual speech changes following STN-DBS. There was 
also a lack of information on surgical factors that could affect speech, (i.e. active 
contact location and amplitude of electrical parameters of stimulation) as well as 
clinical factors (i.e. age, disease duration, speech before surgery, speech response to 
medication and stimulation) that could predict speech outcome. Patients’ own 
perception of how these speech changes affect their quality of life has not been 
investigated either.  
 
The aims of this study were: i) to prospectively examine the short- and long-term 
response to STN-DBS on speech intelligibility in a consecutive series of patients, ii) to 
analyse speech changes using a wide range of perceptual and acoustical measures, iii) to 
identify clinical and surgical factors associated with speech changes, and iv) to examine 
their impact on quality of life using the Voice Handicap Index. 
 
Study 1: Thirty-two consecutive patients with PD were assessed before surgery on- and 
off- medication, then one month, six months and one year after STN-DBS in four 
conditions on- and off-medication with on- and off-stimulation. Fifteen of these patients 
were followed up for three years. A control group of 12 PD patients, randomly assigned 
to medical treatment, were followed up for one year. The speech evaluation protocol 
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consisted of a standardised speech intelligibility scale, maximum sustained phonation 
and a one-minute monologue. Movement was assessed using the motor part (III) of the 
Unified Parkinson’s Disease Rating Scale (UPDRS-III). Data are presented as in means 
± standard deviations. 
 
Speech intelligibility significantly deteriorated following one year of STN-DBS by an 
average of 14.2±20.15% off-medication and 16.9±21.8% on-medication compared to 
respectively 3.6±5.5% and 4.5±8.8% in the medical group. Seven patients showed 
speech amelioration after surgery. Loudness increased significantly in all tasks with 
stimulation. Medially placed electrodes on the left brain were associated with a 
significantly higher risk of speech deterioration than electrodes inside the nucleus. 
There was a strong relationship between high voltage in the left brain and poor speech 
outcome at one year. 
 
Study 2: A further 22 patients (total N=54) were assessed, before and one year after 
surgery, with the same speech protocol, in order to analyse in more detail the perceptual 
speech changes and any associated clinical or surgical predictive factors. There was a 
significant decline mainly in articulation and prosody. Multivariate regression with left 
brain contact position as covariate showed that the strongest predictors of speech 
intelligibility off-medication/on-stimulation at one year were the pre-operative on-
medication speech intelligibility, the pre-operative on-medication motor score, the 
disease duration, and the left brain active contact location (medial vs inside). 
 
Study 3: In order to assess the self perception of speech changes, a subgroup of 20 
patients were asked to rate current post-surgery speech difficulties using the Voice 
Handicap Index (VHI) and used the same measure to retrospectively rate their pre-
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surgery voice. A control group of non-surgical PD patients also completed the VHI. 
VHI scores deteriorated equally in the two groups. However the variability of the 
change in the surgical group was significantly greater than the one in the non-surgical 
group. Correlations between VHI scores and speech intelligibility were significant, both 
before and after surgery, suggesting good validity for both measures. Influence of STN-
DBS on speech is variable and multifactorial, with most patients exhibiting some 
deterioration of speech intelligibility. Both medical and surgical factors need to be taken 
into account when managing these patients. 
 
3.2 Study 1: Effects of bilateral STN-DBS on speech intelligibility and movement 
in consecutive PD patients over time 
Study 1 aimed at describing the speech changes following bilateral STN-DBS over time 
in consecutive PD patients, using a wide range of speech tasks and methods of 
acoustical analysis, and to appraise the role of electrode position and voltage amplitude. 
3.2.1 Patients and methods 
Thirty-two consecutive patients (23 men) were implanted with bilateral STN-DBS 
electrodes between 2005 and 2006 and were included in the study (henceforth surgical 
group). Their mean age was 58.8 years (±6.3, range: 42 to 69). Mean disease duration at 
the time of surgery was 12.5 years (±4.7, range: 6 to 25). The levodopa equivalent daily 
dose (LEDD) (calculated as in Williams-Gray et al. 2007) was 1556 (±671) mg/day. 
Their mean motor score (UPDRS-III) before surgery, without medication was 48.1 
(±17.9, range: 20-89) and with medication 12.4 (±7.8, range: 2-31). 
  
All 32 patients were followed up for one year, and 15 of them were followed up for 
three years after surgery. Twelve patient candidates for DBS, who had been randomised 
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to one year medical treatment as part of a separate study, were used as a control group 
(henceforth “medical group”). Their mean age was 55 years (±9.7, range: 36-69); mean 
disease duration at the time of baseline assessment was 13.2 years (±6, range: 7-26). 
Their mean motor score (UPDRS-III) before surgery without medication was 48.9 
(±10.6, range: 28-62) and with medication 14.1 (±5.2, range: 5-20). 
  
Surgical procedure and contact localisation 
Surgery was performed as previously described (Hariz et al, 2002; Hariz et al, 2003; 
Chen et al, 2006 and Chapter II-Methods). Preoperative stereotactic MR images using 
T2-weighted, fast-acquisition sequences were obtained in all patients12. The subthalamic 
target was visualized on MR images and directly targeted using planning software 
(FrameLink4™, Version 2003, Medtronic®, Minneapolis). Dynamic impedance 
monitoring and electrical stimulation combined with clinical assessment were used to 
provide an indication of the target. Patients were thus implanted bilaterally with a 
quadripolar DBS electrode (Model 3389 DBS lead, Medtronic®, Minneapolis). Post-
operative stereotactic MR images were imported into the planning software allowing 
three-dimensional reconstruction of the images along the electrode trajectory 
(Framelink, Medtronic, MN). Stereotactic localisation of the four electrode contacts was 
performed using a template superimposed on the electrode artefact. The coordinates of 
each contact were transposed onto the pre-operative stereotactic MR images. The 
targeting accuracy, the Eucledian error, defined as the perpendicular distance from the 
electrode trajectory to the intended target coordinates, was calculated geometrically 
from the stereotactic images (Chen et al, 2006; Yelnik et al, 2003). Three neurosurgeons 
(LZ, EH, EP), blinded to the results of STN-DBS on speech, independently assessed 
and agreed on the anatomical position of each contact in relation to the visualised STN 
in the axial and coronal planes. The visualised STN was subdivided into five segments: 
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superior (A), anterior-medial (B), central (C), posterolateral (D) and inferior (E) (Figure 
3.5). Each contact was localised in relation to the closest STN segment and classified as 
being inside, superior, medial, inferior or lateral to that segment. Each contact was 
given two ratings: one based on the anatomical localisation around the STN and its 
surrounding structures; and one based on the STN segment. 
 
3.2.1.1 Patient evaluation 
Patients were assessed after overnight withdrawal of medication at baseline, two weeks 
post-operatively, and six months, one year (N=32) and three years (N=15) post bilateral 
STN-DBS in all four medication and stimulation conditions. Evaluations were carried 
out on the same day for each patient and in the same order. For the off-medication/on-
stimulation condition drugs were withdrawn for at least 12 hours. The on-
medication/on-stimulation assessment took place one hour after the administration of a 
supra-threshold dose of levodopa. For the off-medication/off-stimulation condition 
stimulation was withdrawn for 20-30 minutes before the evaluation, depending on the 
patient’s tolerance. One patient could not be assessed without medication at one year, 
and three patients were not taking any medication at one year.  
 
Speech assessment consisted of three tasks: sustained vowel phonation /a:/ for three 
repetitions, the Assessment of Intelligibility for Dysarthric Speech (AIDS) (Yorkston & 
Beukelman 1981) and a 60-second monologue about a topic of the speaker’s choice (see 
Chapter 2). The Computerised Speech Lab (CSL, 4150, Kay Pentax) was used for 
recording and analysis of all samples. Following speech recordings, movement was 
assessed in all conditions using the UPDRS-III (Fahn and Elton, 1987). 
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3.2.1.2 Data analysis 
Acoustic recordings and analysis were performed as previously described (Methods 
section). The 256 files from the sentence intelligibility test for the 32 patients of the 
surgical group, the additional 30 for the 15 patients followed up for three years and the 
48 files for the medical group were rated blindly, and a percentage of words correctly 
identified was derived. For the acoustical analysis of intensity of sustained phonation, 
reading and monologue we calculated the mean vocal sound pressure level (SPL dB) 
measure from the speech recording of each condition. After obtaining the mean SPL for 
each individual phonation, data were averaged across all maximum duration sustained 
vowel phonations to obtain an overall average mean SPL for sustained phonation (as per 
Ramig, 1995). The long-term average spectrum (LTAS) is a fast Fourrier transform-
generated power spectrum of frequencies represented in the acoustic voice signal. By 
averaging across all speech sounds the LTAS provides insights into the function of the 
voice and the movement of the articulators in connected speech (Dromey, 2003; Duffy, 
2005). For the LTAS analysis the window length was 8,192 points and the statistical 
moments were calculated automatically by CSL for the entire frequency range of 0 to 
22 kHz. 
  
UPDRS-III subscores were divided as follows: rigidity (item 22, range 0-20), tremor 
(item 20-21, range 0-28), axial symptoms (item 27-30, range 0-16), speech (item 18, 
range 0-4) and akinesia (item 23-26, range 0-32).  
 
3.2.1.3 Statistical analysis 
The primary outcome was the change in speech intelligibility from baseline to 12 
months in the surgical group. In addition, a linear regression mixed effects model was 
used to assess the overall effect of time on the measurements. For this analysis patients 
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were declared as random effects, with time as the fixed effect to be estimated. 
Independent t-tests were used to compare the change in speech and motor scores 
between the surgical and medical groups. Acoustic data and motor scores were the 
secondary outcomes. Continuous variables are presented using mean (SD). Univariate 
analysis of variance (with two factors: anatomical description and STN segment) was 
used to explore the impact of contact location on speech outcome. Statistical analysis 
was performed on SPSS-16 for Mac (SPSS, Chicago, IL) and Prism 5 for Mac 
(GraphPad software, Inc.) and was supervised by a statistician (Mr Michael Roughton, 
Senior Statistician at the Cancer Research UK & UCL Cancer Trials Centre). 
 
3.2.2 Results 
3.2.2.1 Surgical group: speech and motor function at one year 
Speech intelligibility (using the AIDS) deteriorated on average by 14.2 ±20.1% 
(p<0.001) after one year of STN stimulation when the patients were off-medication/on-
stimulation compared to off-medication state preoperatively, and by 16.9±21.8% 
(p<0.01) when the patients were on-medication/on-stimulation compared to on-
medication state pre-operatively (Table 3.1 and Figure 3.1). There was substantial 
variability. Speech intelligibility deteriorated in 25 patients (range: -77% to -3%) and 
improved in seven patients (range: 2% to 17%). UPDRS-III speech item 18 identified 
only 12 patients with speech deterioration. There was a significant change of speech 
intelligibility between six months and one year but not between baseline and six 
months. When off-medication/off-stimulation speech intelligibility deteriorated on 
average by 12.6±16.6% (p<0.001) compared to off-medication pre-operatively. 
Switching the stimulation off improved speech intelligibility by 1.5% (n.s.) compared to 
the off-medication/on-stimulation condition.  
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Table 3.1: Speech intelligibility (% of words understood) for the surgical (N=32) and 
medical (N=12) groups at baseline, one month, six months and one year follow-up (the 
surgical group: on-stimulation) (mean ± SD). 
 
Time Surgical group Medical group 
 Off-medication On-medication Off-medication On-medication 
Baseline 75.3 ± 18 77.6 ± 15 74.2 ± 5.6 76.3 ± 5.8 
One month 70.4 ± 19  71± 17    
Six months 70.2 ± 18 69.4 ± 19    
One year 62.7 ± 27 ** § 61.7 ± 26** 70.5 ± 7.9* 71.8 ± 8.4 
*p<0.05, ** p<0.001 for overall effect of time § N=31 
 
Figure 3.1: Speech intelligibility (% of words understood) for the surgical group 
(N=32) at baseline, post-operatively, six months and one year post bilateral STN-DBS 
(on-stimulation) (mean +/- sem). 
 
In terms of speech subsystems, loudness (SPL dB) increased by 7.4 dB for read 
sentences (p<0.0001), by 7.2 dB for monologue (p<0.0001) and by 9.9 dB for phonation 
(p<0.0001) in the off-medication/on-stimulation condition at one year (table 3.2 and 
figure 3.2). There was an increase of the LTAS means for reading (p<0.05) and 
phonation (p<0.001) for the one-year off-medication/on-stimulation condition (table 
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3.3).  
 
Table 3.2: Sound Pressure Level (SPL in dB) means (SD) for the surgical group at 
baseline on- and off-medication, six months and one year. 
 
* denotes p<.05 and ** denotes p<.001.  
Table 3.3: Long Term Average Spectra (LTAS) means (SD) for the surgical group at 
baseline on- and off-medication, six months and one year.  
*denotes p<.05 and ** denotes p<.001. 
 dBSPL 
sentences  
dBSPL 
monologue 
dBSPL 
phonation 
Baseline off-medication 
 
64.8 (5.7) 64.2 (5.5) 66 (8.1) 
               on-medication 
 
69.1 (5.8) 69.4 (5.8) 69.3 (6.9) 
six months  
off-medication/on-stimulation 
 
 
70.3 (6.8) ** 
 
70.5 (7) ** 
 
70.4 (8.8) ** 
 Six months 
 on-medication/on-stimulation 
 
 
70.6 (6.1) 
 
70.7 (5.5) 
 
73.8 (7) * 
one year  
off-medication/on-stimulation 
 
 
72.2 (6) ** 
 
71.4 (6.9) **  
 
75.2 (6.9) ** 
one year 
 on-medication/on-stimulation 
 
 
74.3 (6.7) ** 
 
74.7 (6.8) * 
 
78 (5.6) * 
 LTAS 
sentences  
LTAS 
monologue 
LTAS 
phonation 
Baseline off-medication 
 
252 (97.1) 267.2 (108) 440 (202) 
               on-medication 
 
289 (100.9) 276 (105.7) 491 (220) 
six months 
off-medication/on-stimulation 
 
 
299.2 (129.7) 
 
287.1 (120.1) 
 
548 (221) * 
six months 
on-medication/on-stimulation 
 
 
302.2 (113.8) 
 
304 (135.1) 
 
567 (229) 
one year  
off-medication/on-stimulation 
 
 
289.7(121.8)* 
 
278.1 (115.5) 
 
621 (233) ** 
One year 
on-medication/on-stimulation 
 
 
318 (121) 
 
316 (115.4) 
 
638 (196) * 
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Figure 3.2: Sound Pressure Level (dB) for reading, monologue and phonation for the 
surgical and medical groups (mean +/- sem). 
 
Mean off-medication motor score as measured by the UPDRS-III improved with STN 
stimulation from 47.3±17.8 before surgery to 20.5±11.19 at six months (p<0.0001) 
(56.6% improvement) and 23.3±11.6 at one year (p<0.0001) (50.7% improvement). On-
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medication scores did not significantly change over one year. UPDRS-III score was 
12.4±7.8 pre-operatively, 10.1±7.4 at six months and 13.9±9.6 at one year. The 
levodopa equivalent daily dose (LEDD) was reduced over one year from 1556±671 mg 
to 744±494 mg (52%, p<0.0001). The mean (SD) targeting electrode accuracy was 1.3 
(0.6) mm. The mean amplitude of stimulation at six months was 2.9±0.7 V for the left 
electrode and 3.0±0.6 V for the right electrode with mean frequency 133 Hz and mean 
pulse width 61µsec. The mean amplitude at one year was 3.1±0.8 V for the left 
electrode and 3.2±0.5 V for the right electrode with the same frequency and pulse 
width. There was no significant difference between right and left electrode settings at 
six months and one year.   
 
3.2.2.2 Medical group: speech function at one year 
Speech intelligibility in the medical group (N=12) declined by 3.6±5.5% (p<0.05) in the 
off-medication condition and 4.5±8.8% in the on-medication condition (Table 3.1 and 
Figure 3.3). This decline was not significantly smaller than the one of the surgical group 
(p=0.06 for the change on-medication and 0.08 for off-medication). Eight out of 12 
patients (66%) had some degree of speech worsening (range: -13% to -2%). For the 
medical group, loudness did not change significantly at one year with or without 
medication in any of the speech tasks. Similarly, LTAS means did not significantly 
increase over one year apart from the off-medication reading task. 
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Figure 3.3: Speech intelligibility (% of words understood) for the medical group 
(N=12) at baseline and one-year post (mean +/- sem) 
 
3.2.2.3 Surgical group: speech function at three years  
Fifteen patients out of the 32 initial patients were followed up for three years (table 3.4). 
Out of these, one patient could not be assessed without medication and one patient did 
not take any medication at three years. In this subgroup, speech intelligibility 
deteriorated from 76.2% (±19.4, N=15) pre-operatively in the off-medication condition 
to 59.5 (±36.8, N=14) in the off-medication /on-stimulation condition three years after 
(p=0.019) (figure 3.4). On-medication speech intelligibility deteriorated from 75.7% 
(±16.8, N=15) at baseline to 59.8% (±32.9, N=14) (p=.03) at three years. The average 
deterioration in the off-medication/on-stimulation condition from year one 
(69.07±26.1%) to year three (59.5±36.8%) was 10% (figure 3.1). Detailed examination 
showed six patients improving slightly over three years of stimulation (mean 
improvement +3%) and six patients deteriorating (mean deterioration -44.6%). The 
amplitude of stimulation at three years (3.2 V left, 3.5 V right) was not significantly 
different from year one. Four patients deteriorated more than the average. Two of those 
  
 143 
patients changed their contacts from monopolar to double monopolar with increased 
amplitude. The other two patients had increased voltage. Six patients improved from 
year 1 to year 3 by 7.1% and their improvement was associated with reduced amplitude 
(Volts) of stimulation. 
Table 3.4: Baseline characteristics of the surgical group followed-up for one year 
compared to the surgical group followed-up for three years (mean ± SD). 
 
 
 
 
 
 
 
 
 
Baseline characteristics 
(N=32) 
Patients followed-up 
for one year (N=17) 
Patients followed-up for 
three years (N=15) 
P value 
Age 57.5 ± 7.4 60.2± 4.6 ns  
Time since diagnosis 10.5 ± 3.1 14.4 ± 5.3 0.02 
male 15 7  
UPDRS-IIIoff-medication 47.4 ± 17.7 48.9 ± 18.8 ns 
UPDRS-III on-medication 12.6 ± 8.0 12.1 ± 7.9 ns 
Speech intelligibility off-
medication 
 
74.5± 17.1 
 
76.2 ± 19.4 
 
ns 
Speech intelligibility on-
medication 
 
79.2 ± 13.7 
 
75.7± 16.8 
 
ns 
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Figure 3.4: Speech intelligibility (% of words understood) for the surgical group 
(N=15) at baseline, one month, six months, one year and three years post bilateral 
STN-DBS (on-stimulation) (mean ± sem). 
 
3.2.2.4 Effect of active electrode position on speech intelligibility 
A univariate analysis of variance was used to assess the impact of the position of the 
stimulated contact (see methods) for the left and the right brain, on speech response 
over one year of STN-DBS. In 19 patients the left stimulated contact was inside the 
STN [mean speech change -7.89%, (16.1)], in 11 patients it was medial [mean change -
22.4% (22.4)] and in one patient it was lateral (-45%) (Table 3.5). 
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Table 3.5: Mean speech change (sd) (off-medication/on-stimulation at one year minus 
off-medication pre-operatively) per contact classified according to anatomical 
localisation around the STN area and the STN segment for the left and right brain 
(N=31: one patient could not be assessed without medication at one year).  
 
Anatomical 
localisation 
STN 
segment 
Left brain Right brain 
  Mean 
speech 
change (sd) 
Number of 
contacts 
Mean 
speech 
change (sd) 
Number of 
contacts 
Inside the 
STN 
A 
B 
C 
D 
E 
Total 
6.6 (11.2) 
-5  
-11.8 (12) 
-31 (22) 
2 
-7.8 (16.1)  
5 
1 
10 
2 
1 
19 
-7.2(21.4) 
2 
-15 (12.9) 
 
 
-9.9 (17.4) 
7 
1 
6 
 
 
14 
Superior to 
the STN 
A 
Total 
  -7 
-7 
1 
1 
Medial to 
the STN 
A 
B 
C 
D 
E 
Total 
-15.7(14.2) 
-31(35.4) 
-22 
 
-19 (12.7) 
-22.4(22.4) 
4 
4 
1 
 
2 
11 
 
-77 
-14.2(16.7) 
-16.8(20.3) 
 
-19.2(23.1) 
 
1 
9 
5 
 
15 
Lateral to 
the STN 
A 
B 
C 
D 
 
 
-45 
 
 
 
1 
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E 
Total 
 
-45  
 
1 
-7 
-7 
1 
1 
Total A 
B 
C 
D 
E 
Total 
-3.3 (16.6) 
-25.8(32.8) 
-15.4(14.6) 
-31(22.6) 
-12(15.1) 
-14.2 (20.1) 
9 
5 
12 
2 
3 
31 
-7.2(19.8) 
-37.5(55.8) 
-14.5(14.8) 
-16.8(20.3) 
-7 
-14.2 (20.1) 
8 
2 
15 
5 
1 
31 
 
Anatomical localisation and the STN area are divided into inside the STN, superior, 
medial and lateral to the STN. There were no electrodes inferiorly to the STN. The 
segments of the STN are A: superior, B: anterior-medial, C: central, D: postero-lateral, 
and E: inferior. For further information refer to Figure 1. 
 
Speech deterioration was significantly less for the electrodes positioned inside the STN 
than those positioned medially or laterally to the STN (p=.016). The difference of 
speech change in different segments inside the STN on the left brain was not significant 
(p=.082). However, pairwise comparison showed that speech was on average improved 
for the contacts in the superior part of the STN [+6.6% (11.2)] rather than the 
posterolateral part [-31% (22.3)] (p=.014). A p-value of .05 was taken to be significant 
for all analyses, although this should be viewed in the context of the number of tests 
performed. For the right brain, 14 patients had the stimulated contact positioned inside 
the STN [mean change -9.9% (17.4)], one patient superiorly (mean change -7%) and 15 
patients medially [mean change -19.2%, (23.1)] (Table 3.5 and Figure 3.5). There was 
no significant difference between STN segment or anatomical localisation and speech 
change for the right brain.  
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Figure 3.5: Location of the active contacts in all patients (N=31) at one year post 
bilateral STN-DBS as transposed onto the Schaltenbrand atlas adopting the 
radiological imaging convention (right STN on the left side of the image). Top: coronal 
view adapted from plate 27, f.p. 3.0. Contacts related to the superior (A) and inferior 
(E) segment of the STN are shown. The middle section of the STN in coronal view is 
further subdivided into three segments in the axial plane shown below. Bottom: axial 
view adapted from plate 55, H.v. 4.5. Contact location is shown in relation to the 
Anterio-medial (B), central (C) and postero-lateral (D) segments of the STN. Selected 
abbreviations: Ru: red nucleus, Sth: subthalamic nucleus, Z.i.: zona incerta.   
 
Linear regression analysis was used to assess the association between voltage and 
speech at one year, as well as speech change over a year. There was a strong 
relationship between the amplitude of stimulation in the left brain and speech 
intelligibility in the off-medication/on-stimulation condition at one year (coefficient -
16.1, 95% CI -26.8 to -5.4, p=.007, R squared 0.24), as well as the mean speech change 
over one year of stimulation (coefficient -11.3, 95% CI -19.3 to -3.2 p=.007, R squared 
0.22). The higher the voltage needed in the left brain the worse speech was at one year 
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and the worse the speech change over one year. Similarly, higher voltage was associated 
with worse speech in the on-medication/on-stimulation condition (p=0.02, r squared 
0.1871 for the speech change over a year and p=.0076, r-squared 0.2521 for speech at 
one year). There was a less strong relationship between the amplitude of the right 
electrode and speech at one year in the off-medication/on-stimulation condition (-18.7, 
95% CI -36.7 to -0.6, p=.042, r squared 0.13) and no relationship with speech change 
over a year. There was no relationship between the reduction in levodopa (LEDD at one 
year minus LEDD pre-operatively) and speech outcome and no relationship between 
LEDD at one year and speech in the on-medication/on-stimulation condition. 
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3.3 Study 2. Perceptual speech characteristics in 54 consecutive PD patients 
following one year bilateral STN-DBS and impact of clinical and surgical factors 
on speech outcome 
 
Following on from the results of the acoustical analysis (Study 3.1) it was evident that 
the type of dysarthria from STN-DBS stimulation had different perceptual 
characteristics than that of hypokinetic dysarthria, mainly in respect of vocal loudness. 
A more detailed description of the perceptual characteristics of speech following 
stimulation in the STN would inform not only hypotheses on speech motor control but 
also possible therapy approaches (see Chapter 6-LSVT). Study 2 aimed at analyzing the 
perceptual speech changes and the clinical and surgical factors in order to identify 
predictive factors. 
3.3.1 Patients and methods  
An extra 22 patients, consecutively recruited following the initial 32 (total of 54 
patients), participated in this study (Table 3.6). They were assessed before and at one 
year following surgery.  
Table 3.6: Patient characteristics (N=54) 
Baseline patient characteristics  
Male/Female 34/20 
Age mean ± SD (range) 58.8 ± 6.3 (42 to 69) 
Disease duration mean ± SD (range) 12.5 ± 4.7 (6 to 25) 
Levodopa equivalent daily dose (LEDD) (mg/day) 1556 ± 671 
UPDRS-III off medication  
UPDRS-III on-medication 
48.1 ± 17.9 range 20-89  
12.4 ± 7.8 range 2-31 
 150 
 
Surgical procedure, contact localisation and patient evaluation were performed as 
previously described (Study 1).  
3.3.1.1 Data analysis 
For the perceptual rating the same 22 intelligibility sentences were used. A native 
English trained SLT with three years’ experience, independent to the study and blinded 
to the conditions, rated the 22 sentences from AIDS using the Darley et al (1972) scale 
(henceforth “DAB scale”). The 35 speech dimensions listed by Darley et al (1972) were 
grouped under six clusters as described in Plowman-Prine (2009). Each speech cluster 
was assessed on a seven-point interval scale where one represented the greatest 
deviation from normal speech and seven represented normal speech. Mean speech 
ratings were calculated individually for each of the six speech clusters (articulation, 
respiration, resonance, phonation, prosody and rate) and collectively for the whole scale 
across medication and stimulation settings. All perceptual analysis was performed in the 
same quiet speech laboratory with identical equipment so as to minimize variability 
across listening tasks. Assessment of overall speech intelligibility was always 
determined first so as to eliminate familiarity effects from re-reviewing a given sample. 
After the speech intelligibility rating, each sample of the AIDS sentences was played up 
to six times so that the rater could listen to the sample once while rating the particular 
speech cluster with the specific speech dimensions. Thus a total of 220 speech samples 
were rated. The rater needed approximately ten 6-hour sessions with breaks in between 
to complete the task.  
Speech intelligibility was assessed using the sentence task of the AIDS as previously 
described (Methods section). Sound pressure level (dB SPL) for the read sentences was 
extracted using the CSL software program, as previously described (Methods section 
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and study 3.1). Speaking rate was obtained by dividing the total number of words (220) 
by the duration of the sentence sample in minutes, as instructed in the AIDS manual 
(Yorkston & Beukelman, 1984, p 11).  
3.3.1.2 Statistical analysis 
Primary outcomes were the change in speech intelligibility and perceptual rating  
(total of the DAB scale) from baseline to one year off-medication (one year off-
medication/on-stimulation minus baseline off-medication) and on-medication (one year 
on-medication/on-stimulation minus baseline on-medication). Secondary outcomes 
were the loudness measures and the subscores of the DAB scale (respiration, 
articulation, phonation, resonance, prosody and rate). To assess the impact of STN-DBS 
and medication on acoustic and perceptual data across times we used one-way ANOVA 
with Bonferroni’s multiple comparisons post tests. In order to assess the impact of pre-
operative clinical factors on speech outcome we used first a univariate regression and 
then a multivariate regression on the significant factors. The primary outcomes for the 
regression were the change in speech intelligibility (in %) over one year of STN-DBS 
(one year off-medication/on-stimulation minus baseline off-medication) and the change 
in the total perceptual scale (/42). Statistical analysis was performed on SPSS-18 for 
Mac and Prism 5 for Mac (Graphpad software, Inc).  
3.3.2 Results 
3.3.2.1 Effects of STN-DBS on speech intelligibility and perceptual speech features at 
one year (N=54) 
Speech intelligibility deteriorated on average by 14.4% (p=0.0006) after one year of 
STN-DBS when the patients were off medication and by 12.7% (p=0.001) when the 
patients were on-medication. Both these percentages were similar to the previous cohort 
of patients (N=32). In terms of perceptual ratings the total of the DAB scale (with a 
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score of 42 marking near normal speech) deteriorated by 5.1 points (p=0.001) when 
patients were off-medication and by 6 points (p=0.0001) when patients were on-
medication. When comparing on-medication conditions, analysis of the perceptual 
subscales scores showed a more significant decline in the subscale of articulation (mean 
decline of 1.2 points, p=0.0001), followed by prosody (mean decline of 1.18 points, 
p=0.001), phonation (mean decline of 1.01, p=0.0001), respiration (mean decline of 
0.94, p=0.001), rate (0.90, p=0.001) and finally resonance (0.76, p=0.05). When 
comparing off-medication conditions, analysis of the perceptual subscales showed a 
more significant decline in the subscale of articulation (mean decline of 1.5 points, 
p=0.0001), followed by respiration (mean decline 0.92, p=0.001) and then rate of 
speech (mean decline 0.86, p=0.01) and resonance (mean decline 0.6, p=0.01). There 
was no significant decline for the subscales of prosody and phonation when off-
medication (Table 3.7).  
Table 3.7: Changes in intelligibility (% of words understood) and perceptual speech 
characteristics (as per Darley, Aronson & Brown, 1975) in 55 consecutive PD patients 
following one year of bilateral STN-DBS (mean ± SD) . 
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 Baseline off-
medication  
Baseline on-
medication  
one year off-
medication/on- 
stimulation  
one year on-
medication/on-
stimulation  
Speech 
intelligibility 
98% (4.3) 97% (7.7) 83.9% (28) 84.3% (26.6) 
dB max reading  69.3 (6.9) 73.4 (7) 74.8 (6) 76.2 (6.5) 
Rate (words per 
minute) 
149.3 (26.8) 147 (26) 150.2 (36.3) 140.5 (37.9) 
Total 
perceptual score 
(/42) 
 
32.4 (4.6) 
 
32.5 (5.2) 
 
27.3 (8.8) 
 
26.5 (8.9) 
articulation (/7) 5.9 5.6 4.4 4.4 
respiration (/7) 5 4.9 4.1 3.9 
resonance (/7)  5.6 5.6 4.9 4.9 
phonation (/7) 4.8 5.1 4.4 4.1 
prosody (/7) 4.9 5.3 4.1 4.1 
Rate control (/7) 6 5.8 5.2 4.9 
 
The speech characteristics of the patients with laterally placed left electrode were 
imprecise articulation mainly caused by tongue weakness and lack of precision of the 
alveolar and velar sounds, fatigue with speaking which manifests in faster rate of speech 
and reduced voice volume. Patients with electrodes positioned medially (the majority of 
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the cohort) presented with slower rate of speech, imprecise articulation mainly affected 
by reduced lip movement and with difficulties controlling volume of speech, which is 
usually explosive but more often reduced and breathy. Rate is variable. Patients often 
complained of not being able to control their breathing with speaking and to “run out of 
breath”. Voice often sounds more nasal and their voice becomes strained-strangled with 
prolonged speaking.  
 
3.3.2.2 Predictive value of pre-operative data 
The potential predictive value of pre-operative clinical factors was initially assessed 
using a univariate analysis. The primary outcomes for the regression were the change in 
speech intelligibility (in %) over one year of STN-DBS (one year off-medication/on-
stimulation minus baseline off-medication and on-medication respectively) and the 
change in the total perceptual DAB scale (/42). The main clinical predictive factors 
were: pre-operative speech intelligibility off- and on-medication, pre-operative UPDRS-
III score off- and on-medication, disease duration and age at surgery. Of those, duration 
of PD and UPDRS-III off-medication were consistently predictive of speech outcome 
after one year whereas age was not predictive of any speech outcome (Table 3.8). 
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Table 3.8: Univariate analysis of pre-operative clinical predictive factors on speech 
intelligibility change off- and on-medication and perceptual rating (DAB scale) change 
one year after STN-DBS (N=54). 
Outcome Variable Predictive Variable B-coefficient P<  
Change in speech intelligibility 
AIDS pre-off to one year off/on 
AIDS pre-on 
AIDS pre-off 
UPDRS-III pre-on 
UPDRS-III pre-off 
Duration of PD 
Age at surgery 
-1.8 
-2.5 
0.75 
0.78 
2.77 
0.08 
0.0001 
0.01 
0.23 
0.004 
0.001 
0.87 
Change in speech intelligibility 
AIDS pre-on to one year on/on 
AIDS pre-on 
AIDS pre-off 
UPDRS-III pre-on 
UPDRS-III pre-off 
Duration of PD 
Age at surgery 
0.31 
-3.99 
0.68 
0.51 
1.99 
0.30 
0.52 
0.0001 
0.24 
0.03 
0.004 
0.51 
Change in DAB scale pre-off to 
one year off/on 
AIDS pre-on 
AIDS pre-off 
UPDRS-III pre-on 
-0.43 
-0.99 
0.23 
0.001 
0.41 
0.18 
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UPDRS-III pre-off 
Duration of PD 
Age at surgery 
0.23 
0.47 
0.02 
0.001 
0.042 
0.86 
Change in DAB scale pre-on to 
one year on/on 
AIDS pre-on 
AIDS pre-off 
UPDRS-III pre-on 
UPDRS-III pre-off 
Duration of PD 
Age at surgery 
0.13 
-0.94 
0.32 
0.16 
0.43 
-0.05 
0.2 
0.0001 
0.025 
0.007 
0.014 
0.63 
 
A multivariate regression of the most significant variables from the univariate 
regression, with left brain active contact as a covariate showed that the most significant 
predictive factors for speech intelligibility change when off-medication/on-stimulation 
were the pre-operative speech intelligibility on-medication, the longer disease duration 
and medially placed left brain active contact. For the speech intelligibility change when 
on-medication/on-stimulation only the pre-operative speech off-medication was 
significant (Table 3.9). 
Table 3.9: Multivariate regression of pre-operative clinical predictive factors with left 
electrode contact anatomical description (medial versus inside) as covariate, on speech 
intelligibility change off- and on- medication and perceptual rating (DAB scale) change 
one year after STN-DBS (N=54). 
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Outcome variable Predictive variable B-coefficient P< 
Change in speech intelligibility 
AIDS pre-off to one year off/on 
AIDS pre-on 
AIDS pre-off 
UPDRS-III pre-on 
UPDRS-III pre-
off 
Duration of PD 
Left active 
contact position 
-1.73 
-0.74 
-0.28 
0.00 
2.35 
9.25 
0.000 
0.398 
0.614 
0.990 
0.002 
0.006 
Change in speech intelligibility 
AIDS pre-on to one year on/on 
AIDS pre-on 
AIDS pre-off 
UPDRS-III pre-on 
UPDRS-III pre-
off 
Duration of PD 
Left active contact 
position 
0.67 
-3.05 
-0.88 
0.29 
1.33 
6.65 
0.147 
0.002 
0.172 
0.360 
0.060 
0.063 
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3.4 Study 3: Self perception of speech changes in patients with PD following 
bilateral STN-DBS 
Patients’ own perceptions of speech changes following STN-DBS and how these impact 
their quality of life was the topic of this study. Non-surgical PD patients rated their 
voice and speech as more severely impaired than healthy controls (Fox et al, 1997), 
indicating some awareness of their difficulties. However PD patients rarely report 
difficulties with their voice clinically (Duffy, 2005), perceiving their speech when 
reading and in conversation to be louder than its actual volume (Ho et al, 2000). The 
aim of this study was to assess the self-perception of speech changes following bilateral 
STN-DBS and how it correlates with the clinician’s speech intelligibility ratings.  
  
3.4.1 Patients and methods 
Twenty-three patients between six and 12 months post STN-DBS and 28 patients who 
were also severely affected by the disease and were potential candidates for future 
surgery, were invited to participate. 
 
3.4.1.1 Study design 
The questionnaire “Voice Handicap Index” (VHI, Jacobson, 1997) was used in this 
study. It was developed and validated with patients with a wide range of disorders, 
including neurological disorders and has good test-retest reliability (Jacobson et al, 
1997). It is self-administered and quantifies the patients’ perceptions of the handicap 
they experience in everyday life due to voice disorder. It asks patients to rate 30 
statements about their voice and daily living on a scale of 0 to 4. Ten of each relate to 
the functional, physical and emotional aspects of the disorder. It is the most commonly 
used measure in peer-reviewed studies and has been used as a measure of treatment 
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effectiveness (Sewall et al, 2006; Spielman et al, 2007). Using an adapted version for 
conversation partners, Zraick et al (2007) found good agreement between patients and 
their partners. 
 
Two copies of the Voice Handicap Index (VHI) were sent to the patients. Those who 
had received surgery were asked to rate their speech difficulties as they perceived them 
now and, retrospectively, how they perceived them before surgery. The same 
questionnaire was sent to the non-surgical Parkinson’s patients, asking them to rate their 
speech difficulties now and at the time of their last clinic visit. Clinic visits occurred 
every six months to a year and were used to provide a reference point for the patients, 
allowing them to assess their speech over a similar period as those undergoing surgery. 
The questionnaires gave two scores (with a maximum of 120), with higher values 
indicating a greater perceived handicap resulting from the voice disorder. The VHI 
scores were analysed to assess the patients’ perception of changes in their voice over 
time (since surgery or since the time of their last clinic). 
 
Additional data was available on the patients who underwent surgery. UPDRS-III 
scores were taken as routine procedure before surgery (off-medication) and after 
surgery at six month follow-up (off-medication/on-stimulation). These were available 
for 18 of the 20 patients who received surgery. In addition, surgical patients were asked 
to make a voice recording before (off-medication) and after surgery (off-medication/on-
stimulation) using the Computerized Speech Lab (Kay Elemetrics, Kay Pentax, Model 
4150). Each sample consisted of reading randomly generated sentences from the 
Assessment of Intelligibility of Dysarthric Speech (AIDS, Yorkston & Beukelman, 
1981). Both recordings were available for 18 of the patients and were rated for 
intelligibility by a naïve listener as previously described (Chapter 2 and Chapter 3.1). 
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3.4.1.2 Statistical analysis 
The main analysis examined the changes in VHI scores for the two groups of patients. 
A two factor mixed ANOVA with subjects (non surgical/surgical) as a between subjects 
variable and time (pre-surgery/now for the surgical group; 6-12 months ago/now for the 
non-surgical group) was a within subject variable.  
  
Additional analyses compared the pre- and post-surgical UPDRS-III and intelligibility 
scores for the surgical group using related t-tests. Correlation was used to examine the 
relationship between VHI and intelligibility scores for this group to assess whether 
patients self perceptions and their rated intelligibility were related.  
  
The correlation between the changes in VHI scores and in UPDRS-III scores was also 
examined.  
 
3.4.2 Results 
The questionnaire return rate for post-surgical patients was 20 out of 23 (10 male/10 
female; mean age: 58; range: 35-69). The return rate for non-surgical patients was 20 
out of 28 (11 male/9 female; mean age: 55; range: 43-74). 
   
In both groups, 14 out of 20 participants scored their current voice difficulties higher 
than previously (i.e. they perceived the impact of their voice difficulties before surgery 
or at the time of their last clinic visit to be less than currently). The ANOVA gave a 
significant effect of time (F (1, 38) = 6.339, p < .05) showing that the patients generally 
perceived a deterioration in their speech (Table 3.10). Although the surgical group have 
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higher scores, the difference between the groups fell just short of significance (p = .06). 
As the table shows, the VHI scores for patients in both groups were very variable.    
 
Table 3.10: VHI scores for surgical and non-surgical groups pre and post surgery. 
Higher score denotes greater handicap. 
 
  Before Present 
DBS patients Mean 30.35 45.95 
 SD 34.76 27.47 
Non DBS patients Mean 20.20 27.35 
 SD 22.82 24.02 
 
The interaction between groups and time was not significant, indicating that neither 
group deteriorated more than the other over time. Changes with time were also highly 
variable across patients. This was particularly apparent in the surgical group. The 
absolute values (ignoring deterioration or improvement) for each group were compared 
with an independent t-test. This revealed a highly significant difference (t = 3.50 (d.f. = 
21.41; adjusted for unequal variances), p < .01) between the groups. 
 
A comparison of the surgical groups UPDRS-III scores before and after surgery showed 
a highly significant improvement (t (17) = 6.85, p < .001). A similar comparison for the 
intelligibility scores showed that the deterioration in these scores was not significant  
(t (17) = 1.52, n.s.) (Table 3.11) 
  
Table 3.11: Mean UPDRS-III and intelligibility scores pre- and post-surgery for the 
surgical group. 
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  Before Present 
UPDRS scores Mean 43.89 22.55 
 SD 15.35 13.72 
% Intelligibility Mean 79.05 72.44 
 SD 15.85 22.86 
 
There was a significant negative correlations between VHI scores and intelligibility for 
both the pre-surgery (r = -0.506, p <.05) and post-surgery scores (r = -0.749, p < .001). 
Thus high intelligibility scores corresponded with low VHI scores (i.e. low handicap). 
There was a non-significant, positive correlation between VHI scores and UPDRS-III  
(r = 0.192), suggesting that lower scores on both scales were associated, albeit weakly. 
 
3.5 Discussion 
3.5.1 Short- and long-term effects of STN-DBS on speech  
In our series of 32 consecutive patients, speech intelligibility deteriorated by 14.2% one 
year after STN-DBS, when off-medication, whereas movement measured with UPDRS-
III improved by 50.7%. Twenty-five patients (78%) experienced some degree of 
worsening of speech intelligibility. This was disabling for 13 patients (40%) who 
experienced speech deterioration larger than the average 14.2%. At three years 53% 
(95% CI: 25,81) of patients showed speech deterioration in the off-medication/on-
stimulation condition and 73% (95% CI: 42,92) of patients in the on-medication/on-
stimulation condition, in line with other reports (Piboolnurak et al, 2007; Schupbach et 
al, 2006; Gan et al, 2007; Krack et al, 2003; Rodriguez-Oroz et al, 2005). 
 
This percentage is higher than most clinical series in the literature. Nevertheless, most 
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series have focussed on the motor benefit and speech has mostly been assessed by item 
18 of the UPDRS which shows poor sensitivity to detect speech problems (Richards et 
al, 1994 and our data, Study 3.1). It is therefore likely that speech worsening is under-
reported in most series of the literature. In a meta-analysis of 34 papers (from 1993 to 
2004) Kleiner-Fisman et al (2006) estimated 9.3% of speech deterioration from reported 
data. At six months after bilateral STN-DBS Herzog and colleagues (2003) reported a 
4% incidence of speech problems in their results from 48 consecutive patients. 
At one year, Tir et al (2007) reported a 12% incidence of speech problems, only for 
patients with disease duration longer than 12 years. Thobois et al (2002) reports a 5% 
incidence in 18 patients and Herzog et al (2003) a 6% in 32 patients. Higher incidence is 
reported by Pahwa et al (2003) with 28%, and Volkmann and colleagues (2001) who 
noted a 56% incidence of speech problems in 16 patients. Some groups do not report 
any speech problems following STN-DBS (Jaggi et al, 2004; Romito et al, 2003; 
Vesper et al, 2002). At three and five years the reported incidence of speech problems 
tends to increase: Schupbach et al (2006) reported a 35% incidence at five years of 
STN-DBS and Gan et al (2007) reported a 52% incidence in 36 patients at three years. 
The highest incidence is reported by Piboolnurak (2007) with 69.7% (23 patients in 33). 
Krack et al (2003) and Rodriguez-Oros (2005) reported a progressive deterioration of 
speech over five years follow-up, particularly for the on-medication/on-stimulation 
condition. In our series, at three years, eight out of 15 patients (53%) showed speech 
deterioration in the off-medication/on-stimulation condition and 11 patients in the on-
medication/on-stimulation condition (73%). Interestingly in some patients speech 
deterioration was partly reversible and improvement was linked to amplitude reduction 
and/or change of contacts from medial to inside. The numbers though are too small to 
make any more substantial claims. 
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 The incidence of speech problems seems higher with STN-DBS than GPi-DBS. 
Volkmann et al (2001) reported a 56% incidence of speech problems only in the STN 
group, with speech worsening further with medications. Rodriguez-Oroz (2005) 
reported 18% of patients with speech problems following STN-DBS compared to 5% 
following GPi-DBS. 
 
Disease progression in the medical group accounted for only a 3.6% deterioration of 
speech intelligibility off-medication and 4.5% on-medication over one year. Despite the 
small size of the medical group, the clear difference between the two groups makes it 
unlikely for the worsening in the surgical group to be related only to disease 
progression. One study that has compared the outcome of a DBS group and a medical 
group reported a 10% deterioration of speech in the DBS group and 1% in the medical 
group at six months follow-up; however they had no specific measure of speech 
(Deuschl et al, 2006). Weaver et al (2009) and Williams et al (2010) do not report data 
on speech progression following one year of medical therapy versus one year of STN-
DBS.   
 
3.5.2 Role of medication and stimulation parameters on speech response  
Speech response was not significantly improved by administration of levodopa before 
or after STN-DBS. Indeed, for some patients, speech was worse on-medication/on-
stimulation, as reported earlier (Krack et al, 2003; Rodriguez-Oroz et al, 2005; 
Volkmann et al, 2001), especially in patients with residual orofacial dyskinesias 
(Rousseaux et al, 2004). The amount of reduction of levodopa was not associated with 
speech deterioration either. 
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The majority of the speech deterioration in the surgical group occurred between six 
months and one year. This was not alleviated by switching the stimulation off. Also 
voltage was not significantly increased between six months and one year.  
 
Systematic evaluation of the anatomical location of the electrode contact and its effects 
on speech showed that electrodes placed medial to the left STN were worse for speech 
intelligibility than electrodes inside the STN, confirming results from other studies. 
Plaha and colleagues (2006) reported that stimulation in contacts dorsomedial or medial 
to the STN have resulted in reversible, hypophonic and slurred speech, despite marked 
improvement in limb movement. In the same study contacts in caudal zona incerta and 
the one inside the STN did not induce dysarthria as a side effect. Stimulation of the 
prelemniscal radiation has also been reported to cause dysarthria despite improvement 
in tremor and rigidity (Velasco et al, 2001). Paek and colleagues (2008) investigated the 
clinical outcome from bilateral STN-DBS in 53 patients. Speech, as measured with the 
UPDRS-III, item 18, improved only in the patients whose electrodes were positioned 
within the STN as opposed to the red nucleus or the area between the STN and the red 
nucleus. In our study the limited number of electrodes in each area (for example, one 
lateral electrode for each side) makes any assumptions tentative. 
  
Equally information on the particular STN segment where the active contact is and 
speech outcome is scarce. In our study stimulation in the left superior segment of the 
STN improved speech by 6.6% over a year compared to a deterioration of 31% from 
stimulation in the left posterolateral segment (D). Despite the different methodology of 
electrode localisation, stimulation of this same superior segment (A) is reported to be 
more effective for limb motor control (Yelnik et al, 2003; Hamel et al, 2003; Yokoyama 
et al, 2006). Improvement in both speech and motor control from stimulation of this 
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segment compared to improvement predominantly in motor control with stimulation of 
the posterolateral segment may have implications for surgeons when targeting the STN. 
However there was too limited a number of electrodes in each of the five segments 
inside the STN to make firm assumptions on their effects on speech. Additionally, there 
is scarce evidence on the somatotopy of the STN and speech. In a study of PD patients, 
neurons corresponding to the oromandibular musculature were found in the middle of 
the STN (Rodriguez-Oros, 2002). In the monkey, neurons in the dorsolateral and lateral 
part of the STN and in the substantia nigra were particularly active during oral 
movements for feeding (DeLong et al, 1983; Mora et al, 1977; Wichmann et al, 1994; 
Nambu et al, 1996). These reports may not be relevant to the effects of STN stimulation 
in humans and on speech in particular. 
  
Higher voltage on the left STN at one year was also associated with speech 
deterioration. The worsening effect of higher voltage has been described before (Krack 
et al, 2003; Tornqvist et al, 2005; Tripoliti et al, 2008). Some studies have attributed 
this deterioration to the spread of current in the internal capsule (Benabid et al, 2009; 
Krack et al, 2003; McIntyre et al, 2004; Tommasi et al, 2007). In our study the strong 
association of a medial contact and higher voltage with poor speech outcome points 
towards a different mechanism. A spread in the cerebellothalamic tract has been 
proposed by our group and others (Gallay et al, 2008; Plaha et al, 2006; Tripoliti et al, 
2008; Astrom et al, 2010; see also Chapter 4).  
 
The stronger association of the left STN contact with speech response conforms to the 
findings from other studies (Santens et al, 2003; Wang et al, 2006). Santens and 
colleagues (2003) analysed the effects of left and right STN separately on different 
perceptual aspects of speech in seven patients. There was a significant deterioration of 
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prosody, articulation and intelligibility when stimulating the left STN compared to the 
right STN alone. All patients reported subjective decrease of speech intelligibility 
following bilateral STN stimulation. Wang and colleagues (2006) investigated the effect 
of unilateral STN-DBS on speech in 20 PD patients, 10 operated only on the left STN 
and 10 only on the right. Patients with left STN stimulation decreased their articulatory 
accuracy and speaking rate.  
 
3.5.3 Acoustical data and speech response 
Higher LTAS means in both reading and monologue when on-medication was a 
predictive factor of good speech outcome. Dromey (2003) examined the use of a 
number of acoustical variables to describe PD speech and concluded that lower LTAS 
means was the variable that differentiated PD speech most from that of normal controls. 
Perceptually lower LTAS means would suggest a weakness in the upper harmonics (i.e. 
consonants and mainly fricatives), with the main acoustic power concentrated towards 
the lower frequencies (mainly vowels). High frequency consonants are more important 
for comprehending speech (Horwitz, 2008). However, the relationship between these 
acoustic measures and perceptual judgements is still not clear (Lofqvist & Mandersson 
1987; Tanner et al, 2005). Thus lower LTAS means can represent the breathy phonation 
of vocal fold palsy (Hartl et al, 2003) or indeed higher LTAS means can represent the 
“overpressured phonation” of spastic dysphonia (Izdebski, 1984).  
 
There was a discrepancy between deterioration in speech intelligibility and 
improvement in loudness, which is contrary to other studies in PD dysarthria where 
increased loudness is associated with increased speech intelligibility (Rosen et al, 2006; 
Tjaden & Wilding 2004; Neel, 2009). This discrepancy is part of an ongoing debate in 
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the speech motor control literature. Connor & Abbs (1991) examined the variations in 
amplitude and velocity of movement in three jaw lowering tasks: 1) single, rapid, 
visually guided movement, 2) equivalent movement associated with a single speech 
syllable (/da/) and 3) well-learned speech movement produced in a natural sequence 
(“say /da/ again”). PD jaw movements were characterised by reductions in velocity/ 
amplitude only when performed under visual guidance. There was no such impairment 
during speech actions. This dissociation in performance of speech versus non-speech 
motor tasks may be a reflection of the different neural control. Riecker et al (2000) 
showed that non-speech lateral tongue movements were associated with bilateral 
cerebellar activation whereas speaking was accompanied by unilateral (right-sided) 
activation of the cerebellum. Ziegler (2003) postulated that there is a case for task-
specificity in oromotor control, based on dissociations between speech and non-speech 
tasks. 
  
Our finding supports similar findings from the limb motor literature on the effects of 
STN-DBS, which show increase in force production but deterioration on more complex 
movement (Brown & Eusebio, 2008; Chen et al, 2006; Vaillancourt et al, 2004). So far 
evidence of impaired performance following STN-DBS has been limited to selected 
cognitive tasks (Brown et al, 2006; Hershey et al, 2004; Jahanshahi et al, 2000) and 
complex manual tasks (Brown et al, 2006). Recently Alberts et al (2008, 2010) showed 
that complex cognitive and motor performance declined significantly with bilateral 
STN-DBS. Human conversation is a unique complex task of cognitive and motor 
nature, requiring fast and precise movement under constantly changing circumstances.  
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3.5.4 Perceptual characteristics of speech following one year of STN-DBS in 54 
consecutive patients 
In our cohort of 54 consecutive patients we used the DAB scale to identify the 
perceptual changes on speech after one year of STN-DBS. In their original studies of 
1969, Darley et al analysed the speech of 32 PD patients, without medication and using 
the same scale, and they described the characteristics of hypokinetic dysarthria. In order 
of severity their patients presented with impaired prosody (monopitch, reduced stress, 
monoloudness), articulation (imprecise consonants), respiration (inappropriate silences, 
short rushes), phonation (harsh voice, breathy voice) (p 257). 
 
In our study patients pre-operatively without medication seem to present with the 
similar characteristics, i.e. more severely affected prosody, followed by phonation, and 
respiration (Study 2, Table 3.7). However the pattern was different at one year post 
STN-DBS. The characteristics that seem to deteriorate more significantly when off-
medication/on-stimulation are articulation, followed by respiration (which reflects 
patient’s complaint of difficulty breathing). There is no effect of stimulation alone on 
phonation and prosody. When on-medication/on-stimulation however the pattern 
changes and the impact on articulation, prosody and phonation become significant, 
reflecting again the more severe overall deterioration of speech when on-medication/on-
stimulation.  
 
3.5.4.1 Comparison with dysarthrias from lesions in the area of internal capsule  
Stimulation in the deep brain structures provides the opportunity to study their role in 
speech motor control in a more precise manner than the dysarthria caused by lesions in 
the same areas and to hypothesise on the relative role of each structure on speech motor 
control. The most common description of dysarthria following lacunar strokes (in the 
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areas of putamen, caudate, thalamus, pons, and internal capsule) is limited to vague 
terms such as “slow dysarthria, slurred, unintelligible or thick”. 
 
The corticobulbar fibres for head and neck occupy the genu of the internal capsule. 
Electrodes positioned laterally to the STN would affect the posterior part of the internal 
capsule. Pure dysarthria syndrome has been described by Ichikawa et al (1991) in nine 
patients caused by infarcts at the superior limb of the anterior portion or corona radiata 
or the superior portion of the genu of the internal capsule: “The most prominent speech 
abnormalities were a “thick” tongue or slurring with incomplete articulation, some 
patients showed mild slowness of their speech but speech was not scanning, explosive, 
hypophonic or dysprosodic” (Ichikawa, 1991, p 809). Kim (1994) described the same 
syndrome in 13 patients with infarcts in the area of corona radiata. Takahashi et al 
(1995) described the lesions in 40 patients with dysarthria mainly from lesions in the 
left corona radiata/junctional zone. Ozaki et al (1986) described five cases with sudden 
onset of dysarthria in the anterior internal capsule, “impaired articulation with slurred 
speech with nasal features, but no dysphagia. Weakness of the tongue was not detected. 
Soft palate movements were well preserved. No facial palsy”. Urban et al (1999) 
describes five patients with pure dysarthria due to extracerebellar lacunar strokes in the 
area of internal capsule and corona radiata. 
 
Focal ischaemic lesions in the genu of the internal capsule have been reported to cause 
orofacial and laryngeal paresis due to massive disruption of the corticobulbar tract 
which is broadly described as unilateral upper motor neuron (UUMN) dysarthria, with 
pyramidal signs, unless the lesion is bilateral when dysarthria is spastic (Tredici et al, 
1982 but assessed with early CT scanning). The involvement of the genu of the right 
internal capsule in spasmodic dysphonia (SD) was revealed in a study by Simonyan et 
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al (2008) using DTI and post-mortem histopathology. They also found involvement of 
the posterior limb of the internal capsule, putamen, globus pallidus and cerebellum. 
However the type of voice impairment and the microstructural abnormalities in the 
internal capsule in the SD patients suggest a different pathological process than that of a 
lesion. Noda (1994) also reported micrographia as a concomitant symptom of lacunar 
infarctions involving the putamen or the genu of the internal capsule.  
 
3.5.4.2 Lesions in the cerebellothalamic tract 
The cerebellum is involved in the motor control via the ventrolateral thalamus and has a 
modulatory role in coordinating voice and speech production (Günther, 2006). Arboix 
(2007) compared the presentation of thalamic haemorrhage versus internal capsule/basal 
ganglia haemorrhage and found that speech disturbances are more frequent in patients 
with the latter (44%) rather than the former (21%) but they do not provide any further 
description. There is also a case of Horner’s syndrome due to ipsilateral posterior 
hypothalamic infarction with contralateral faciobrachial weakness and dysarthria 
(Austin & Lessell, 1991). Urban (2006) studied the lesion location of 62 consecutive 
patients with dysarthria due to a single non-space occupying infarction. Of the 85.5% 
extracerebellar lesions, 46.8% were in the striatocapsular region with dysarthria mainly 
caused by left-sided lesions. Cerebellar lesions were characterised by articulatory 
problems (consonant articulation, speaking rate slowed over time, prolonged phonemes 
and syllables, articulatory inaccuracy, reduction or elision of phonemes and syllables, 
repetition of phonemes and syllables and vowels imprecise or distorted”) more so than 
voice problems.4
                                                 
4 Both the putamen and the thalamus are shown to be involved in reading at the level of 
speech production, they are more activated when subjects read meaningless written 
syllables (Bohland & Guenther, 2006) or completed stem words (Rosen et al, 2000) 
when performed aloud rather than silently. The left thalamus (and not the putamen) 
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3.5.5. Pre-operative predictive factors 
One of the main aims of this study was to provide clinicians and patients with 
information on the possible effects of STN-DBS on their speech prior to surgery. 
Speech outcome was not linked to either age or pre-operative motor scores, unlike 
motor outcome (Welter, 2002; Charles, 2002; Guehl, 2006). Indeed, speech problems 
may arise at any stage of the disease process and are not necessarily related to the 
degree of motor disability (Metter & Hanson, 1986). The best predictive factor for 
speech response after one year of STN-DBS when off-medication/on-stimulation was 
the residual speech problem after medication before surgery. Thus, the better the speech 
on-medication pre-operatively, the better the outcome one year post, off-medication/on-
stimulation. Or inversely, the fact that the severity of the residual parkinsonian speech 
score when “on-medication” was predictive of a poor post-operative outcome is 
probably explained by the presence of non-dopaminergic lesions within the basal 
ganglia, (Agid, 1991) which would not respond to stimulation. The reason why longer 
disease duration is predictive of poorer speech outcome may be also related to the 
severity of speech problems pre-operatively. The only predictor of poor speech outcome 
at the on-medication/on-stimulation condition was the pre-operative off-medication 
speech. This could reflect the residual ability to compensate and mediate the combined 
effects of medication and stimulation on the motor control of speech following STN-
DBS. 
 
3.5.6 Self-perception of speech changes following one year of STN-DBS 
This study investigated the perception of patients’ speech difficulties following  
STN-DBS. Speech difficulties were assessed using the VHI which is a measure of 
                                                                                                                                               
plays a consistent role in name retrieval (Price & Friston, 1997). (See also Seghier & 
Price, 2009 for the role of the putamen in reading aloud). 
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participants’ self perceptions of their voice. Patients were also required to score their 
speech difficulties retrospectively over a period of six to 12 months. The main analysis 
showed that both surgical and non-surgical groups perceived their voice as deteriorating 
over the period of the study. Fourteen out of 20 members of each group reported 
deterioration. However the VHI changes in the surgical group were more variable than 
those in the non-surgical group. A comparison of the changes showed a highly 
significant difference between the groups. The analysis also showed that the overall 
difference between the groups was close to significance. Its failure to show a more 
striking difference may reflect the high level of variability between patients in both 
groups. 
  
Relationship of motor, intelligibility and VHI scores in the STN-DBS group 
UPDRS-III scores were only available for the surgical group of patients. These show a 
strongly significant improvement after surgery and are in contrast with the decrease in 
patients’ satisfaction with their speech as assessed by the VHI. The correlation between 
these two was not significant, however. This suggests there is no close relationship 
between the improved UPDRS-III scores and the decline in VHI scores. This 
inconclusive result owes much to the variability in speech changes after DBS. Whereas 
UPDRS-III scores improved strongly and fairly consistently, changes in the VHI scores, 
as seen above, were very inconsistent and not always negative. 
 
On the other hand, the high correlation between the intelligibility scores and the VHI 
was a very important finding. Objective speech assessment, such as the speech 
intelligibility rating, precludes evaluation of the impact of speech disorders on everyday 
life. Therefore the VHI, which is used to measure the influence of voice problems on 
one’s quality of life, offers unique information for the multidimensional diagnosis of 
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dysarthria. In the literature opinions on the possible correlation between the objective 
and subjective parameters of speech assessment differ widely and they are mainly 
limited to acoustic measures The correlation with speech intelligibility, a measure of 
percentage of words understood by a naïve listener, shows that the VHI can be used 
with patients with PD to evaluate the impact of their speech impairment on their quality 
of life.  
 
Two aspects of this study are novel. Firstly, it uses the VHI as a means of obtaining a 
patient’s own estimation of their voice problems. This reflects a patient’s own 
experience of speech difficulties in everyday situations and the effect of their dysarthria 
on their quality of life. The study also investigated the accuracy and validity of 
retrospective evaluation of speech changes over time. In view of reports of patients’ 
poor awareness of their speech (Duffy, 2005; Ho et al, 1999a, 1999b, 2000) there may 
be doubts as to whether retrospective assessments are reliable. In our study patients’ 
ratings of their speech changes, including those made retrospectively, were significantly 
correlated with the blind assessment of their intelligibility by an independent listener. 
This suggests that the patients’ own assessments are valid and accurate; moreover they 
may be more sensitive than the intelligibility scores.  
 
The results of this study are consistent with previous findings and suggest that the VHI 
can be used with patients with Parkinson’s disease. To assist the patients they were 
given a clear reference point at which to recollect their voice (before surgery for the 
surgical group and their last clinic visit for the non-surgical group). While this appeared 
to help them, the retrospective element of the methodology is not generally 
recommended. Clinically, however, it may be useful. Patients are often seen at 
relatively lengthy intervals (six months in the present case) and enquiries about changes 
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in their symptoms are likely to be made at these times. The findings here suggest that 
some reliance may be placed on their perceptions of changes in their voice over such 
periods. 
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CHAPTER 4: EFFECTS OF CONTACT LOCATION AND 
VOLTAGE AMPLITUDE ON SPEECH AND MOVEMENT 
IN BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN 
STIMULATION  
4.1 Summary 
Contact site and amplitude of stimulation have been suggested as possible factors 
influencing the variability of speech response to STN-DBS.  
 
In this double-blind study we assessed 14 patients post bilateral STN-DBS, without 
medication. Six conditions were studied in random order: stimulation inside the STN at 
low voltage (2V) and at high voltage (4V); above the STN at 2V and 4V, usual clinical 
parameters and off-stimulation. The site of stimulation was defined on the post-
operative stereotactic MRI data. Speech protocol consisted of the Assessment of 
Intelligibility of the Dysarthric Speech, maximum sustained phonation and a one-
minute monologue. Movement was assessed using the UPDRS-III.  Stimulation at 4V 
significantly reduced speech intelligibility (p=.004) independently from the site of 
stimulation. Stimulation at 4V inside the nucleus significantly improved the motor 
function (p=.0006). A subgroup of patients (N=10) was studied further using patient-
specific finite element computer models and the electric field generated during the 
various electrical settings could be visualized. The aim of this study was to relate the 
anatomical aspect of the simulated field to acute effects of speech intelligibility and 
movement. The results showed that a current spread in the pallidofugal and 
cerebellothalamic pathways, medially to the STN, could be responsible for the 
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stimulation induced speech deficits.  
   
The significant improvement in movement coupled with significant deterioration in 
speech intelligibility when patients are stimulated inside the nucleus at high voltage 
indicates a critical role for electrical stimulation parameters in speech motor control. 
 
4.2 Introduction 
Speech motor outcome following STN-DBS could be dependent on both clinical factors 
such as speech impairment before surgery and speech response to medication and 
surgical factors such as contact site and electrical parameters of stimulation15;16. The 
aim of the present study is to evaluate the role of the voltage amplitude on speech of the 
location of the stimulated contact and the role and motor function. Study 1 aimed at 
exploring the relative contribution of voltage amplitude and contact location (inside 
versus outside the STN) and Study 2 aimed at exploring the spread of current in the 
fasciculus cerebellothalamicus (fct) medially to the STN. 
4.3 Study 1: Effects of voltage amplitude and contact location (inside versus 
outside the STN) on speech and movement in bilateral subthalamic nucleus deep 
brain stimulation 
4.3.1 Patients and methods 
Fourteen patients diagnosed with PD and treated with bilateral STN-DBS for at least six 
months were recruited consecutively, as they were coming for their routine clinical 
follow-up. All patients had at least one contact on each side within the STN, as 
determined by localization on post-operative stereotactic MRI. No patients had 
previously been treated surgically for their PD. Their mean age (SD) at the time of 
surgery was 60 (6.5) years, the mean duration of PD before surgery was 15.6 (5) years 
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and the mean duration of STN stimulation at the time of this study was 13.6 (8.6) 
months. Their mean Unified Parkinson’s Disease Rating Scale (UPDRS-III) score off-
medication pre-operatively was 40.1 (11) and on-medication 11.7 (6.8). The mean 
speech intelligibility off- medication was 86.3% (9.7) and on-medication 87.8% (9.3) 
(Table 4.1).  
 
Table 4.1: Settings of usual clinical contacts at the time of evaluation and effect on 
motor and speech (% of words correctly understood) symptoms (all evaluations off-
medication).  
 
Patient  
             UPDRS-III 
ON stim           OFF stim 
  Speech intelligibility (%) 
ON stim        OFF stim 
        Contact (Volts) 
Left brain      Right brain 
1.  28 52  80% 93% 2 (3.6V) 5 (4.4V) 
2.  16  57  73% 75% 1 (2.4V) 4 (3.5V) 
3. 20  50  60% 70% 1 (3V) 5 (3V) 
4. 36  62  15% 30% 2 (3.5V) 5 (3.5V) 
5.  41  71  50% 60% 0 (3.5V) 4 (2.6V) 
6.  20  51  71% 76% 1 (3.8V) 5 (3.8V) 
7.  12  49  78% 74% 1 (3.5V) 5 (3V) 
8. 26  48  70% 60% 2 (3.1V) 6 (3.1V) 
9.  33  64  54% 45% 0 (3V) 5 (4V) 
10.  17  42  86% 83% 1 (1.8V) 4 (2.7V) 
11.  32  42 45% 52% 2 (3.5V) 5 (3.5V) 
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12.  21 41  65% 85% 1 (2.8V) 5 (3.3V) 
13.  19  45  60% 62% 1 (3V) 5 (3.6V) 
14.  27  59  10% 55% 1 & 
2(3.2V) 
5 (3.5V) 
Mean 
(SD)  
24.8 (8.4) 52.2 (9) 58.3% 
(22.6) 
65.7% 
(16.9) 
3.1V 3.3V 
 
4.3.1.1 Surgery and contact localisation  
Surgery was performed as previously described (See Methods). For this study, a 
neurosurgeon (LZ) independently assessed the anatomical position of each contact in 
relation to the visualised STN in the axial and coronal planes. The contact closest to the 
centre of the STN (henceforth “inside”) and that furthest from the centre of the STN 
(usually the uppermost one-henceforth “outside”) were thus identified. These were not 
always the active contacts used for chronic stimulation (Table 1). Based on the mean 
amplitude of stimulation at the time of assessment (3.1V for the left brain, 3.3V for the 
right) we defined low voltage as 2 Volts and high voltage as 4 Volts. The pulse width 
and frequency were kept at the clinical setting of the time of stimulation (for all patients 
in this study frequency was 130 Hz and pulse width was 60 µsec). 
 
4.3.1.2 Patient evaluation 
This is a double blind within-subjects study. Both assessors (PDL and ET) and the 
patients were blinded as to the stimulation condition. Stimulation parameter changes 
were performed by a trained collaborator, independent to the assessments. 
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Patients were studied after overnight withdrawal from their anti-parkinsonian 
medication. Six conditions were assessed in a random order, the four experimental 
conditions: inside the nucleus at 2V; inside the nucleus at 4V; outside the nucleus at 2V; 
outside the nucleus at 4V, as well as DBS OFF and DBS ON with usual clinical 
parameters. Following each change of parameters patients had a 15 minutes waiting 
before the evaluation.  
The speech evaluation consisted of three tasks: sustained vowel phonation “ah” for 
three repetitions, the Assessment of Intelligibility for the Dysarthric Speech20 (AIDS) 
and a 60-seconds monologue about a topic of the speaker’s choice. The AIDS is the 
most widely used standardised test for measuring speech intelligibility (see Methods). 
The intelligibility score is the percentage of words correctly transcribed after two 
exposures to the sentences21 by a native English speaker, blinded of the conditions.  
The Computerised Speech Lab (CSL, Kay Pentax, 4150) was used for recording and 
analysis of all samples. Acoustic recordings were obtained using a calibrated Shure SM 
48 dynamic microphone, with a 15 cm mouth-to-microphone distance, at a 22 kHz 
sampling rate in a sound treated room. For the measurement of the intensity-Sound 
Pressure Level (SPL dB) of the sustained phonation, calibration occurred at the 
beginning of each recording session using a 600 Hz tone at 15 cm, measured with a 
Quest 2100 SPL meter to allow for the conversion of CSL values to SPL22. Following 
speech recordings, movement was assessed using the UPDRS-III.  
4.3.1.3 Data analysis 
The 84 files from the AIDS sentences were rated blindly (EF) and a percentage of 
words correctly identified, was derived. For the acoustical analysis of intensity of 
sustained phonation, reading and monologue we calculated the mean vocal SPL dB 
measures from the speech recording of each condition.  
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To explore the impact of contact location and voltage amplitude for the four 
experimental conditions we used two factors within subjects ANOVA with factor A 
electrode contact site (with two levels: inside and outside) and factor B voltage 
amplitude (with two levels: high – 4 V and low – 2 V). Paired t-tests were used for post-
hoc means comparisons. 
For the comparison of speech and motor scores at the ON versus OFF STN-DBS 
conditions we used paired t-tests. The two-tailed level of significance was set at 5%. 
Statistical analysis was performed on SPSS-12 for Windows (SPSS Inc., Chicago, IL, 
USA) and Origin 7.5 (OriginLab Corporation, Northampton, MA 01060, USA). 
4.3.2 Results 
4.3.2.1 Speech intelligibility 
High voltage had a significantly worsening effect on speech intelligibility in comparison 
to low voltage [F (1,52)=9.05, p=0.004]. The mean speech intelligibility score for the 
“inside/high” condition was 53.4% (SD 26.09), “outside/high” 53.42% (SD 26.93), 
“inside/low” 72.2% (SD 14.07) and “outside/low” 69.21% (SD 15.6) (Fig 4.1). Post hoc 
comparisons indicate that the mean speech intelligibility for the inside/high condition 
was significantly lower than the inside/low condition (p=0.02) with a mean 
deterioration of 18.7%. There was no main effect of contact location [F (1,52)=0.068, 
p=0.79]. The interaction effect between contact site and voltage was not statistically 
significant for speech or movement [F (1,52) = 0.06, p=0.79] and [F (1,52) = 0.59, 
p=0.44] respectively.  
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Figure 4.1: Median (inside horizontal line), Means (small square), quartiles (first and 
third) and range of data points of speech intelligibility scores (in % of words 
understood) per stimulation condition. 
The average deterioration when stimulated at high voltage (inside and outside the STN) 
compared to low voltage was 16.5%. Detailed examination of individual patients’ data 
reveals two distinct subgroups of patients, one group not or less affected by the 
increased amplitude of stimulation and one group showing a higher than the average 
deterioration of speech with increased amplitude. A blinded assessor (MIH) examined 
the electrode location of the patients in these two subgroups in more detail. Patients 
whose speech was less affected had electrodes positioned more posteriorily in the STN 
area (Figure 4.2a). Patients showing marked deterioration had electrodes positioned 
more medially or anteriomedially to the STN (Figure 4.2b). 
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Figure 4.2a: Example of electrode location of a patient whose speech did not change 
with high voltage stimulation.  
 
Figure 4.2b: Example of electrode location of a patient with marked speech 
deterioration when stimulated at high voltage. 
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4.3.2.2 Acoustic measures  
We used a two-factor within-groups analysis of variance to explore the impact of 
contact location and voltage amplitude on intensity (SPL dB) for sustained phonation, 
the one minute monologue and the read sentences. The interaction effect between 
contact location and voltage amplitude was not statistically significant for either speech 
task. The main effects for contact location [F (1,52)=0.61, p=0.43] and voltage 
amplitude [F (1,52)=0.22, p=0.63] did not reach statistical significance for intensity 
(SPL dB) measures of sustained vowel phonation. Similarly the main effects for contact 
location [F (1,52)=3.25, p=0.07] and voltage amplitude [F (1,52)=0.0005, p=0.98] for 
the intensity (SPL dB) of the one-minute monologue were not significant. The main 
effects for contact location [F (1,52)=0.61, p=0.43] and voltage amplitude [F 
(1,52)=0.22, p=0.63] for the intensity (SPL dB) of the read sentences were not 
significant either (Table 4.2). 
Table 4.2: Mean and standard deviation of dB SPL (15cm) during sustained phonation 
/aa/, reading AIDS sentences and monologue at each stimulation condition.  
Stimulation 
condition 
SPL (dB) for 
sustained phonation 
Mean (SD) 
SPL (dB) for AIDS 
read sentences 
Mean (SD) 
SPL (dB) for one 
minute monologue 
 Mean (SD) 
Inside/high 71.5 (5.7) 73.7 (5.6) 73 (6.6) 
Inside/low 71.1 (6.6 72.2 (6.1) 71.35 (5.8) 
Outside/high 68.9 (5.9) 70.2 (5.9) 68.5 (6) 
Outside/low 69.7 (4.3) 73.2 (5.9) 70.14 (5.44) 
OFF stimulation 69.4 (6.3) 71.8 (6) 71 (6.5) 
clinical settings 70.8 (7.8) 72 (6.4) 71.64 (7.8) 
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4.3.2.3 Motor scores 
High voltage had a significantly more beneficial effect on movement than low voltage 
[F (1,52)=13.33, p=0.00061] (mean UPDRS-III “inside/high”: 23.7, (SD 7.2), 
“inside/low”: 35.4 (SD 13.6), “outside/high”: 31.4 (SD 7.4) and “outside/low”: 39 (SD 
9.7)). Contacts inside the STN had a significantly more beneficial effect on movement 
than contacts outside the STN [F (1,52)=4.54, p=0.03] (Figure 3). The interaction 
between contact site and voltage was not statistically significant [F (1,52) = 0.59, 
p=0.44] for the UPDRS-III. Post hoc comparisons indicate that the mean UPDRS-III for 
the inside/high condition was significantly lower (i.e. better function) than the 
inside/low condition (p=0.0088). Equally the UPDRS-III score for the outside/high 
condition was significantly lower than the outside/low condition (p=0.029). Post-hoc 
comparisons indicate also that the mean UPDRS-III score for the inside/high was 
significantly lower (i.e. better function) than the outside/high. There was no statistically 
significant difference between the inside/low and outside/low conditions (p=0.114).   
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Figure 4.3: Median (inside horizontal line), Means (small square), quartiles (first and 
third) and range of UPDRS-III scores per stimulation condition. 
4.3.2.4 Speech and motor score with stimulation-on at clinical parameters versus off-
stimulation. 
A paired samples t-test was conducted to evaluate the impact of stimulation-on at 
clinical settings and off-stimulation on speech intelligibility (AIDS) and on UPDRS-III 
motor score. The difference between speech intelligibility on- (mean=58.3% SD=22.63) 
and off-stimulation (mean=65.78%, SD=16.99), [t (26) = 0.98, p=0.33] was not 
significant. The mean decrease in speech intelligibility when on-stimulation was 7.4%. 
There was a statistically significant improvement in UPDRS-III motor scores when 
patients were stimulated at clinical parameters (mean 24.8, SD 8.4) versus off 
(mean=52.28, SD=9), t (26) = 8.31, p=.000, with a 95% confidence interval ranging 
from 20.65 to 34.2. 
4.4 Study 2. The role of the cerebellothalamic tract on speech intelligibility: a 
patient-specific model-based investigation of speech intelligibility and movement 
during deep brain stimulation.  
In order to investigate further the variability of speech response with high voltage 
stimulation, in particular the spread of current medially to the STN, we studied a 
subgroup of patients further. Patient specific finite element computer models were set 
up for each patient and the electric field generated during various electrical settings was 
visualized. The overall aim of this study was to relate the anatomical aspect of the 
simulated electric field to acute effects of speech intelligibility and movement. This 
study was a collaboration with the department of Biomedical Engineering, Linköping 
University, Sweden (Astrom et al, 2010). 
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4.4.1 Patients and methods  
4.4.1.1 Patient selection 
Ten out of the 14 patients of Study 1 were included in this study (Table 4.3) based on 
their stimulation-induced effects on speech intelligibility. The patients fell into three 
groups: Group A (patients 1-2) included patients with substantially impaired speech 
intelligibility during 4 Volt (V) amplitude settings compared to off stimulation. Group 
B (patients 3-6) included patients with slightly impaired speech intelligibility during 4V 
amplitude settings compared to off-stimulation, and group C (patients 7-10) included 
patients whose speech intelligibility was not impaired during 4V amplitude settings. 
The stimulation-induced impairment of speech intelligibility was considered substantial 
if a reduction of ≥ 30% was present, slight if a reduction of 7 -10% was present, and not 
impaired if a reduction of ≤ 1% was present (Table 4.3).  
Table 4.3: Speech intelligibility and UPDRS-III scores during 4V, 2V, and off-
stimulation for the subgroup of 10 patients who were studied further. 
 
Patients Group Speech 
2 V 
Speech 
4 V 
Speech 
Off 
UPDRS-
III 
2 V 
UPDRS-
III 
4 V 
UPDRS-
III 
Off 
1 A 45% 7% 60% 52 28 71 
2 A 84% 55% 85% 19 21 41 
3 B 70% 20% 30% 33 33 62 
4 B 65% 50% 60% 34 26 48 
5 B 63% 61% 70% 29 31 50 
6 B 68% 55% 62% 52 32 45 
7 C 74% 75% 76% 47 14 51 
8 C 77% 83% 75% 42 24 57 
9 C 68% 55% 53% 21 29 42 
10 C 55% 50% 45% 56 25 64 
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4.4.1.2 Patient specific simulations and visualisation 
Electric field simulations were performed for all patients with 2V and 4V electric 
potential settings which were used during the assessments. The electric field was 
visualised in three dimensions with isolevels at 0.2 V/mm together with the anatomy on 
two-dimensional colour-coded axial and coronal slices. The contours of the electric 
field isolevels were traced onto the axial and coronal slices where they were colour-
coded according to the assessment scores on speech intelligibility. Red colour indicated 
substantially impaired speech intelligibility (≥ 30% impairment), orange colour 
indicated slightly impaired speech intelligibility (7-10% impairment), and white colour 
indicated no reduction of speech intelligibility (≤ 1% impairment) (Figure 4.4). 
Surrounding structures of the STN e.g. the pallidofugal fibres and fct, were identified 
and traced onto the model images with help from atlases presented in Gallay et al, 
(2008) and Morel (2007).  
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Figure 4.4: Patient-specific simulation of DBS in the STN. The electric field was 
visualized with isolevels at 0.2 V/mm. The isolevels were traced onto axial and coronal 
images. In this figure the trace was coloured in red, which indicates substantially 
decreased speech intelligibility. 
 
4.4.1.3 Atlas model 
In order to improve the understanding of the anatomical relation between the STN and 
its surrounding structures, a 3D atlas model of the STN, red nucleus (RN), fct, al, fl, 
fasciculus thalamicus (ft), substantia nigra pars reticulata (SNr), substantia nigra pars 
compacta (SNc), globus pallidus interna (GPi), and the globus pallidus externa (GPe) 
was created in Matlab 7.0 (The MathWorks, USA). The anatomical model was based on 
axial images from a stereotactic atlas of the human thalamus and basal ganglia by Morel 
(2007). The atlas model also included a modelled DBS electrode positioned in the 
posterodorsal part of the STN with an animated electric field at contact 2. 
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Figure 4.5: Three-dimensional atlas model. A three-dimensional atlas model of the 
STN, RN, fct, al, fl, ft, SNr, SNc, GPi, and GPe together with a modelled DBS electrode 
placed in the posterodorsal area of the STN. An electric field was visualized with a 
transparent isolevel in white colour. (From: Astrom et al, 2010). 
 
4.4.2 Results 
4.4.2.1 Speech intelligibility and the fct 
The patients in group A (patients 1-2) suffered from substantial stimulation-induced 
impairment of speech intelligibility during high amplitude stimulation (i.e. 4V) (Table 
4.3). These two patients had at least one active electrode contact positioned in the 
posterior part of the STN. The simulated electric field isolevel covered except for the 
STN also a major part of the fct during high amplitude stimulation. Patient 1 suffered 
from stimulation-induced impairment of speech intelligibility also during low amplitude 
stimulation (i.e. 2V). The electric field isolevel in relation to the fct, al, fl, and ft is 
presented in Table 4.4. 
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The speech intelligibility in group B (patients 3-6) was noticeably impaired during high 
amplitude settings, although to a smaller degree than the patients in group A (Table 
4.3). The patients of group B had at least one electrode contact positioned in the 
posterior and/or medial part of the STN. In patient 3, 4 and 6 at least one of the active 
contacts were also positioned ventral to the centre of the STN. At least one of the 
electric field isolevels covered part of the fct during high amplitude stimulation. In 
patient 5, speech intelligibility was reduced also during low amplitude stimulation. The 
electric field isolevel in relation to the fct, al, fl, and ft is presented in Table 4.4. 
 
The patients in group C (patients 7-10) did not suffer from stimulation-induced speech 
impairments during high or low amplitude stimulation (Table 4.3). Patient 7-9 had 
electrode contacts positioned in the dorsal part of the STN area, while the left electrode 
contact in patient 10 was located more ventral. This electrode was pulled up ~2.5 mm 
one week after the post-operative images were acquired. Despite the fact that this was 
compensated for in the model, the position of this electrode is uncertain. The 
distribution of the electric field isolevels during high amplitude stimulation did not 
cover part of the fct in patient 7-9, and slightly covered part of the fct in patient 10.  
The electric field isolevel in relation to the fct, al, fl, and ft is presented in Table 4.4. 
 
Table 4.4: The position of the left (L) and right (R) active electrode contacts were 
described in relation to the centre of the STN. The spatial distribution of the electric 
field isolevels during high amplitude stimulation (4 V) were described in relation to the 
fct, al, fl, and ft, where N = did not cover, S = slightly covered, and C = considerably 
covered the structure.  
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Patients Electrode contact 
position 
Electric field isolevel covered: 
(L/R side)  fct al fl ft 
1 L 
R 
dorsal, posterior 
dorsal 
C 
N 
N 
S 
C 
C 
C 
C 
2 L 
R 
centre 
posterior 
S 
C 
N 
N 
C 
C 
N 
N 
3 L 
R 
ventral, medial 
ventral, medial, posterior 
C 
C 
N 
N 
C 
C 
C  
C 
4 L 
R 
medial 
ventral, medial, posterior 
N 
C 
N 
N 
C 
C 
C 
S 
5 L 
R 
medial 
medial 
S 
S 
N 
S 
C 
C 
C 
C 
6 L 
R 
ventral 
posterior 
S 
S 
N 
N 
S 
S 
N 
N 
7 L 
R 
dorsal 
dorsal 
N 
N 
N 
N 
C 
C 
C 
C 
8 L 
R 
dorsal 
dorsal 
N 
N 
C 
C 
C 
C 
C 
C 
9 L 
R 
dorsal, medial 
dorsal, medial 
N 
N 
S 
C 
C 
C 
C 
C 
10 L 
R 
ventral, medial 
dorsal, anterior 
S 
N 
N 
N 
C 
C 
S 
C 
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4.4.2.2 Movement 
Movement as scored by the UPDRS-III was improved in all patients to various degrees 
during both low and high amplitude settings compared to off-stimulation (Table 4.3). 
Patients 2, 3 and 5, had similar motor scores during both low and high amplitude 
stimulation, while patient 1, 6, 7 and 10 showed large differences in the UPDRS-III 
between low and high amplitude stimulation. The electric field isolevel in relation to the 
fct, al, fl, and ft is presented in Table 4.4. High amplitude stimulation was more 
consistent in improving the motor scores than low amplitude stimulation. This was also 
the case in patients whose speech intelligibility was substantially impaired by the 
stimulation. No general differences were found in the acute stimulation-induced effects 
on movement between groups A, B, and C. 
 
4.5 Discussion 
4.5.1 The role of high voltage on speech intelligibility 
We have demonstrated in this study that speech intelligibility can deteriorate with high 
voltage for contacts both inside and outside the STN. Deterioration in speech 
intelligibility was not linked to a significant deterioration of vocal loudness. High 
voltage stimulation of contacts inside the STN can have a beneficial effect on motor 
scores and at the same time induce a significant deterioration of speech intelligibility. 
The degree to which speech is affected by high voltage stimulation was variable 
between patients.  
 
The role of high voltage on speech confirms previous reports. Tornqvist et al (2005) 
found an impairment of speech following a 25% increase in voltage or with frequencies 
185 Hz and 130 Hz, compared to 70 Hz. Krack et al (2002, 2003) and Tommasi et al 
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(2007) have also reported speech deterioration with increased electrical parameters such 
as frequency and voltage. 
 
In our study speech motor deficits subsequent to high voltage STN-DBS include 
breathy and hypernasal voice quality, intermittently continuous voicing of a 
hyperfunctional character, and slowed lip, tongue and jaw movements, leading to 
imprecise articulation. In addition, dystonic contractions of the laryngeal and velar 
muscles may emerge during connected speech, but not in association with 
laughing/crying or production of isolated vowels. These characteristics are not typical 
of the syndrome of hypokinetic dysarthria as initially described by Darley and co-
workers (1969) in patients with Parkinson’s disease. Rather, the observed profile of 
speech motor deficits must be considered a variant of mixed dysarthria, encompassing 
bradykinetic and dystonic features. Further evidence for a mixed dysarthria type 
emerging from STN stimulation is the lack of change in vocal intensity despite the 
decreased intelligibility. This is contrary to other studies in PD dysarthria where 
increased loudness is associated with increased speech intelligibility (Tjaden et al, 2004; 
Rosen et al, 2006). 
 
Several hypotheses could explain the worsening effect of STN-DBS on speech. STN 
could have a different role or a different somatotopy for speech and body motor control. 
Another hypothesis is that the current could spread to other pathways in the area.  
 
The somatotopy of the STN with respect to speech is very poorly understood, mainly 
due to lack of animal models. In monkeys, neurons in the dorsolateral part of the STN 
and the substantia nigra have been identified to be particularly active during oral 
movements for feeding (Mora et al, 1977; DeLong et al, 1983). Mouth movements have 
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been elicited by electrical stimulation applied in the STN area (Mora et al 1977). In the 
non-parkinsonian monkey the face was represented in the most lateral zone of the STN 
(Wichmann et al, 1994). 
 
4.5.2 Stimulation-induced speech impairment and spread of current to neighbouring 
structures 
The electric field generated by DBS electrodes is capable of spreading to a large volume 
of tissue (McIntyre et al, 2004). Guiot and colleagues (1961) had first hypothetised that 
the spread of current to the cortico-bulbar tract during intraoperative electrical 
stimulation could be responsible for speech impairment. This has recently been 
suggested by Krack et al (2003). Tommasi and colleagues (2007) analysed the 
pyramidal tract side effects (PTSEs) induced by increased voltage of stimulation. They 
also studied the relationship between the voltage threshold for the PTSEs and the 
distance from the centre of the used contact to the medial border of the pyramidal tract 
as measured on MRI in 14 patients treated with bilateral STN-DBS (i.e. for 28 
electrodes). They differentiated between stimulus-dependent contractions of muscles 
referred to as speech organs and dysarthria defined as a) the subjective effort to speak 
reported by the patient and the objective observation by the physician of the qualitative 
speech changes time-locked to the stimulus, b) the worsening of speech disturbances in 
parallel with the voltage increase and c) the reproducibility of these effects. They found 
increased contractions in the forehead, eyebrow, eyelid, cheek, lip and chin with 
progressive increase in voltage. Contractions of the lower face were opposite to the 
stimulation site for all the electrodes and bilaterally for the upper face. Dysarthria was 
observed for seven out of 28 electrodes and it was characterised by hypophonic, slurred 
speech, rapid fatiguing and hesitation with frequent, long pauses. However dysarthria 
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was rarely involved as the initial PTSE. Initial PTSEs were located in the face. They 
also found a linear correlation between the distance from the chronically used contact 
and the medial pyramidal tract border and the voltage threshold for motor contractions. 
This confirmed their hypothesis that the observed motor contractions were induced by 
spread of current to the pyramidal tract. However they report no correlation between the 
motor contractions of the face observed as early signs of PTSEs in the majority of the 
electrodes and dysarthria, observed in a small number of patients and with increased 
stimulation voltage. However if the effects on speech were caused by the spread of 
current to the internal capsule, and the corticobulbar pathways for laryngeal motor 
control, we would expect a significant change on sustained phonation and other 
acoustical parameters of connected speech, which is not observed in our data.  
 
Spread into other pathways, namely the pallidofugal and the cerebellothalamic fibres 
could affect speech and it is especially likely from patients with medially placed 
electrodes (Morel, 2007). Results from the simulations showed that patients with 
stimulation-induced speech impairments had electrodes placed medial and/or posterior 
to the centre of the STN. In these patients the electric field isolevel during high 
amplitude stimulation only slightly extended laterally into the corticobulbar fibres. 
Thus, it is not likely that the speech impairments were attributed to stimulation of 
corticobulbar fibres.  
 
4.5.3 Stimulation-induced speech impairment and the fasciculus cerebellothalamicus 
In a study by Plaha and co-workers (Plaha et al, 2006) stimulation related dysarthria 
was noticed in patients with active electrode contacts positioned medially to the STN. 
The authors believed that stimulation of fibres from the fct that control movements of 
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the vocal cords was likely the cause of the dysarthria. In addition, Velasco et al (2001) 
found that three out of ten patients suffered from stimulation-induced dysarthria from 
electrodes placed in the prelemniscal radiation which run medially to the STN and 
contain cerebellar fibres. These results are in agreement with the present findings. In 
addition, the fct projects to the motor thalamus with primary projections to the ventral 
intermediate nucleus (VIM) (Gallay et al, 2008). Thus, current spread into the fct may 
constitute a possible cause of the well-known stimulation-induced speech impairments 
during VIM DBS. In addition in the present study it was shown that speech 
intelligibility was impaired only when the 0.2 V/mm electric field isolevel covered part 
of the fct and not when the electric field isolevel covered a major part of the 
pallidofugal fibres without covering the fct. This is the important finding of this study. 
 
4.5.4 Limitations of the simulation study 
It is important to recognize that the patient specific models and electric field simulations 
presented in this study only provide a rough estimation of the electric field generated by 
DBS (Astrom et al, 2009). Most importantly, the 0.2 V/mm electric field isolevel should 
be interpreted as a boundary wherein the electric field is 0.2 V/mm or larger, and not as 
the volume of tissue influenced by the stimulation. Various neural components (soma, 
axons and dendrites) are affected differently depending on their size and orientation in 
the electric field, and the volume of tissue influenced by DBS is still not known. The 
0.2 V/mm isolevel was used in this study for visualization of relative changes of the 
electric field between high and low amplitude stimulation. The uncertainty of the 
volume of influence exists in parallel with the uncertainty of the brain anatomy and 
physiology on a detailed level. Atlases presented by Gallay and colleagues (2008) and 
Morel (2007) were used to identify and trace the contours of structures and fibre-paths 
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in the surrounding of the STN onto the axial and coronal images. However, these traces 
only provide an approximation of the true locations of these structures and fibre paths 
due to e.g. slight misplacement of the atlas, the MRI not being aligned with the anterior 
commissure – posterior commissure (AC-PC) plane, and patient individual anatomical 
variability.  
 
The results indicate that movement can be improved by DBS for a wide range of 
electrode contact locations and electrical settings within the STN area. Stimulation of 
the fct may be a possible cause of stimulation-induced dysarthria during STN-DBS. 
Special attention to stimulation induced speech-impairments should be taken in cases 
when active electrodes are positioned medial and/or posterior to the centre of the STN. 
However, only the acute effects were assessed which is not always equivalent with the 
long-term effects. Assessments during unilateral stimulation of the STN have suggested 
that the effect on speech intelligibility is hemisphere specific (Santens et al, 2003; Wang 
et al, 2003). Although highly relevant, unilateral assessments were not performed in this 
study in order to keep the examination time reasonable. Moreover, the small sample size 
of the present study accentuates carefulness when interpreting the results.  
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CHAPTER 5: EFFECTS OF MEDICATION AND 
SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION 
(STN-DBS) ON TONGUE MOVEMENTS IN SPEAKERS 
WITH PARKINSON'S DISEASE USING 
ELECTROPALATOGRAPHY (EPG): A PILOT STUDY. 
5.1 Summary 
Speech problems in PD following STN-DBS can be due, in part, to articulatory 
breakdown. Timing and accuracy of tongue movement can affect articulation. The aim 
of this pilot study was to quantify the effects of bilateral STN-DBS and medication on 
articulation, using Electropalatography (EPG).  
 
Two patients were selected to participate for their contrasting speech response to STN-
DBS: PT1 showed deterioration of speech intelligibility with stimulation whereas PT2 
showed improvement. They were studied under four conditions: on- and off-medication 
and on- and off-stimulation. The EPG protocol consisted of a number of target words 
with alveolar (/t/, /d/) and velar (/k/, /g/) stops, repeated 10 times in a random order. The 
results illustrated the variable effects of stimulation and medication on articulation and 
the role of tongue movements on speech intelligibility. The study quantified more 
articulatory imprecision for alveolar stops than velars. Furthermore, the findings 
provided evidence that stimulation with medication has a more detrimental effect on 
articulation than stimulation alone in both patients.  
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This pilot study illustrates the variability of response to STN-DBS, the way stimulation 
can affect the timing and amount of tongue movements as well as the role of tongue 
movements on speech intelligibility. It is also the first study to use EPG to quantify 
tongue articulation during speech following STN-DBS. 
 
5.2 Introduction  
A number of studies on PD articulation have reported that stop consonants (/p,t, 
k,g,b,d/) were imprecise and sound like fricatives (/f, θ, χ, v, γ, δ/) (Logemann, 1981; 
Weismer, 1984). So far initial reports on the effects of STN-DBS on speech have 
showed a marked improvement of lip and tongue force, as measured with non-speech 
oral motor tasks. Gentil and colleagues (Gentil et al, 1999) studied the oral force control 
of ten selected patients using load-sensitive devices to measure the compression forces 
generated by the upper and lower lip and tongue. STN stimulation improved speech 
performance as measured with the UPDRS-III speech item 18, and increased the 
maximal strength, accuracy and precision of the articulatory organs. The same group 
reported the beneficial effects of stimulation on acoustical data of 26 PD patients 
(Gentil et al, 2001; Gentil et al, 2003). Pinto and colleagues (Pinto et al, 2005) 
illustrated a variable effect on speech in four case studies. Response to STN stimulation 
ranged from improvement with medication and stimulation to deterioration with 
increased voltage intensity. More recent studies point out this dissociation between 
improvement in acoustic measures of speech and decline in speech intelligibility 
(Klostermann et al, 2007; D’Alatri et al, 2008; Pützer et al, 2008). Putzer et al, (2008) 
reported the presence of articulation problem, mainly fricated stops in five out of nine 
patients when on-stimulation. Most of the studies mentioned so far are based either on 
acoustic measures, or on non-speech oro-motor tasks (with load-sensitive devices), with 
limited indication of the underlying articulatory problem during speech. In comparison 
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to the studies mentioned above we wanted to use a method that enables quantification of 
changes in consonant production during speech. Electropalatography (EPG) was the 
technique of choice for this articulatory analysis, because it can detect articulatory 
undershoot (Hardcastle et al, 1985) and thus reflects levels of articulatory precision. 
EPG is a technique that measures the amount of tongue to palate contact during speech. 
McAuliffe et al (2006a; b) investigated consonant production in nine patients with PD 
(non-operated) with a mild to moderate dysarthria using EPG. Contrary to expectations, 
they found no differences between their subjects and healthy controls in terms of 
segment duration, spatial characteristics or variability (McAuliffe et al, 2007). At the 
same time, perceptual ratings revealed impaired speech rate and target undershoot, 
which could not be quantified with EPG. 
  
The aim of this pilot study was to use EPG to study the movements of the tongue to the 
palate in two patients with bilateral STN-DBS. We aimed to focus on velar and alveolar 
stops (/t/, /k/) because from clinical observation we anticipated most articulatory 
problems in tongue tip and back-of-the tongue sounds.  
This study was a collaboration with Dr M. Hartinger and Prof. William Hardcastle from 
University of Edinburgh. 
 
5.3 Patients and methods 
5.3.1 Patients 
Two patients (PT1 and PT2) were selected for the pilot study, on the basis that DBS 
produced contrasting effects on their speech. Both patients were assessed pre- and post-
operatively using the Assessment of Intelligibility of Dysarthric Speech (AIDS, 
Yorkston & Beukelman, 1984) and the Unified Parkinson’s Disease Rating Scale, Part 
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III (UPDRS-III), as part of their routine clinical testing off- and on-medication and off- 
and on-stimulation. STN-DBS improved the motor symptoms of both patients (Table 
5.1A). 
 
Speech intelligibility was rated as described before (Chapter 2 and 3). PT1’s speech 
intelligibility deteriorated with STN-DBS, especially when on medication, whereas PT2 
had the opposite effect, his speech intelligibility was improved following one year of 
stimulation (Table 5.1B). Speech for PT1 when off-medication/on-stimulation was 
characterised by imprecise consonants, reduced voice volume, monopitch, 
monoloudness, rapid rate and reduced stress. This pattern deteriorated with medication, 
mainly the articulatory imprecision and the strained-strangled voice quality. Conversely 
the pattern was improved when the patient was off-medication/off-stimulation. PT2’s 
speech was characterised by some consonant imprecision and mildly strained voice with 
the opposite effect of medication and stimulation. 
Table 5.1A: Patient details  
 
Table 5.1B: Speech intelligibility data of the participants as measured by the 
Assessment of Intelligibility of Dysarthric Speech (Yorkston et al, 1981) before the 
operation on- and off-medication and one year after (nearest time point to the EPG 
experiment) off-medication/on-stimulation, off-medication/off-stimulation and on-
patient age disease 
duration 
UPDRS-III baseline    UPDRS-III post-operative 
PT1 57 15 21 (on) 
 
16 (off/ON) 
11 (on/ON) 
PT2 55 9 60 (off) 
10 (on) 
 
16 (off/ON) 
2 (on/ON) 
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medication/on-stimulation. The data is the percentage of words understood per 
hundred.  
 
 
5.3.2 Electropalatogrophy 
EPG is a safe and non-invasive technique. Individual artificial palates were 
manufactured for each speaker. The artificial palate incorporates 62 touch-sensitive 
electrodes (see Figure 5.1) and records details of the location and timing of tongue 
contacts with the hard palate during speech. The speakers practiced using the artificial 
palate at home and then took part in the experiment. According to McAuliffe et al 
(2006a) after wearing the palate for 45 minutes speakers generally produce normal 
speech articulation (consistent with the no palate condition). 
 
Figure 5.1: EPG palate (left) and computerised EPG frame EPG frame (right). 
 
patient Baseline 
on-
medication  
Baseline 
off-
medication 
post-operative 
off-meds/on-
stim 
post-operative 
off-meds/off-
stim 
post-
operative 
on-meds/on-
stim 
PT1 82% 90% 45% 72% 55% 
PT2 90% 75% 92% 82% 95% 
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5.3.3 Stimuli 
In order to keep co-articulatory and prosodic effects constant the test material was 
recorded in a highly controlled manner. The EPG protocol consisted of a number of 
monosyllabic target words with alveolar and velar stops, repeated up to 10 times in 
random order. 
 
The words (take, Tate, cake, Kate) contained a CVC structure where C = /t/ or /k/ and V 
= /ei/. The four words were embedded in the frame sentence 'It's a ___ again' to keep the 
co-articulatory effects on the initial and final sounds constant. Stops were chosen 
because most speech errors in parkinsonian dysarthria occur on these sounds 
(McAuliffe et al, 2006a). Furthermore, we were interested in the comparison of tongue 
tip (alveolar) versus tongue back (velar) movements, since some authors propose that 
back of tongue movements are more impaired in PD speech (Logemann et al, 1978, 
Logemann & Fisher, 1981).  
 
Because speech production is known to be highly variable generally, and even more so 
in parkinsonian dysarthria, (McAuliffe et al, 2007), we aimed to record 10 repetitions of 
each target in a random order to measure the variability of articulation patterns. During 
the recording the speakers were asked to read the sentences from a monitor in a normal 
and habitual way while wearing the EPG palate. Data presented here focus on the 
production of sounds in initial position only. 
 
5.3.4 Experimental conditions 
The WinEPG system was used to record EPG (100 Hz) and acoustic data 
simultaneously (44,100 kHz). The recordings were carried out on one day in four 
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conditions, lasting a maximum of 10 minutes each, in the following order: 1. off-
medication/on-stimulation 2. off-medication/off-stimulation 3. on-medication/on-
stimulation 4. on-medication/off-stimulation. 
 
The on-medication recordings were started one hour after the oral intake of the patients’ 
anti-parkinsonian medication. Following the on-medication/on-stimulation recording 
the stimulator was switched off for the on-medication/off-stimulation recording. The 
delay before starting the on-medication/off-stimulation recording was 10 minutes for 
PT1 and less than two minutes for PT2, who showed rapid deterioration and discomfort 
when the stimulator was switched-off. PT2 recorded a maximum of five repetitions of 
each word in these conditions. 
  
5.3.5 Data analysis 
Articulate Assistant software (version 1.16) was used to analyse the EPG data. The 
alveolar zone was defined as the first four rows of the palate, where the electrodes are 
relatively close together. 
 
Figure 5.2: Defined alveolar zone in the EPG palate. 
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The velar zone comprised the last four rows. Our definition of velar closure does not 
necessarily presuppose full contact across the EPG palate, because actual articulatory 
closure may occur posterior to the last row of electrodes.  
 
Figure 5.3: Defined velar zone in the EPG palate. 
  
The data analysis was undertaken in two parts, segmentation of data and measurement 
of temporal and spatial characteristics. 
 
5.3.5.1 Segmentation of closure phase 
Because of the articulatory differences in the four conditions we devised consistent 
segmentation criteria that applied to accurate as well as impaired articulation (for 
example in the case of frication of stops, where no closure and release phase was 
produced). 
The alveolar zone consists of 30 electrodes (figure 5.2). The defined onset of the closure 
phase marks the time point where a clear increase of tongue contacts in this region 
could be determined. For example for the initial alveolar stop /t/ in 'take' or 'Tate' the 
onset of the alveolar closure was the EPG frame where 12 out of 30 electrodes (40%) 
were activated. Figure 4 illustrates how the onset of the closure phase coincides with the 
abrupt increase of alveolar contacts in the middle trace where the EPG frames are 
displayed. This increase of activated contacts is displayed in the bottom trace of the 
figure and is marked as “onset”. Where it was not possible to use this criterion (i.e. in 
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cases of frication) we used the onset of acoustic energy to define the beginning of the 
consonant (Figure 5.4). 
 
 
releaseclosure
/t/ /ei/ /k/
max
onset 
 
Figure 5.4: Segmentation points for the target word 'take'. The segmentation lines mark 
the on- and off-sets of the different articulatory phases. The upper trace shows a 
spectrogram where the left annotation line marks the onset of the closure. The middle 
trace shows the succession of EPG frames every 10ms. The individual palate diagrams 
are staggered in two rows. In the bottom trace two lines are shown: one for the total 
number of contacts in the alveolar zone (red) and the other for the totals in the velar 
zone (green). The onset of the closure phase coincides with the time point in the bottom 
trace showing an abrupt increase in the number of alveolar contacts. This time point 
refers to the first EPG frame which shows a complete closure in the alveolar zone.  
The segmentation of the release is the synchronized time point of the burst in the 
spectrogram and where in the EPG frame the number of alveolar contacts decreases. 
 
5.3.5.2 Temporal measurement 
Consonant duration, i.e. the duration of contact for each segment measured in msec was 
used to describe the temporal characteristics of articulation. In the case of frication, only 
one time interval, namely that of the frication phase, was measured (see Figure 5.5). 
 
5.3.5.3 Spatial measurement 
Spatial characteristics were calculated based on the mean number of contacts at the 
frame of maximum contact during the closure phase (alveolar, velar) or, in cases such as 
the ones shown in Figure 5, during the frication phase.  
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In the case of abnormal stop production where no clear closure and release phase was 
produced (Figure 5.5), we measured the duration of the frication phase and identified 
the EPG frame with the maximum number of contacts to analyse the precision of 
articulation.  
 
 
Figure 5.5: Example of frication of the stop /t/ in 'take'. The EPG frames in the middle 
trace show an incomplete closure in the alveolar zone and a more /s/-like sound is 
produced. In the spectrogram no decreases of energy after the previous vowel can be 
seen and no burst which marks the beginning of a release ephase. The absence of these 
characteristics coupled with the presence of spatial noise indicates frication. 
 
Each target word was analysed separately, this means that “take” was not combined 
with “Tate” because the initial stops were in two different environments (with possible 
effects of the final consonant). In the off-stimulation stimulation condition of PT2 only 
three to five repetitions were recorded due to the deteriorating disease symptoms. 
Therefore the mean values of those symptoms are based on smaller numbers. 
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5.3.6 Statistical analysis 
Two-way ANOVAs were conducted with the independent factors medication and 
stimulation and the dependent variables segment duration and maximal contact. 
 
Statistical comparisons of articulation across the four recording conditions were 
undertaken using a two-way analysis of variance (ANOVA). The calculations were 
based on mean values of the 10 repetitions of each target word. In order to quantify 
imprecise consonant articulation, descriptive statistics were used to count the cases 
where stops were produced without a complete constriction in any one of the rows in 
the defined articulatory region. 
 
Spearman r correlation coefficient between temporal and spatial data was calculated in 
order to determine any relationship between these two different parameters. 
 
Due to the fact that the patients were selected on the basis of their different response to 
STN-DBS the results will be reported separately. 
 
5.4 Results 
5.4.1 Patient PT1 
PT1’s speech when on-stimulation was reduced in intensity, with fast rate and indistinct 
articulation. Intelligibility ratings showed a decrease from 72% intelligible speech when 
off-medication/off-stimulation to 55% when on-medication/on-stimulation. 
 
Overall reduced speech intelligibility was linked with imprecise articulation in the form 
of fricated stops (Table 5.2). This phenomenon occurred mainly at the on-
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medication/on-stimulation condition. In the off-medication conditions, stimulation 
clearly caused more frication. The stops sounded spirantised (similar to /s/). The 
frication seems to be influenced by the place of articulation (Table 5.2): frication 
occurred in velar but not in alveolar stops when on-medication/off-stimulation. 
Furthermore, higher numbers of frication of the initial stops /t/ and /k/ could be seen in 
words including final /t/ in comparison to final /k/ words, when on-medication/on-
stimulation. Anticipatory tongue-tip (alveolar) gestures seemed to result in more 
frication than velar gestures.  
 
Table 5.2: Absolute frequency of normal and fricated (in brackets) production of 
closure phase for PT1 and PT2. 
 
  medication off medication on 
word speaker Stim- off Stim- on Stim- off Stim- on 
take PT1 10 7(3) 10 8(2) 
PT2 0(6) 10 1(9) 10 
Tate PT1 10 9(1) 10 1(9) 
PT2 0(5) 10 0(10) 8(2) 
cake PT1 10 8(2) 5(5) 6(4) 
PT2 0(4) 10 1(9) 8(2) 
Kate PT1 10 8(2) 7(3) 2(8) 
PT2 0(3) 10 1(9) 8(2) 
 
5.4.1.1 Temporal characteristics 
Consonant duration, i.e. the duration of contact for each segment measured in ms, was 
used to describe the temporal characteristics of articulation. When PT1 was off-
stimulation he showed an increase in segment duration. As the ANOVA results show 
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(Table 5.3) there were significant temporal effects of stimulation on the segment 
duration (except for “cake”). Medication had no effect on the duration of alveolar or 
velar stops. 
 
Table 5.3: Means and standard deviations for the consonant duration split by 
articulatory region (alveolar-velar) for PT1.  
 
The interaction of medication and stimulation was significant for alveolars but not for 
velars. In the alveolar stop production stimulation affected the durations when the 
patient was off-medication (166.6±24.0ms when off-medication/off-stimulation  
versus 132.1±11.3ms when off-medication/on-stimulation) but not on-medication 
(145.8±17.1ms when on-medication/off-stimulation versus 134.9±17.9ms when  
on-medication/on-stimulation) (Figure 5.6). The same tendency can be seen in the 
example of “cake” (Figure 5.7), where PT1 produced longer durations when off-
stimulation. 
cake
cond mean SD mean SD mean SD mean SD
med/stim
off/OFF 166.6 24.0 159.7 15.1 158.4 18.9 157.8 27.3
off/ON 132.1 11.3 122.3 18.0 146.6 49.1 131.5 14.0
on/ON 134.9 17.9 129.2 14.4 134.6 9.2 130.5 13.3
on/OFF 145.8 17.1 142.2 17.3 145.9 14.8 139.2 17.1
ANOVA F(1,36)= F(1,36)= F(1,36)=
med
stim 
med*stim 2.2; p=.149
8.7; p=.006*
2.7; p=.108
F(1,36)=
1.9; p=.171
0.0; p=.973
1.7; p=.195
take
2.5; p=.126 
15.6; p=.000* 
4.3; p=.046* 5.6; p=0.23*
24.0; p=.000*
1.1; p=.304
Tate
PT1
alveolars velars
Kate
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Figure 5.6: Means and standard deviations of the stop duration (in ms) in the word 
“take” for PT1 and PT2. 
 
Figure 5.7: Means and standard deviation of the stop duration (in ms) of “cake” in PT1 
and PT2. 
 
5.4.1.2 Spatial characteristics 
PT1 produced higher number of contacts for the alveolar closure of “take” in the off-
stimulation condition in both on- and off-medication (Figure 5.8). Articulation for PT1 
became less precise when stimulation was on. The results of the two-way ANOVA 
revealed a significant main effect of stimulation on the precision of tongue movements 
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in all the target words (Table 5.4). The main effect of stimulation was significant for 
alveolar but not for velar stops.  
Table 5.4: Means and standard deviations for the number of activated contacts of the 
tongue with the hard palate in the relevant articulatory region.   
 
 
Figure 5.8: Mean number of contacts during the closure phase of /t/ in 'take' in % for 
PT1. 100% means contact in 10 out of 10 repetitions in the relevant EPG zone. In cases 
where stops were fricated, the frame with the maximum number of contacts was 
included in the mean values as well. The numbers and different shadings refer to 
percentage values that show the mean number of activated electrodes for the multiple 
repetitions of the word. The black shading and a ‘100’ in figure 10 mean that this 
electrode was touched in all of the repetitions (= 100% activated electrode) while '0' 
means that there was no contact in any of the repetitions. 
 
5.4.1.3 Correlation 
In order to explore the relationship between timing (duration of contact) and articulatory 
precision (number of contacts), correlation coefficients were calculated. The results 
showed that prolonged durations do correlate with improved articulatory accuracy in 
PT1 (r2=0.61for “take”, 0.40 for “tate”; 0.52 for “cake”; 0.99 for “Kate”). Thus it seems 
that deterioration of articulation in PT1 when on-stimulation was related to a decrease in 
cake
cond mean SD mean SD mean SD mean SD
med/stim
off/OFF 80 2.2 79 5.5 63.4 2.1 63.7 2.2
off/ON 65.3 12.2 70.7 8.6 55 2.2 55.6 3.2
on/ON 54.3 15.1 49.3 13.8 54.4 3.7 54.7 3.7
on/OFF 78 4.5 75.7 8.2 63.1 2.4 64 3.0
ANOVA
med
stim 
med*stim
F(1,36)=
0.1; p=.760
81.1; p=.000*
0.3; p=.595
103.1; p=.000*
F(1,36)=
0.4; p=.5340.0; p=.865
F(1,36)=
18.3; p=.000*
31.5; p=.000*
8.0; p=.008*
F(1,36)=
4.2; p=.048*
36.7; p=.000*
2.0; p=.164
PT1
alveolars velars
take Tate Kate
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consonant durations, which resulted in what perceptually we describe as articulatory 
undershoot.  
 
5.4.2 Patient 2 (PT2) 
PT2 intelligibility improved from 90% pre-operatively on-medication to 95% post-
operation (on-medication/on-stimulation). Speech when off-stimulation was reduced in 
intensity and slowed in rate (Table 5.1B). 
 
Overall PT2 produced fricated stops in both the velar and the alveolar targets. Frication 
was found in both off-stimulation conditions. In terms of medication effects, articulation 
was more imprecise when on-medication compared to off-medication. 
  
5.4.2.1 Temporal characteristics 
Medication with stimulation significantly influenced segment durations in speaker PT2: 
when off-stimulation articulation was slower with longer durations, mainly for the velar 
sounds (Table 5.5) (mean segment duration= 308ms for “cake” off-medication/off-
stimulation versus 110ms off-medication/on-stimulation). Such a large difference was 
not observed in the alveolar sounds. The 2-way ANOVA results also showed a 
significant main effect of medication (“take”: F=10.2. p<0.01, “Tate”: F=8.7, p<0.01, 
“cake”: F= 70.1, p<0.001, Kate: F=73.8, p<0.001). The interaction effect of medication 
and stimulation was significant in velar tongue movements (“cake”: F=14.5, p<0.001; 
“Kate”: F=5.7, p<0.05) but not in alveolar stops (“take”: F=0.3, n.s.; “Tate”: F=0.9, 
n.s.). Figures 5.6 and 5.7 illustrate the relative long duration for the velar stops, in the 
off-medication/off-stimulation condition. Thus medication for PT2 seems to increase 
the rate of speech, however in comparison with the on-stimulation conditions 
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medication alone (i.e. at the on-medication/off-stimulation condition) does not 
normalise speech rate.  
 
Table 5.5: Means and standard deviations for the consonant duration split by 
articulatory region (alveolar-velar) for PT2. 
 
5.4.2.2 Spatial characteristics 
While stimulation and medication showed noticeable temporal effects on velar 
articulation, there were no significant effects in terms of spatial characteristics (main 
effect of medication for “cake”: F=2.6, n.s; “Kate”: F=3.9, n.s.; main effect of 
stimulation for “cake”: F=0.8, n.s.; “Kate” F=1.2, n.s.). There were however effects on 
alveolar targets (main effect of medication for “take”: F=28.9, p<0.001; “Tate”: F=12.9, 
p=0.001; main effect of stimulation for “take”: F=39.7, p=0.001; “Tate” F=112.0, 
p=0.001) (Table 5.6). In terms of interaction effects between medication and stimulation 
on the precision of tongue movements there was no consistent difference between 
alveolar and velar stops (“take”: F=0.0, n.s, “Tate”: F=4.9, p<0.05, “cake”: F=14.4, 
p<0.001, “Kate”: F=3.1. n.s.). (Table 5.5). 
cake
cond mean SD mean SD mean SD mean SD
med/stim
off/OFF 145.4 19.1 175.3 43.9 308.9 55.3 283.6 10.1
off/ON 141.2 16.9 140.8 16.4 110.7 18.1 122.4 9.7
on/ON 116.7 13.4 122.8 23.8 136.7 62.2 126.4 31.0
on/OFF 128.3 24.9 139.8 24.1 210.9 34.6 217.4 57.5
ANOVA F(1,32)= F(1,31)= F(1,30)= F(1,29)=
med
stim 
med*stim
73.8; p=.000*
5.7; p=.024*
8.7; p=.006*
8.1; p=.008*
0.9; p=.341
4.9; p=.034*
70.1; p=.000*
14.5; p=.001*
4.5; p=.043*
1.5; p=.232
0.3; p=.569
PT2
alveolars velars
take Tate Kate
10.2; p=.003*
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Figure 5.9: Mean number of contacts during the closure phase of /t/ in 'take' in % for 
PT2. It shows that most precise articulation could be found off-medication/on-
stimulation, whilst on-medication/on-stimulation PT2 produced less alveolar contacts. 
When the stimulator was switched off, the negative medication effects in comparison to 
articulation without medication can be seen again. Another interesting observation 
about this speaker is that in the off-stimulation conditions, when speech intelligibility 
deteriorated, additional velar contacts were noticeable. Thus, target undershoot in the 
alveolar region and overshoot in the velar region could be detected. 
 
 Table 5.6: Means and standard deviations for the number of activated contacts of the 
tongue with the hard palate in the relevant articulatory region.   
 
 
5.4.2.3 Correlations 
Calculation between timing and articulatory precision in speaker PT2 resulted in higher 
coefficients for velars (r2=0.42 for “cake”; 0.48 “Kate) than for alveolar stops (r2= 0.10 
for “take” and 0.20 for “Tate”). Thus in PT2 slowing in speech production was not an 
indicator of improved articulatory precision in general.  
 
cake
cond mean SD mean SD mean SD mean SD
med/stim
off/OFF 80 2.2 29.3 6.4 34.4 0.0 35.4 4.8
off/ON 65.3 12.2 75.7 6.3 38.4 1.5 39.7 2.9
on/ON 54.3 15.1 54.7 14.5 36.6 2.1 40 3.5
on/OFF 78 4.5 24.3 9.7 39 3.3 40.9 4.3
ANOVA F(1,30)=
med
stim 
med*stim
112.0; p=.000*
4.9; p=.035*
F(1,29)=
3.9; p=.058
1.2; p=.270
3.1; p=.088
2.6; p=.114
0.8; p=.373
14.4; p=.001*
F(1,32)= F(1,31)=
12.9; p=.001*28.9; p=.000*
velars
Kate
39.7; p=.000*
0.0; p= .919
alveolars
take Tate
PT2
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5.4.3 Comparison of the two patients 
As anticipated from the selection of the patients, the results for the EPG were able to 
show both the contrasting effects of stimulation on stop articulation for the two speakers 
and the contrasting effects of medication and stimulation together. 
 
In both patients stimulation had a significant effect on segment duration. Medication 
changed the timing significantly in PT2 but not in PT1. A decrease of speech rate 
improved the articulatory precision of PT1 as documented by means of correlations 
between spatial and temporal data. By contrast the speech of PT2 was only improved 
when on-stimulation. When PT2 was off-stimulation velar sounds were significantly 
slower, but without any change at the number of EPG contacts. The number of contacts 
for the alveolar sounds was significantly influenced by both stimulation and medication. 
  
The differences in target control between the two speakers can be seen clearly in the 
EPG frames in Figures 5.8 and 5.9. While PT1 showed complete closures in one of the 
first rows in the alveolar region off-medication and off-stimulation, speaker PT2 
produced the best closures off-medication/on- stimulation. Articulatory precision in 
these examples was better off-medication.  
 
5.5 Discussion 
In this pilot study we used EPG to quantify the timing as well as the articulatory-spatial 
effects of deep brain stimulation and medication on the speech of two selected patients. 
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5.5.1 Spatial characteristics 
The two speakers differed in their EPG contact patterns in that PT1 produced 
incomplete closures for /t/ in the on-stimulation condition (signifying articulatory 
undershoot) while PT2 showed no such effects when on-stimulation. In PT2 speech rate 
was slowed and the longer the stimulator was off the weaker the speech output became 
in the spectrogram. More frication and co-articulatory effects were characteristic of the 
off-stimulation conditions.  
 
For both speakers, velar movements were affected in a similar way to alveolars. In 
Putzer et al (2008) frication was noted most frequently in the alveolar stop /t/ and never 
on velar or labial stops. The authors argued that fine motor control of the tongue tip is 
more differentiated and more influenced by vowels than tongue back movements. This 
argumentation confirms the findings of McAuliffe et al (2006a) and Gurd et al (1998) 
but is contrary to Logemann & Fisher (1981) and Weismer (1984) who described a 
particular impairment of tongue back movements. EPG provides the possibility to 
quantify tongue movements that are normally hidden from view. The detected 
articulatory target undershoot is evidence for reduced amplitudes of movement, which 
could be the reason for the imprecise consonant articulation (e.g. Ackermann et al, 
1997; McAuliffe et al, 2006a). 
   
5.5.2 Temporal characteristics 
While both medication and stimulation had significant effects on the accuracy of 
articulation (spatial information), the effects on segmental durations were variable. In 
PT2 medication but not stimulation had a significant effect on consonant durations. The 
reverse effect could be found in PT1. An increase in the durations for PT1 was coupled 
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with an improvement of speech in the off-stimulation condition, whereas for PT2 off-
stimulation led to an abnormal slowing of speech. Interestingly, stimulation had the 
greatest influence on alveolar durations in PT1 and on velar movements in PT2. Thus 
different timing influences on the place of articulation for both speakers can be 
assumed. 
  
5.5.3 Medication and stimulation effects 
The speakers were chosen for the pilot study because of their contrasting response to 
stimulation. However, we found similarities when on-stimulation/on medication: In 
both speakers the precision of alveolar stops was worse when on-medication/on-
stimulation compared to off-medication/on-stimulation. Most precise articulation (using 
presence or absence of frication of stops as a criterion; see Figure 5.5) could be found in 
the off-medication/off-stimulation condition in PT1 and off-medication/on-stimulation 
in PT2. Their on-medication counterparts (on-medication/off-stimulation for PT1 and 
on-medication/on-stimulation for PT2) showed frication. It can be concluded that 
administration of dopaminergic medication caused deteriorating articulation in both 
patients. This finding may suggest that the fine motor control of lingual movements 
during speech is considerably more sensitive to the changed cortico-striatal circuits 
caused by stimulation and medication than gross motor control of limb movements. 
Rousseaux et al (2004) also noted that intelligibility of spontaneous utterances and 
sentence reading was slightly reduced not solely in the on-stimulation condition but 
coupled with the effect of levodopa medication. 
  
In other EPG studies on parkinsonian dysarthria it has been observed that articulatory 
errors may be related to temporal aspects of speech (e.g. McAuliffe et al, 2006a). 
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McAuliffe et al (2006a) also detected target undershoot in their EPG studies. They 
assumed that undershoot of the target consonant was not the cause of articulatory errors. 
They argued that reduced tongue pressure resulted in impaired articulation. Pinto et al 
(2003) measured the force of articulators but not during speech. They provided evidence 
that deep brain stimulation improved the force control of the upper lip, lower lip and 
tongue in comparison to movements without stimulation. 
  
5.5.4 Methodological issues 
The background aim of this pilot study was to investigate the effects of stimulation and 
medication on tongue articulation using EPG. The limited number of patients limits the 
generalisation of the results. However, EPG showed changes of articulation in terms of 
spatial as well as temporal features. In their methodologically comparable studies, 
McAuliffe et al (2006a, b, 2007) detected articulatory undershoot in individual 
speakers, but not as a significant group difference to the control group. They also 
observed a discrepancy between perceptually identified articulatory undershoot in 
patients with PD and the lack of difference in the EPG data. They argued that EPG 
possibly failed to detect lingual movement impairment, because it only measures 
contacts of the tongue with the hard palate and not the approach to the palate. The 
authors also discussed the role of timing as a potentially important indicator of precise 
articulation. In our study, EPG detected significantly different articulatory patterns in 
the four recording conditions. On the other hand, specifying reliable and consistent 
segmentation criteria was a challenging task because of the considerable differences in 
speech production in the four recording conditions. In the literature, reliable methods of 
EPG data segmentation are described for normal speakers by Byrd et al (1995). But 
these methods could be used for the dysarthric speakers. For further qualitative and 
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quantitative measurements of lingual fine motor control of articulation in disordered 
speech, the methods of data segmentation have to be applied to a larger scale of patients 
in order to examine more generally the effects of medication and stimulation on 
parkinsonian dysarthria. 
 
5.6 Conclusion 
This pilot study provided evidence that EPG is a suitable experimental phonetic 
technique to quantify spatial and temporal aspects of articulation in patients with 
Parkinson’s disease. We observed 1) contrary effects of stimulation and medication on 
tongue articulation in both speakers, 2) different timing effects on alveolar and velar 
stop production and 3) deteriorating effects on speech accuracy in on-medication 
compared to off- medication conditions. 
  
On the basis of the results of this pilot study it would be worthwhile investigating the 
issues in a larger EPG study to verify how stimulation changes articulatory patterns in 
more detail and to find out more about the underlying processes of speech motor 
control. In terms of speech therapy, evidence is needed as to whether and how speech 
which is negatively affected by stimulation can be improved using articulation, rather 
than voice, as a target, and EPG biofeedback. 
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CHAPTER 6: TREATMENT OF DYSARTHRIA 
FOLLOWING SUBTHALAMIC NUCLEUS DEEP BRAIN 
STIMULATION FOR PARKINSON’S DISEASE 
6.1 Summary  
This study aimed to examine the efficacy of an existing, intensive speech treatment  
(the Lee Silverman Voice Treatment, LSVT) on dysarthria after STN-DBS.  
The LSVT was administered in ten patients with STN-DBS (surgical group) and ten 
patients without (medical group). Patients were assessed before, immediately after and 
six months following the speech treatment using sustained phonation, a speech 
intelligibility scale and monologue. Vocal loudness, speech intelligibility and perceptual 
ratings were the primary outcome measures. 
Vocal loudness and perceptual scores improved significantly across tasks for the 
medical group only. Speech intelligibility did not significantly change for either group. 
Results in the surgical group were variable with four out of ten surgical patients 
deteriorating after LSVT.  
Investigating the efficacy of existing speech treatments following STN-DBS could 
inform on the nature of speech impairment as well as attempt to improve speech. 
 
6.2 Introduction 
The aim of this study was to assess whether an established behavioral treatment for 
parkinsonian dysarthria has a beneficial effect on speech problems following STN-DBS. 
Treatment of speech following STN-DBS has not been investigated so far.  
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The Lee Silverman Voice Treatment (LSVT) is a very intensive treatment (four hourly 
sessions per week for four consecutive weeks) that has been developed to treat speech 
problems for patients with PD. The five essential concepts of the LSVT include: 1. 
Focus on voice (increase amplitude of movement, increase vocal loudness), 2. Improve 
sensory perception of effort depending on the situation, what they call “calibration”,  
3. Administer treatment in a high effort style, 4. Intensity of treatment (four times per 
week for 16 sessions in one month), and 5. Quantify treatment related changes (mainly 
using the decibel scale). The LSVT is based on the hypothesized features underlying the 
voice disorder in PD (Ramig, 1995), namely the overall reduced amplitude of the 
speech mechanism that leads to “soft voice that is monotone”. Thus the whole approach 
centres on a specific therapeutic target: increasing vocal loudness (increasing amplitude 
of movement). This key target of loudness acts as a “trigger” to increase effort and 
coordination across the speech production system. Another feature of PD dysarthria is 
the reduced sensory perception of actual reduced voice volume and the effort needed to 
produce “normal” loudness. By incorporating sensory awareness training with motor 
exercises, LSVT facilitates acceptance and comfort with increased loudness, and the 
ability to self-monitor vocal loudness (Trail, 2005). Findings from initial treatment 
studies (Ramig et al, 1995) on 40 patients with PD (26 treated with LSVT and 19 with 
respiratory treatment) showed post LSVT increases in loudness ranging from 8-13dB 
SPL across a variety of speech tasks. Follow-up studies showed that these gains were 
maintained for one year (Ramig et al, 1996) and two years follow-up (Ramig et al, 
2001). The main outcome measure in these studies was the change in dB SPL across 
sustained phonation, reading the “Rainbow passage” and a monologue. All patients in 
these studies were PD patients treated with best medical (pharmacological) therapy.  
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6.3 Patients and methods 
6.3.1 Participants 
Ten patients with PD treated with bilateral STN-DBS (“surgical group” mean age 
59.4±4.5 years, mean disease duration 13.6±5.3 years, mean H&Y stage when on-
medication and on-stimulation 2.1±0.2) and 10 patients with only medically treated PD 
(“medical group” mean age 63±9.7 years, mean disease duration 8.6±6.5 years, mean 
H&Y stage when on-medication 1.7±0.3) participated in this study. All patients were 
referred by the Movement Disorder Consultants of the National Hospital for Neurology 
and Neurosurgery, Queen Square, London, UK. There were no changes of patients’ 
stimulation or medication during the treatment. The mean amplitude of stimulation at 
the time of the treatment in the surgical group was 3.09 V (±0.28) for the left brain and 
3.26 V (±0.58) for the right brain. For the surgical group (N=9, one patient was 
operated in France so no pre-operative data were available) pre- and post-operative data 
on speech intelligibility were available through routine clinical assessment. Speech 
intelligibility declined from 97.38% (±4.9) pre-operatively on-medication to 83.67% 
(±30.5) post-operatively on-medication/on-stimulation. There was a great variability of 
speech response to stimulation within the surgical group (as evidenced by the high 
standard deviation) with one patient improving, three remaining the same, and five 
deteriorating. 
6.3.2 Treatment 
The LSVT was delivered by a trained and experienced SLT (ET) in the same way to all 
patients as instructed by the LSVT Foundation protocol4. The main goal of LSVT is “to 
maximize phonatory efficiency by improving vocal fold adduction and overall laryngeal 
muscle activation and control”8 (LSVT Training Manual, p 495). The treatment is 
  
 225 
intensive (four hourly sessions per week for four weeks) and requires high effort to 
increase vocal loudness.  
6.3.3 Speech assessment 
All patients were assessed pre, post and six months after the treatment (FU). The tasks 
included sustained phonation /a/ for three repetitions, the Assessment of Intelligibility 
for the Dysarthric Speech (AIDS), and a 60-seconds monologue about a topic of the 
speaker’s choice. The Computerized Speech lab was used for recording and analysis of 
all samples. Acoustic recordings were obtained using a calibrated Shure SM 48 dynamic 
microphone, with a 15 cm mouth-to-microphone distance at 22 kHz sampling rate in a 
sound treated room. For the measurement of intensity (SPL dB) of the sustained 
phonation, AIDS sentences and monologue calibration occurred at the beginning of 
each recording using a Quest 2100 SPL meter at 15 cm, as described before (Chapter 2 
and 3).  
6.3.4 Data analysis 
For the acoustical analysis of intensity of sustained phonation, reading and monologue 
we calculated the mean vocal sound pressure level (SPL dB) measures from the speech 
recording of each condition. The AIDS sentences were rated blindly by an independent 
speech and language therapist (LS), blinded to the patients’ treatment (surgical or 
medical) and the timing of the assessment (pre-post-FU). The percentage of words 
correctly identified was derived from the AIDS sentences according to the instructions 
of the manual. To explore the impact of the LSVT on perceptual characteristics of 
speech we used the 35 speech dimensions listed by Darley et al (1975) grouped under 
six speech clusters (Plowman-Prine et al, 2009) (Table 6.2). Each speech cluster was 
assessed on a seven-point interval scale, where seven represented normal speech and 
one represented the greatest deviation from normal. Mean speech ratings were 
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calculated for each of the speech-sign clusters across the groups in the three time points 
with a maximum total of 42 representing a near-normal speech. All perceptual analysis 
was performed in the same quiet speech laboratory with the same equipment. 
Assessment of overall intelligibility was always determined first. Then the rater could 
listen to the monologue file up to six times, one for each speech cluster to determine the 
perceptual rating.  
6.3.5 Statistical analysis 
The primary outcome was the change in mean SPL dB across the three tasks. Secondary 
outcomes were the change in speech intelligibility (% of words understood) and the 
change in the total perceptual rating of monologue between baseline and follow-up in 
the medical and surgical groups. A two-way ANOVA with factor 1 time (pre-post and 
FU) and factor 2 group (medical vs. surgical) was used to compare the effect of the 
LSVT in the two groups of patients across time points. Bonferroni post tests were used 
to explore the change between baseline and follow-up within groups. The relationship 
between impact of STN-DBS on speech intelligibility and the effect of LSVT was 
examined using Spearman r correlation coefficient, with change from LSVT in both 
speech intelligibility and perceptual measures as dependent (outcome variable). 
Similarly we examined the relationship between voltage amplitude and change in 
speech post LSVT. 
6.4 Results 
Patients in the two groups did not differ significantly at baseline in any of the measures. 
Mean vocal loudness increased significantly across all tasks for the medical group 
between baseline and FU but not for the surgical (Table 6.1).  
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Table 6.1: Means (SD) of SPL dB at 15cm mouth-to-microphone distance for 
phonation, reading and monologue in the surgical and medical groups across time 
points. 
LOUDNESS PRE LSVT POST LSVT FU LSVT 
Phonation 
DBS 
MED  
 
77.2 (7.3)  
76.6 (11.1) 
 
81.7 (8.7)  
84.1 (8.5)* 
 
79.9 (7.2)ns 
86.5 (3.5)** 
Reading 
DBS 
MED  
 
76.4 (5.8)  
74.5 (6.6) 
 
80.9 (5.7)  
81.3 (8.1)* 
 
79.5 (6.2)ns 
85.3 (2.9)** 
Monologue 
DBS 
MED 
 
77.4 (4.1)  
75.2 (7.0) 
 
76.1 (6.5)  
78.9 (6.3) 
 
79.3 (5.7)ns 
81.9 (3.5)* 
*p<.05, **p<.001 for time 
Speech intelligibility did not significantly change in the two groups between baseline 
and follow-up (surgical group 88.5±23.4% at baseline and 83.1±21.7% at FU and 
medical group 95.1±7.9% and 98.2±2.9% respectively).  
Results from the perceptual rating of the monologue showed significant main effect  
for group in the subsections of articulation (F (1,36) =10.1, p=0.0051) respiration, 
(F(1,36)=8.4, p=0.009), phonation (F(1,36)=4.9, p=0.038), and the total score 
(F(1,36)=8.1, p=0.01), with only the medical group showing an improvement. There 
was also a significant main effect for time for the respiration (F(2,36)=4.5, p=0.01) 
prosody, (F(2,36)=7.1, p=0.002), and the total score (F(2,36)=6.1, p=0.004) showing 
that over time the medical group improved. There was an interaction effect for 
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respiration (F (2,36)=5.07, p=0.01), phonation (F(2,36)=5.77, p=0.006) and the total 
score (F(2,36)=6.3, p=0.004). Post hoc Bonferroni tests showed that these measures 
improved in the medical group both post and at FU whereas respiration deteriorated in 
the DBS group (Table 6.2). 
Table 6.2: Means (SD) of perceptual rating for the monologue task in the medical and 
surgical groups across time points. Mean ratings are calculated for each cluster (scale 
of 1 to 7). Total of 42 is the maximum and denotes near normal speech. 
PERCEPTUAL 
SCALE  
PRE LSVT POST LSVT FU LSVT 
Resonance (/7) 
DBS 
MED 
 
5.4 (1.1)  
5.9 (0.5) 
 
5.7 (1.1)  
6.2 (0.4) 
 
5.8 (1.4)  
6.2 (0.4) 
Prosody (/7) 
DBS 
MED 
 
5.2 (1.0)  
5.6 (1.0) 
 
5.5 (1.5)  
6.7 (0.6)*** 
 
5.4 (1.6)  
6.4 (0.8)* 
Articulation 
(/7) 
DBS 
MED 
 
4.5 (2.1)  
5.9 (1.6) 
 
4.5 (1.6)  
6.2 (0.7) 
 
3.6 (1.8)  
6.3 (0.6) 
Rate (/7) 
DBS 
MED  
 
4.8 (1.9)  
5.5 (1.2) 
 
5.0 (1.4)  
6.3 (0.9) 
 
4.4 (1.9)  
6.1 (0.8) 
Phonation (/7) 
DBS 
MED 
 
5.0 (1.3) 
5.1 (0.9) 
 
4.8 (1.5)  
6.1 (0.7)** 
 
4.4 (1.1)  
5.9 (0.7)* 
Respiration (/7) 
DBS 
MED 
 
4.5 (1.3)  
5.1 (1.2) 
 
4.8 (1.3)  
6.2 (0.6)** 
 
4.0 (1.5)*  
6.1 (0.5)** 
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Total (/42) 
DBS 
MED 
 
29.4 (7.0)  
33.0 (4.6) 
 
30.4 (6.9)  
37.8 (3.2)*** 
 
27.9 (7.5)  
37.3 (2.9)** 
*p<.05, **p<.01, ***p<.001  
A more detailed analysis of the perceptual ratings of monologue showed that four out of 
ten patients in the DBS group deteriorated following LSVT, three remained the same 
and three had a transient only improvement. The speech of the patients who deteriorated 
was characterized by a strained-hoarse voice quality, an excess loudness variations, 
monoloudness, monopitch, reduced stress, imprecise consonants, distorted vowels 
insufficient breath support leading to short phrases. These features worsened with effort 
for increased loudness. 
There was no relationship between the effect of STN-DBS on speech intelligibility and 
the impact of LSVT (post-treatment) on speech intelligibility and perceptual ratings of 
the monologue. Also there was no relationship between voltage amplitude and the 
impact of LSVT on perceptual ratings. 
6.5 Discussion      
Our study shows that LSVT has a significant effect on vocal loudness and perceptual 
ratings of speech in patients with PD treated medically and not in patients with PD 
following STN-DBS. Patients with STN-DBS presented with a variable response to 
LSVT treatment, with no sustained improvement and with four out of ten patients 
showing worsening of their perceptual ratings at FU.  
The rationale for the treatment goals and tasks of the LSVT is based on the perceptual 
characteristics of hypokinetic speech and the hypothesized oral and laryngeal motor 
impairment, mainly the reduced amplitude of vocal fold adduction3 observed in PD. 
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LSVT also targets the abnormal sensory processing of the reduced amplitude output. 
Patients commonly report that they are using sufficient effort for loud speech but their 
friends and spouses are losing their hearing rather than consider that they are speaking 
softly (Fox et al, 1997; Spielman et al, 2007). LSVT directly addresses this sensory 
mismatch and teaches patients with PD to recalibrate the amount of effort needed for 
normal loudness. Apart of the motor (hypokinesia) and sensory (lack of immediate 
feedback) aspects of PD speech, LSVT also targets motor learning, by using treatment 
strategies that incorporate cueing and repetition. Overlearning a new motor task through 
intensive practice and repetition can improve task automaticity and create a stronger 
memory (habit) for the motor behavior (Schmidt & Lee, 1999, as reported in Spielman 
et al, 2007). This intensive, high effort work on vocal loudness can bring significant 
improvement, as reported in clinical studies so far4 and observed in our medical group. 
The limited gains on speech of patients with STN-DBS observed in our study can be 
due to differences in the pathophysiology of dysarthria, the sensory processing (self 
perception of speech deficit) or the ability for motor learning. Speech following STN-
DBS can be perceptually different from the hypokinetic dysarthria initially described by 
Darley and colleagues (1975). Voice can occasionally sound strained, strangled and 
breathless, resulting in scanning, “one-word-at-a-time” speech. Articulation can be 
affected mainly in alveolar and velar sounds (Putzer, 2008) (and Chapter 7, EPG study). 
Klostermann and colleagues (2007) examined acoustic measures of speech and patient 
self-reports on- and off-stimulation and found that despite an improvement in the 
acoustical measures both patients and their clinicians rated speech as worse when on-
stimulation. Speech can be affected by voltage amplitude and contact location (Tripoliti 
et al 2008) as well as clinical pre-operative factors. The neural correlates of speech 
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following STN-DBS may be different from that of non STN-DBS treated PD patients 
(Liotti et al, 2003; Pinto et al, 2004, see also Chapter 1).  
The effects of STN-DBS on sensory processing of speech and motor learning have not 
been examined systematically so far. Alberts et al (2008) and Frankemolle et al (2010) 
have used a dual task cognitive-motor task to show that DBS can compromise 
performance, mainly due to the spread of current in the non-motor regions of the 
subthalamic nucleus. They also observed that the greatest dual-task cost or loss in 
performance was observed in the motor task (a force-tracking task) rather than the 
cognitive task. Speech can be described as a complex cognitive-motor task and the 
LSVT heavily relies on training both. Thus the limited effect of LSVT on surgical 
patients might be partially due to the stimulation effect on motor learning and ability for 
dual processing. However, we would need a non-speech control task (e.g. drumming) to 
examine whether the limited effect of LSVT is due to the effect of STN-DBS on 
cognitive–motor learning or on speech. 
In our study, the small number of patients in the two groups limits the generalisation of 
the results. Larger numbers could allow an analysis of the characteristics of the surgical 
patients who benefit from LSVT versus those who don’t, mainly with regards to active 
contact localisation. As the LSVT is based on principles of motor learning (Trail et al, 
2005; Nieuwboer et al, 2009) it would be interesting to investigate any impairment in 
motor learning for the subgroup of surgical patients who did not maintain the gains, or 
indeed to compare the two groups.  
The studies on the efficacy of the LSVT so far have reported data mainly on vocal 
loudness (Trail et al, 2005). Thus it is difficult to compare our data on speech 
intelligibility and the perceptual aspects of speech. Perceptual ratings from the Ramig 
group have concentrated on use of a Visual Analogue Scale for a pair of read sentences 
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(Spielman et al, 2007), “better-worse” judgement of the “Rainbow Passage” (Sapir et al, 
2002 and 2003), and perceptual rating of vowels (Sapir, 2007). Recently, the Ramig 
group (Halpern, 2010) has presented the results from an extended version of LSVT. 
Patients during the two extra weeks of treatment worked either with articulation or with 
carryover into all communication settings. Their results show that all patients increased 
in SPL dB from pre- to post-treatment but they do not report follow-up data. Further 
investigations are needed into the efficacy of tailoring therapy to the particular speech 
problems post STN-DBS or of providing therapy before STN-DBS in order to 
maximize the benefits of the procedure. 
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CHAPTER 7: AERODYNAMIC STUDY ON SPEECH IN 
PATIENTS WITH PD FOLLOWING BILATERAL STN-
DBS 
7.1 Summary 
Adequate respiratory motor control is essential for speech but may be impaired in PD. 
The aim of this study was to examine the impact of STN-DBS on respiratory control for 
speech and its relationship to speech intelligibility and loudness. 
Five consecutive patients (one female) were tested pre-operatively on- and off-
medication and at six months post STN-DBS off-medication and on- and off-
stimulation. Three extra patients were assessed at six months only, off-medication, on- 
and off-stimulation. The Aerophone II was used to measure vital capacity, mean flow 
rate during phonation, a syllable repetition task /ipipipi/ and a sentence repetition task 
(“buy bobby a puppy”). Mean and peak intraoral air pressure was also calculated for the 
syllable and sentence repetition tasks. Data were correlated with changes in speech 
intelligibility and loudness for read sentences. 
Mean and peak air pressure for speech increased significantly between pre- and post-
surgery for both medication conditions. Vital capacity increased significantly when on-
stimulation compared to off-stimulation. No other measure changed significantly 
between off- and on-stimulation. None of the aerodynamic measures were correlated 
with speech intelligibility or loudness at six months. Loudness pre-operatively off-
medication was correlated with peak air pressure post-operatively 
off-medication/on-stimulation. Data from this study were also compared to normative 
values. 
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Mean and peak air pressure for speech may increase following STN-DBS. This is not 
correlated with changes in speech intelligibility or loudness. 
7.2 Introduction 
Respiratory impairment may be linked to several features of hypokinetic dysarthria, 
namely decreased loudness, short phrases and fast rate of speech. Studies of vital 
capacity, intraoral air pressure and airflow during speech show that patients with PD 
tend to have lower scores than healthy controls (Netsell et al, 1975; Solomon & Hixon, 
1993). However the degree to which these measures influence speech intelligibility and 
vocal loudness is still uncertain. Furthermore there is only one study examining the 
effect of STN-DBS on respiratory control (Hammer et al, 2010). They reported 
increased respiratory driving pressure (i.e. intraoral air pressure) with stimulation.  
The authors did not report changes from pre-operative data, and they did not correlate 
speech intelligibility or acoustic measures to these changes.  
The aim of this study was to investigate the effect of bilateral STN-DBS on respiratory 
speech function in consecutive patients and its impact on speech intelligibility and 
loudness.  
7.3 Patients and methods 
7.3.1 Patients 
Five consecutive patients were assessed before and at six months following bilateral 
STN-DBS. A further three patients were assessed only at six months (total of eight 
patients). Their mean age was 59.5 years (±5.1), mean time since diagnosis was 11.6 
years (±4.4), UPDRS-III pre-operatively off-medication was 54.8 (±25.5) and on-
medication 11.25 (±10.02) and at six months UPDRS-III off-medication /on-stimulation 
was 23.8 (±12.5) (p=0.0094 for UPDRS-III pre-operative off-medication to post-
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operative off-medication/on-stimulation). Their mean speech intelligibility pre-
operatively off-medication (N=5) was 67.75% (±22.31) and on-medication 72.0% 
(±20.79) and at six months off-medication/on-stimulation (N=8) 70.0% (±15.15%), and 
off-medication/off-stimulation 61.6% (±30.2%). 
7.3.2 Aerodynamic measures and data analysis  
The aerodynamic measures were obtained following the methods described in Yiu et al 
(2004) using a Kay Elemetrics Aerophone II model 6800. Airflow and pressure 
calibration were carried out according to the manufacturers’ instructions. The 
recordings were carried out in a sound-treated room with each patient seated in an 
upright position in a straight backed chair. Each patient was required to undertake four 
tasks: measurement of vital capacity, production of most comfortable sustained vowel 
phonation, production of strings of vowel-consonant syllables (/ipipi/) and production 
of a sentence (“Buy Bobby a puppy”). The choice of the syllable and sentence repetition 
tasks was based on the recommendations from Smitheran & Hixon (1981). Each 
recording session took approximately 20 minutes. For the vital capacity the patient was 
instructed to make a good seal around the carbon tube, connected to the transducer of 
the Aerophone II, and the recording setting was 0-5ml for females and 0-10 ml for 
males. The instruction was “breathe in as deep as possible and breathe out all the air 
through the tube until the lungs are completely empty”. The task was repeated three 
times and the highest value of the three was taken as representative of the patient’s VC. 
The task gives information about the maximum volume of air which can be exhaled 
following a maximum inhalation. It thus provides an estimate of the amount of air 
potentially available for phonation. It is measured in ml. Normative values vary in the 
literature but we considered 4.9 L for males and 2.3 L for females.  
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For the remaining tasks the Rothenberg face mask was used, which was connected to 
the transducer of the Aerophone. The mask was held tightly against the face by one of 
the investigators, due to possible movement problems. In this task the patient was 
instructed to sustain the vowel /a/ at a comfortable pitch and loudness for approximately 
five seconds following a normal inspiration. This task was preferred over the maximally 
sustained vowel because the latter is not generally representative of the normal 
expiratory duration or volume during phonation (Terasawa et al, 1987). The /a/ 
phonation was repeated three times and the mean flow rate was obtained for each 
production. The task gives information about the phonatory function, and it represents 
the total volume of air used for phonation divided by the duration of phonation and the 
unit is ml/sec. The normal values depend on height (there is no significant male/female 
difference) and range between 100-160 ml/sec. Below 80 ml/sec voice could be 
hyperfunctional and above 200 ml/sec hypofunctional. 
In the vowel-consonant string production each patient was asked to produce the vowel 
/i/ followed by a bilateral plosive /p/ repeated consecutively for minimum seven times 
(/ipipipi/) at a comfortable pitch and loudness. The mask was tightly held over the 
patient’s face by one of the investigators and a 12 cm long polyethylene tube, with 2.5 
mm diameter, was placed on top of the tongue for each production. The production was 
repeated three times and the mean and peak intra-oral air pressure was measured. The 
task gives information for voice efficiency. It is based on the assumption that oral 
pressure is equal to subglottal air pressure during the articulation of an unvoiced plosive 
where the lips are closed and the vocal folds are fully opened (as in /p/). This task is 
based on the work by Smitheran & Hixon (1981) who examined the air pressure from 
different combinations of consonants and vowels. Since then the /ipipi/ utterance has 
been routinely used for the measurement of intraoral air pressure. Hiss et al (2001) 
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examined the effect of age, gender and repeated measures on intraoral air pressure on 60 
adults comprised of ten males and ten females in each of the three age groups (i.e. 20-
39, 40-59 and 60-83 years) and found that there is no statistically significant difference 
in intraoral air pressure as a function of age, gender or repeated measures. Thus 
intraoral air pressure was chosen as the primary outcome of this study. The sound 
pressure level setting was at 50-100dB SPL, the pressure range at 0-10cm H2O, the flow 
range at 0-500 ml/sec. The same procedure was repeated for the production of /buy 
Bobby a puppy/ sentence, repeated three times. Data on healthy adults show that there is 
no statistically significant difference in intraoral air pressure as a function of age or 
gender (Hiss, 2001). Thus normal values range from 5.55 to 6.70 cm H2O, with a mean 
of 6.20 cm H2O.  
Four types of analysis were carried out: 
From the vital capacity task the highest score of the three trials was retained for 
analysis. From the vowel phonation task the mean flow rate (ml/sec) was calculated by 
including the lowest point of the rising slope (i.e. the beginning of phonation) and the 
lowest point of the falling slope (i.e. the end of phonation) on the sound pressure level 
waveform display. From the /ipipi/ the peak intraoral pressure measurement was based 
on the middle five /pi/s in each string. These five /pi/s were extracted by identifying the 
lowest point of the rising slope of the second peak and the lowest point of the falling 
slope of the sixth peak on the sound pressure display. From the sentence production the 
airflow and intraoral pressure measurements were carried out by extracting the lowest 
point of the first rising slope (i.e. the beginning of the sentence) and the lowest point of 
the falling slope of the last peak (i.e. the end of the sentence) in the sound pressure 
display. With these analyses the following aerodynamic measures were extracted: 
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• Mean flow rate (MFR) for the /a/ phonation sustained for a comfortable period of 
time (measured in ml/sec). 
• Mean (MAP) and peak (PAP) subglottal air pressure estimated from the syllable 
repetition task /ipipi/ (measured in cm H2O). 
• MFR for the above syllable repetition task. 
• MAP and PAP and MFR for the sentence task5
• Vital capacity (VC) (measured in L). 
. 
Data were inspected for inclusion based on the method described by Higgins & Saxman 
(1991). In their study participants whose minimum flow went below 0.05 l/sec were 
considered to have had mask leaks serious enough to jeopardize the validity of their 
data. In our study there were no data excluded, possibly because leaks were avoided by 
an experimenter holding the mask on the face, rather than the patient. 
Speech intelligibility was measured routinely before the operation (N=5) on-and off 
medication and at six months (N=8) as described previously (Chapter 3). Loudness data 
(SPL dB) for the read sentences were collected and analysed as described before 
(Chapter 3). 
Statistical analysis 
Primary outcome was the change in MAP and PAP of syllable and sentence repetition 
task at six months post STN-DBS (N=5) at the off- and on-medication/on-stimulation 
conditions. Secondary outcomes were: 1.the change in VC and MFR in phonation, 
                                                 
5 Healthy speakers in the upright position produce conversation using between 40-60% 
of their vital capacity (20-40% when supine); this amounts to approximately 20% of the 
average adult male five litre vital capacity (Hixon et al, 1973). Thus conversational 
speech usually consumes only a moderate portion of the mid-range lung volume. 
  
 239 
syllable and sentence repetition; 2.the change with stimulation at six months (off-
medication/off-stimulation minus off-medication/on-stimulation) in all measures (N=8); 
3. the relationship between PAP and speech intelligibility as well as average loudness 
(SPL dB) of read sentences was examined using Spearman’s r correlation coefficient;  
4. comparison with normative data. Paired t-tests were used for comparisons across 
conditions at six months and across time (pre-six months).  
7.4 Results 
The MAP for the sentence task changed significantly from 1.37 cm H2O pre-operatively  
on-medication and 1.59 cm H2O pre-operatively off-medication to 2.01 cm H2O post 
off-medication/on-stimulation. The PAP increased significantly for the sentence task, 
from 6.13 cm H2O pre-operatively on-medication and 6.11 cm H2O off-medication, to 
7.79 cm H2O post-operatively off-medication/on-stimulation. The PAP also increased 
significantly for the syllable repetition task from 5.95 cm H2O pre-operatively on-
medication to 9.27 cm H2O post-operatively off-medication/on-stimulation. There was 
no significant change in VC and MFR of any task between pre-operative and six months 
(Table 7.1).  
Table 7.1: Mean (±sd) of aerodynamic measures, before (N=5) and 6 months after 
(N=8), off- and on-medication and off- and on-stimulation. 
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VC=vital capacity (normal values 4.9L), MFR=mean flow rate (normal values 100-160 
ml/sec), MAP=mean intraoral air pressure, PAP=peak intraoral air pressure (normal 
values 6.2cm H2O). *p<0.05, **p<0.01. 
 
Measure Pre-operative  
on-med 
Pre-operative 
off-med 
6 months  
off-med/on stim 
6 months  
off-med/off-stim 
VC (L) 3.67 (0.83) 3.64 (0.57) 3.76 (1.11) 3.30 (0.94)** 
MFRphon 
(ml/sec) 
200.0 (155.9) 230.4(147.7) 204.6 (146.2) 215.5 (174.1) 
MFR /ipipi/ 83.2 (40.4) 96.6 (103.6) 178.4 (107.5) 134.6 (93.1) 
MFR 
sentence 
107.3 (36.2) 118.8 (50.7) 122.4 (64.7) 120.0 (82.45) 
MAP /ipipi/ 
(cm H2O) 
3.55 (3.4) 2.83 (1.21) 2.88 (2.54) 3.75 (4.18) 
MAP 
sentence 
1.37 (0.35) 1.59 (0.42) 2.01 (0.97)* 2.25 (1.08) 
PAP /ipipi/ 
(cm H2O) 
5.95 (4.71) 10.53 (6.65) 9.27 (4.29)* 8.71 (3.06) 
PAP 
sentence 
6.13 (1.76) 6.11 (1.57) 7.79 (1.61) ** 7.12 (2.08) 
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Comparison of data off-medication/on-stimulation with off-medication/off-stimulation 
at six months showed that the only measure that significantly increased with stimulation 
was the vital capacity (Figure 7.1). Spearman’s r correlation between speech 
intelligibility and aerodynamic measures at six months showed no relationship between 
the two measures. Loudness of read sentences was not correlated to MAP or PAP of the 
sentence or syllable repetition task at six months. Loudness (SPL dB) of read sentences 
pre-operatively off-medication was positively correlated with the PAP of syllable 
repetition task off-medication/on-stimulation (Spearman r 0.85, p=0.023).  
 
Figure 7.1: Vital capacity (in L) off- and on-stimulation at six months, off-medication 
Comparison of normal values of VC showed that patients with PD scored below the 
normal values of 4.9ml across all time point and conditions, with the lowest being the 
off-medication/off-stimulation condition at six months. Equally MFR for phonation is 
much above the average 100-160ml/sec, and at levels above 200ml/sec it could be 
linked to hypofunctional voice. Normal values of PAP for the syllable repetition task 
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are around 6.2 cm H2O.Values pre-operatively were within the normal limits, but they 
exceed those post-operatively.  
7.5 Discussion 
The aim of this study was to investigate the role of the aerodynamic function on speech 
difficulty after STN-DBS. Many patients report becoming more “short of breath” after 
STN-DBS, with breath support enough only for three to four word phrases. Perceptual 
analysis of the speech from a group of patients at one year post STN-DBS also showed 
that respiration was one of the components that deteriorated significantly (Chapter 3). 
Deterioration of respiratory function can have an effect on both phonation and prosody. 
The primary outcome was the impact of bilateral STN-DBS on mean and peak intraoral 
air pressure of speech in consecutive patients. One of the secondary outcomes was to 
investigate the relationship between changes in respiratory function with vocal loudness 
and speech intelligibility. A strong relationship could point towards a therapy strategy 
involving respiratory control.  
Peak oral pressure values were chosen as a primary outcome due to the stability they 
show in repeated measurements, different age groups and between genders (Hiss, 2001). 
There was a significant increase of MAP and PAP for speech and syllable repetition at 
six months compared to the pre-operative values. Lower than normal air pressure has 
been reported in people with PD previously (Netsell et al, 1975; Solomon & Hixon, 
1993). Oral pressure can be a good estimate of the driving pressure delivered to the 
larynx and the upper airway structures for speech. However the influence of the oral 
structures on intraoral pressure (mainly the larynx and the velopharyngeal valving) 
makes it difficult to determine whether the higher than expected oral pressure post STN-
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DBS is due to the airway system or the upper airway valving6
                                                 
6 During the /ipipi/ utterance the two types of sounds (/i/ and /p/) involve different 
combinations of valving adjustments. For the /p/ there is a closed phase and the release 
phase. The closed phase requires the laryngeal valve open and the velopharyngeal and 
oral valves closed. The release phase (for the initiation of /i/) maintains the open larynx 
and the closed velopharynx but involves an abrupt opening of the oral valve. 
Additionally the larynx needs to vibrate for the vowel /i/ sound. (from Smitheran & 
Hixon, 1981).  
. The fact that in our 
study, higher air pressure was not accompanied by higher mean flow rate suggests a 
laryngeal/velopharyngeal valving basis, rather than purely respiratory. Additionally VC 
measures were lower than the normal values even post-operatively, in accordance with 
the literature on PD (De Pandis, 2002; Weiner et al, 2002). Increased intraoral air 
pressure has been linked with increased laryngeal resistance and increased vocal 
loudness (Stathopoulos, 1986) in healthy controls. However in our study air pressure 
was not linked to vocal loudness for the sentence task. This is in accordance with Ramig 
& Dromey (1996), who examined the link between cued increased air pressure and 
vocal loudness in 20 patients with PD and found no relationship. Thus most of the 
changes with stimulation point towards increased vocal fold and /or velopharyngeal 
closure (air pressure) and not increased respiratory driving pressure (air flow). This is 
consistent with the observation of tight-strained voice quality and occasional 
hypernasality observed in speech following STN-DBS (Chapter 3). Hammer et al 
(2010) also found that post-DBS PD patients showed changes consistent with increased 
respiratory driving pressure and increased vocal fold closure. They also found that most 
participants exceeded a typical operating range for these respiratory and laryngeal 
control variables, which is in agreement with our data. However they do not provide 
any acoustical or perceptual information on speech changes and they do not make any 
assumptions about the reasons for these changes.  
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Speech intelligibility was not correlated to any of the aerodynamic measures. However 
the pre- to post-operative decline for the five patients was not significant either. This 
could be due to the small number of participants (N=5). Additionally, in the 
longitudinal study (N=32, Chapter 3.2) the majority of speech decline occurred between 
six months and one year. There are no reports in the literature on the relationship of 
speech intelligibility and aerodynamic measures in PD. Studies on hearing impaired 
speech (Itoh & Horii, 1985) show that more frequent inspirations were linked to poorer 
speech intelligibility but they only report air flow measures.  
Limitations of this study include the small number of participants and the lack of pre-
operative data for all of them. A longer follow-up (more than 6 months) would possibly 
show some deterioration in speech intelligibility and could eb correlated with more 
marked changes in aerodynamics. However the reported initial data are an indication 
that patients’ reports and the observed respiratory problems post STN-DBS may be due 
to laryngeal/velopharyngeal valving problems rather than purely respiratory.  
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CHAPTER 8: EFFECTS OF BILATERAL GPI-DBS ON 
SPEECH IN PATIENTS WITH DYSTONIA 
8.1 Summary 
GPi-DBS is an effective treatment for patients with dystonia. The effects on speech 
have not been systematically reported. The aim of this study was to prospectively 
evaluate the effect of GPi-DBS on speech in a series of dystonia patients. 
Twenty five patients with dystonia were assessed before and 12 months after bilateral 
GPi-DBS. The aetiology of dystonia was as follows: eleven were primary generalised 
(six DYT-1 positive, five DYT-1 negative), seven were cervical/cranial dystonia, two 
myoclonic dystonia, one tardive dystonia plus Tourette’s, one hemidystonia, two 
dystonia following stroke and one dystonia following a post-anoxic episode. The speech 
protocol consisted of sustained phonation, reading sentences from the AIDS, and one 
minute monologue. Post-operative recordings were made with patients being on-
stimulation and on their usual medications. Analysis consisted of loudness (SPL dB) 
across all tasks, rate of speech (measured in words per minute) and speech 
intelligibility.  
Speech intelligibility did not significantly change. Rate of speech increased significantly 
for reading. SPL dB did not change significantly for any task. Detailed examination of 
data revealed a subgroup of eight patients whose speech changed perceptually from 
normal/hyperkinetic to hypokinetic, mainly characterised by fast rate of speech, 
indistinct articulation and reduced volume. 
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Speech following GPi-DBS can show a wide variability. The presence of hypokinetic-
parkinsonian features warrants further investigation. 
8.2 Introduction 
The benefit of GPi-DBS on speech for patients with dystonia has not been investigated 
prospectively and in detail. However speech changes as measured by the BFM scale 
have been reported in the literature.  
8.3 Patients and methods 
8.3.1 Participants 
Twenty five patients with dystonia were assessed before and 12 months after bilateral 
GPi-DBS. The aetiology of dystonia was as follows: eleven were primary generalised 
(six DYT-1 positive, five DYT-1 negative), seven were cervical/cranial dystonia, two 
myoclonic dystonia, one tardivedystonia plus Tourette’s, one hemidystonia, two 
dystonia following stroke and one dystonia following a post-anoxic episode. They were 
assessed before the operation and at 12-36 months after (mean 21.5±10.6 months). 
Their average age was 46.1±14.6 years and average time since diagnosis was 18.3± 6.3 
years. Their BFM score pre-operatively was 35.2 (±17.02) and post-operatively 12.07 
(±9.07) (p<0.0001). 
 
8.3.2 Tasks 
The tasks included sustained phonation /a/ for three repetitions, the Assessment of 
Intelligibility for the Dysarthric Speech (AIDS), and a 60-seconds monologue about a 
topic of the speaker’s choice. The Computerized Speech lab was used for recording and 
analysis of all samples. Acoustic recordings were obtained using a calibrated Shure SM 
48 dynamic microphone, with a 15 cm mouth-to-microphone distance at 22 kHz 
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sampling rate in a sound treated room. For the measurement of intensity (SPL dB) of 
the sustained phonation, AIDS sentences and monologue calibration occurred at the 
beginning of each recording using a Quest 2100 SPL meter at 15 cm, as described 
before (Chapter 2 and 3). One patient with secondary dystonia was anarthric, so he 
couldn’t participate at the speech recordings, but video recordings were made instead. 
Post-operative recordings were made with patients being on-stimulation and on their 
usual medications. 
8.3.3 Analysis 
Primary outcome was the change in speech intelligibility, loudness (SPL dB) and rate of 
speech (words per minute) in the read sentences of the AIDS. Secondary outcomes were 
the change in loudness and rate of speech for the monologue and the change in loudness 
for the sustained phonation. T-tests were used for the comparison of pre- and post-
surgery outcomes. The subgroups of primary DYT-1 positive, primary DYT-1 negative 
and cervical/cranial dystonia patients were examined in greater detail due to the large 
variability observed, based on the following criteria: a. patients whose speech loudness 
deteriorated across all tasks and speech rate increased, b. patients whose speech 
loudness increased across tasks and c. patients who remained the same. 
8.4 Results 
Speech intelligibility as measured by the AIDS did not significantly change (baseline 
97.08±10.4% post-operative 97.2±9.7%). The change in loudness of read sentences 
showed a great variability but there was no significant difference overall (Figure 8.1) 
(mean SPLdB pre-operative: 74.2±7.6; mean SPLdB post-operative: 73.2±7.3, p=0.44). 
Rate of speech (words per minute) was significantly increased (Figure 8.2) (mean rate 
pre-operative: 122.3±27.3; mean rate post-operative: 130.6±25.0, p=0.03).  
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Figure 8.1: Loudness of read sentences (the AIDS) in SPL dB for 25 patients with 
dystonia. 
 
Figure 8.2: Rate of speech (words per minute) for read sentences (AIDS). 
Loudness did not significantly change in sustained phonation (mean SPLdB pre-
operative: 72.7±9.3; mean SPLdB post-operative: 74.3±7.6) or monologue (mean 
SPLdB pre-operative: 73.0±9.3; mean SPLdB post-operative: 74.4±6.7). Rate of speech 
did not significantly change for monologue either (mean rate pre-operative: 131.9±30.4; 
mean rate post-operative 130.9±32.3). The patient with generalised secondary dystonia 
who was anarthric was able after DBS to operate a Lightwriter (a typewriter with the 
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facility of artificial speech) which gave him a way to communicate. That was due to 
improvement in upper limb function.  
 
The average amplitude of stimulation at the post-operative assessment was 3.5±0.45V 
for the left brain and 3.56±0.46V for the right brain; mean pulse width for the left was 
78.9±17.9μsec and 83.3±16.4μsec for the right; mean frequency for the left was 
124.2±25.2 Hz and 130±0 Hz for the right. 
8.4.1 Primary DYT-1 positive 
Two out of six patients developed signs of hypokinetic dysarthria, mainly reduced 
volume across all tasks and increased speech rate in both reading and monologue. Three 
patients showed increased volume across all tasks and no sign of hypokinetic dysarthria, 
and one patient complained of “slurred and more difficult” speech mainly linked to 
increased voltage. Two more patients complained of mouth and lips pulling with 
increased voltage that was remedied with reduced amplitude. The complaint in these 
cases was immediately following the increase of stimulation. However they did not 
show signs of hypokinetic dysarthria. 
8.4.2 Primary DYT-1 negative 
Two out of five patients with primary generalized DYT-1 negative dystonia developed 
signs of hypokinetic dysarthria. One of them had laryngeal dystonia as well, treated 
mainly with BOTOX. The speech symptoms might have been influenced by the timing 
of his injections. Two patients complained of voltage related face and mouth pulling 
which was relieved with change of parameters.  
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8.4.3 Cervical/cranial 
Four out of seven patients with cervical dystonia showed signs of hypokinetic 
dysarthria, and three remained the same. The hypokinetic signs were more pronounced 
in these patients. They were typically not aware of their more quiet voice and they 
commented how other people complained about it. One patient with tardive cervical and 
Tourette’s complained of softer voice but this was not transient, related to stimulation 
parameters. 
8.5 Discussion 
Speech intelligibility following GPi-DBS did not significantly change in our series of 
25 patients. There was however a variable response to stimulation. Eight patients out of 
the 18 in the above subgroups showed signs of hypokinetic dysarthria, as characterized 
by reduced voice volume, fast rate of speech and indistinct articulation. A separate 
group of patients complained of face/mouth/lip pulling when adjusting stimulation 
parameters, a symptom relieved with change of these parameters and not accompanied 
by signs of hypokinetic dysarthria. 
Both clinical and surgical factors could have affected the speech outcome in dystonia. 
From the clinical factors, speech before surgery and type of diagnosis could possibly 
have affected the presence of hypokinetic signs in speech post-surgery. From the eight 
patients who presented with these signs post-operatively, only one had signs of 
dysarthria pre-operatively, and those were of the hyperkinetic type due to laryngeal 
dystonia, treated with BOTOX. These features were not observed in patients with 
secondary or myoclonic dystonia, however the numbers are small. The majority were 
patients with cervical dystonia. Ostrem et al (2007) reported induction of bradykinesia 
in 10 out of 11 patients with cervical dystonia, but with no detailed description of 
speech changes.  
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The origin of these speech symptoms could be either corticospinal, through the spread 
of current in the internal capsule or extrapyramidal, due to modification of basal ganglia 
output. The hypothesis of spread of current to the corticospinal pathway is corroborated 
by the tension and stiffness (often described as “pulling”) that is occasionally observed 
around the mouth following stimulation adjustment. However this was transient and 
was relieved by change of stimulation parameters. It was not accompanied by persistent 
hypokinetic dysarthria.  
The delayed onset of hypokinetic dysarthria following adjustment of stimulation, argues 
against direct capsular effect for this specific symptom, which tends to be immediate 
once threshold is reached. Thus the most probable explanation is the modification of the 
basal ganglia output through inactivation of the pallidothalamic outflow from the 
ventral GPi. Krack (1998) and Bejjani (1997) made similar observation during pallidal 
stimulation of PD where akinesia could be elicited with ventral GPi (lower contact) 
stimulation and relieved with dorsal GPe (higher contact) stimulation. Ventral contacts 
also led to pronounced improvement in rigidity, which would suggest a different 
pathophysiology for the two symptoms. The explanation of these findings may also 
relate to pallidal anatomy. Anatomical and physiological studies in primates have 
shown that the sensorimotor territory of the GPi is ventral and posterior, with the face 
and the arm being ventral and posterior and the leg more dorsal (Iansek et al, 1980; 
Parent et al, 1995; Delong et al, 1985). With the posteroventral GPi being also the 
preferred site for stimulation (Tisch et al, 2007) it would be logical to assume that the 
akinetic effect of the preferred ventral GPi stimulation is more pronounced in the face-
upper limb area (Figure 8.3).  
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Figure 8.3 Highly simplified schematic summary of the basal ganglia circuitry in 
dystonia. Note the overactivity of the direct putamenopallidal direct pathway leading to 
reduced output of the medial globus pallidus and increased thalamic input to the cortex. 
GPi medial globus pallidus; GPe lateral globus pallidus; STN subthalamic nucleus; 
PPN pedunculopontine nucleus. From: Berardelli et al,l 1998, Brain. 
 
Limitations of this study include the small and, by the nature of dystonia, not 
homogeneous sample and the lack of multiple data points for each patient to observe the 
change through time and the change in the degree of hypokinesia. Having more detailed 
movement data for bradykinesia would have given more information on the nature of 
hypokinetic speech.   
8.6 Conclusion 
Speech intelligibility following GPi-DBS is not significantly affected in patients with 
dystonia. Hence speech improvement should not be the primary criterion when 
considering surgery. There was a delayed onset hypokinetic effect on speech in some 
patients with primary dystonia which warrants further investigation. 
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CHAPTER 9: GENERAL DISCUSSION 
9.1 Effect of STN-DBS on speech in patients with PD. 
This work includes the first large series of consecutive patients with detailed speech 
evaluation before and after bilateral STN-DBS (PD) and GPi-DBS (dystonia). The aim 
was to systematically observe and describe the speech changes following DBS and to 
analyse the surgical and clinical factors associated with it in order to advise patients and 
to form hypothesis on the role of high frequency electrical stimulation on speech. 
In our series of 32 consecutive PD patients speech intelligibility deteriorated by 14.2% 
one year after STN-DBS and by 16.7% three years after (N=15), whereas movement 
measured with UPDRS-III improved by 50.7%. The control group of medical therapy 
alone (N=12) showed a 3.6% deterioration of speech intelligibility over a year, so 
disease progression alone would not explain the deterioration of the surgical group. 
Seven patients showed some amelioration of speech after surgery illustrating the 
variability of the impact of STN-DBS on speech. A further 22 consecutive patients 
(Total N=54) were assessed in order to analyse in more detail the perceptual speech 
changes. Articulation and prosody were primarily affected, and a non-typically 
parkinsonian speech pattern emerged. Two case studies illustrated the variability of 
speech response, using electropalatography: stimulation affected the precision and 
amplitude of tongue movement only for the patient whose speech deteriorated with 
stimulation. A subgroup of STN-DBS patients (N=20) were asked to complete a 
questionnaire on the effect of speech changes on their quality of life and the results were 
compared with a subgroup of non-surgical PD patients. Patients’ reports on speech 
changes correlated highly with the independent speech intelligibility ratings, and 
reflected the variability of speech response following STN-DBS. 
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Speech deteriorated in the majority of patients (78%) one of the highest percentages 
reported in the literature. The use of UPDRS-III speech item 18, in the majority of 
studies, to measure speech change might have contributed to this symptom being under-
reported so far. Recent studies with longer follow-up have reported speech as a side 
effect more frequently and with a higher incidence. Thus similar percentages are 
reported by Piboolnurak (2007) with 69.7% and by Fasano (2010) with a 70% incidence 
of speech problems after 5 years of STN-DBS, and hypophonia being the most frequent 
motor side effect. In parkinsonian patients following GPi-DBS speech deterioration is 
not so frequently reported following GPi-DBS (Volkmann et al 2001; Rodriguez-Oroz 
et al, 2005, Rouaud et al 2010). Nevertheless, GPi-DBS has been less extensively 
studied than STN-DBS. There are no control groups with long follow-up to compare the 
effect of disease progression to stimulation.  In our study speech deterioration was not 
correlated to any other motor subscale of the UPDRS-III nor to the amount of 
medication before and after surgery. It was gradual, more often beginning at 6 months 
and becoming progressively worse.  
9.2 Factors associated with speech deterioration 
The risk factors associated with speech deterioration have been assessed. The pre-
operative clinical factors predictive of speech deterioration at one year of STN-DBS 
were a poor pre-operative score of speech intelligibility on-medication and a longer 
disease duration. The fact that the severity of the residual parkinsonian speech score 
when on-medication was predictive of a poor postoperative outcome is probably 
explained by the presence of non-dopaminergic lesions within the basal ganglia (Agid, 
1991). Better speech pre-operatively could also mean greater ability to compensate for 
the disruption of speech through stimulation. Longer disease duration could also be 
linked with more extensive non-dopaminergic degeneration (Agid 1991).  
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However the variability of speech response, some patients with good speech 
intelligibility pre-operative were greatly affected by stimulation, was indicative of other 
factors for the speech outcome. Contact position and amplitude of stimulation are 
important factors. In our study speech deterioration was more frequently linked to 
medially placed left active contact. Our acute study also showed that increased voltage 
(4V) significantly reduced speech intelligibility both with contacts inside and outside 
the STN. The role of amplitude or frequency of stimulation has been shown in other 
studies (Tornqvist et al 2006). This could suggest a spread to other pathways. So far in 
the literature (Krack et al 2003, Tommasi et al 2008) speech deterioration was assigned 
to current spread to the internal capsule. In order to visualize the electric field generated 
during the various electrical settings a patient-specific computer model was generated. 
This showed that the increase in voltage of medially placed electrodes could affect the 
cerebellothalamic tract, and this could account for the speech deficit. 
9.3 Possible mechanisms underlying speech change after STN-DBS 
The basal ganglia and cerebellum have been assumed to be anatomically separate and to 
perform distinct functional operations. Recent studies have provided evidence for 
anatomical link between basal ganglia and cerebellum in monkeys, and specifically 
between the STN and dentate nucleus of the cerebellum (Bostan et al 2010). The role of 
cerebellum in speech production has not been extensively discussed in the literature of 
speech motor control (Price 2010) even though it is clearly activated during articulation 
(Brown et al 2009) and auditory self-monitoring during speech production (Zheng et al 
2009). Lesions in cerebellum can cause dysarthria mainly characterised by reduced 
articulatory precision (both imprecise consonants and prolonged vowels), slurred 
pronunciation, exaggerated stops, slowed rate of speech and rough voice quality 
(Ackermann et al 1992, Urban et al, 2003). In our study, patients with left active contact 
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medially to the STN presented with similar perceptual characteristics, namely imprecise 
articulation, slurred pronunciation and prosodic insufficiency (slowed rate of speech and 
inappropriate pauses). The additional speech characteristic was a marked dystonic 
quality in the voice, sounding tight, strained and strangled, becoming worse with 
prolonged use, not present with cough or laugther, and in most cases being associated 
with oromandibular or neck and upper limb dystonic posture, made worse with 
speaking. This tight voice quality was reflected in the increased mean and peak air 
pressure for speech as assessed with aerodynamics. These dystonic features could still 
be a sign of cerebellar – thalamic involvement. Thalamic lesions can cause limb 
dystonia and the responsible lesions occur more frequently in the nuclei linked to the 
cerebellum, rather than the basal ganglia (Jinnah & Hess, 2006; Lehericy et al, 2001). 
The cerebellum has also been involved in verbal fluency tasks (Eickhoff et al 2009). 
Decline in verbal fluency is the most prominent neuropsychologic impairment 
following STN-DBS (Fasano 2010), with still unknown pathogenic mechanism. 
Increased activity in the cerebellum and the right anterior insula has also been 
implicated in the speech motor control of developmental stuttering, along with 
overactivity bilaterally in the basal ganglia (Watkins et al 2008). Re-emergence of 
childhood stuttering following STN-DBS has been reported in the literature (Burghaus 
et al, 2006) and was apparent in one of our patients.      
A further hypothesis on the pathophysiology of speech impairment following STN-DBS 
could be the disruption of the cortical pathways utilized for speech. An early imaging 
study of PD patients showed that STN-DBS performed during a motor task involving 
decision making and motivational aspects induced metabolic activation of the SMA, the 
dorsolateral prefrontal cortex and the anterior cingulated cortex (Limousin et al 1997). 
This metabolic activation of cortical areas involved in motor, cognitive and 
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motivational functions implies that STN-DBS can affect all three functional territories 
of the basal ganglia (Krack et al 2010). Areas that are more specific to speech 
production in normal adults are the left middle frontal gyrus, left anterior insula, left 
putamen, bilateral head of caudate, anterior cingulated, pre-SMA, SMA, motor cortex 
and cerebellum (Price 2010). These areas are shared among the three functional 
territories of basal ganglia activity: the SMA and pre-SMA from the sensorimotor 
territory, the prefrontal dorsolateral cortex from the associative territory and the anterior 
cingulated from the limbic territory. A prolonged disruption of these pathways through 
electrical stimulation could contribute to the delayed onset of speech problems and their 
gradual deterioration.      
9.4. Management of speech problems following STN-DBS 
Managing the speech problems post bilateral STN-DBS can be challenging due to the 
unpredictability of the symptoms, the gradual progression over time, and the sensitivity 
to voltage and contact parameters. The speech profile following surgery can be different 
from that of the typical hypokinetic parkinsonian dysarthria. The LSVT is an effective 
speech treatment for people with PD. However when administered to PD patients post 
STN-DBS the results were not as positive as with non-surgical PD patients. Comparison 
with a control medical group showed that patients either did not maintain the effect of 
this intensive treatment or they deteriorated. Thus other ways for preventing and 
managing speech must be found. Team work, for detailed assessment of the contact and 
voltage effects on speech, has been more successful clinically, along with appropriate 
selection of patients and pre-operative advice. The use of biofeedback, as in the 
immediate self-monitoring of tongue movements during electropalatography, could be 
another way of treatment that requires further investigation. 
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9.5 Effects of GPi-DBS on dystonia patients 
Speech intelligibility did not significantly change in the 25 dystonia patients, of diverse 
aetiology, who were assessed before and after GPi-DBS. However detailed examination 
of data showed a subgroup of patients whose speech changed from hyperkinetic to 
hypokinetic, with reduced volume, fast rate and indistinct articulation. The most 
probable explanation is the modification of the basal ganglia output through inactivation 
of the pallidothalamic outflow from the ventral GPi. However further studies are 
needed, in particular more electrophysiologic and limb motor data to make a firm 
hypothesis. 
9.6 Methodological issues and limitations of the study 
There are inherent difficulties when trying to evaluate the effects of stereotactic 
stimulation procedures on speech. These procedures target the triad of parkinsonian 
symptoms, tremor, rigidity and bradykinesia. Patient selection for surgery is 
mostlybased on potential limb motor improvement and not speech.  
 
Most of the studies so far on the speech effects of GPi and STN-DBS were on small 
samples of selected patients. Comparison was between off-stimulation and on-
stimulation at varied post-operative timings and without pre-operative data. There was 
also a lack of a large control sample to compare speech changes induced by 
neurosurgical interventions to those induced by the disease process and 
pharmacological intervention over time. A larger control sample of medical therapy 
alone, with longer follow-up, would have given greater power in our study. 
 
The choice of a speech protocol that adequately reflects the complexity of speech, 
through the respiratory, phonatory and articulatory systems and can represent the 
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changes in functional communication is an ongoing debate (Weismer, 2006; Ziegler, 
2003). The need to accurately assess speech problems led to the development of speech 
and language specific protocols. Buck and Cooper (1956) developed perhaps the most 
comprehensive speech scale for the speech examination of pre and postoperative 
parkinsonian patients. Despite the fact that the main speech tasks remain the same, 
namely counting, diadochokinesis, reading of set sentences and conversation, there 
seems to be a wide variability of measures. There are no studies so far evaluating the 
changes in conversational speech despite the fact that patients tend to report increased 
speech difficulties following neurosurgery. This is partly due to technical issues, mainly 
controlling the rate of speech, the order and choice of words used. Still, this is a 
limitation of this study. Analysing the narrative speech not only acoustically but in 
terms of speech intelligibility would give us a more naturalistic perspective of speech 
changes.  
 
9.7 Hypotheses and future studies 
The main hypotheses concern the mechanism of action of deep brain stimulation on 
speech and the understanding of the variability in speech response. Speech could be 
affected by the disruption of the cerebellothalamic pathway or the re-organisation of 
mainly cortical pathways involved in speech production. In order to investigate these 
hypotheses further first we need to continue the collection of consecutive prospective 
speech data along with information from the anatomic location of the active contacts 
and electrical parameters. Increasing the sample would also allow for a more detailed 
analysis of the somatotopy of the STN in respect of speech.  
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The most valid way of testing our hypothesis would be an imaging study, preferably 
before and one year after STN-DBS. This would allow us to observe the individual 
changes in activated pathways and it might help to understand the variability.  
Verbal fluency is another area that hasn’t been addressed in this study since the primary 
aim was the investigation of motor speech changes. The fact that it is one of the 
consistent areas of deterioration along with speech makes it an interesting topic for 
further study. 
Unilateral stimulation of STN and the effects on speech need further investigation as 
well. There are technical issues in measuring speech activity due to the variability of 
electrode positioning in the left and right brain and the compensation inherent in the 
speech mechanism from the axial speech muscles. EMG could be used in tandem with 
perceptual and acoustical ratings in order to examine the effect of unilateral stimulation 
on speech motor control. 
In the dystonia patients speech intelligibility did not significantly change following 
GPi-DBS. At an individual patient level, the appearance of hypokinetic features 
following at least one year of stimulation warrants further investigation. 
The ultimate aim is to understand the nature of speech changes in order to either avoid 
them or bypass them using a successful therapy strategy. Further investigation of 
biofeedback methods, like the electropalatography, with articulation as main aim should 
be the next step, in order to develop a new treatment for speech problems after 
stimulation. 
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Appendices 
 
Appendix 1: Unified Parkinson’s Disease Rating Scale 
 
III. MOTOR EXAMINATION 
18. Speech 
0 = Normal. 
1 = Slight loss of expression, diction and/or volume. 
2 = Monotone, slurred but understandable; moderately impaired. 
3 = Marked impairment, difficult to understand. 
4 = Unintelligible. 
19. Facial Expression 
0 = Normal. 
1 = Minimal hypomimia, could be normal "Poker Face". 
2 = Slight but definitely abnormal diminution of facial expression. 
3 = Moderate hypomimia; lips parted some of the time. 
4 = Masked or fixed facies with severe or complete loss of facial expression; 
lips parted 1/4 inch or more. 
20. Tremor at rest (head, upper and lower extremities) 
0 = Absent. 
1 = Slight and infrequently present. 
2 = Mild in amplitude and persistent. Or moderate in amplitude, but only intermittently present. 
3 = Moderate in amplitude and present most of the time. 
4 = Marked in amplitude and present most of the time. 
21. Action or Postural Tremor of hands 
0 = Absent. 
1 = Slight; present with action. 
2 = Moderate in amplitude, present with action. 
3 = Moderate in amplitude with posture holding as well as action. 
4 = Marked in amplitude; interferes with feeding. 
22. Rigidity (Judged on passive movement of major joints with patient relaxed in sitting position. 
Cogwheeling to be ignored.) 
0 = Absent. 
1 = Slight or detectable only when activated by mirror or other movements. 
2 = Mild to moderate. 
3 = Marked, but full range of motion easily achieved. 
4 = Severe, range of motion achieved with difficulty. 
23. Finger Taps (Patient taps thumb with index finger in rapid succession.) 
0 = Normal. 
1 = Mild slowing and/or reduction in amplitude. 
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 
4 = Can barely perform the task. 
24. Hand Movements (Patient opens and closes hands in rapid succesion.) 
0 = Normal. 
1 = Mild slowing and/or reduction in amplitude. 
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 
4 = Can barely perform the task. 
25. Rapid Alternating Movements of Hands (Pronation-supination movements of hands, vertically 
and 
horizontally, with as large an amplitude as possible, both hands simultaneously.) 
0 = Normal. 
1 = Mild slowing and/or reduction in amplitude. 
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 
4 = Can barely perform the task. 
26. Leg Agility (Patient taps heel on the ground in rapid succession picking up entire leg. Amplitude 
should be at least 3 inches.) 
0 = Normal. 
1 = Mild slowing and/or reduction in amplitude. 
2 = Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement. 
3 = Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement. 
4 = Can barely perform the task. 
27. Arising from Chair 
(Patient attempts to rise from a straightbacked chair, with arms folded across chest.) 
0 = Normal. 
1 = Slow; or may need more than one attempt. 
2 = Pushes self up from arms of seat. 
3 = Tends to fall back and may have to try more than one time, but can get up without help. 
4 = Unable to arise without help. 
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28. Posture 
0 = Normal erect. 
1 = Not quite erect, slightly stooped posture; could be normal for older person. 
2 = Moderately stooped posture, definitely abnormal; can be slightly leaning to one side. 
3 = Severely stooped posture with kyphosis; can be moderately leaning to one side. 
4 = Marked flexion with extreme abnormality of posture. 
29. Gait 
0 = Normal. 
1 = Walks slowly, may shuffle with short steps, but no festination (hastening steps) or propulsion. 
2 = Walks with difficulty, but requires little or no assistance; may have some festination, short steps, 
or propulsion. 
3 = Severe disturbance of gait, requiring assistance. 
4 = Cannot walk at all, even with assistance. 
30. Postural Stability (Response to sudden, strong posterior displacement produced by pull on 
shoulders 
while patient erect with eyes open and feet slightly apart. Patient is prepared.) 
0 = Normal. 
1 = Retropulsion, but recovers unaided. 
2 = Absence of postural response; would fall if not caught by examiner. 
3 = Very unstable, tends to lose balance spontaneously. 
4 = Unable to stand without assistance. 
31. Body Bradykinesia and Hypokinesia (Combining slowness, hesitancy, decreased armswing, small 
amplitude, and poverty of movement in general.) 
0 = None. 
1 = Minimal slowness, giving movement a deliberate character; could be normal for some persons. 
Possibly reduced amplitude. 
2 = Mild degree of slowness and poverty of movement which is definitely abnormal. 
Alternatively, some reduced amplitude. 
3 = Moderate slowness, poverty or small amplitude of movement. 
4 = Marked slowness, poverty or small amplitude of movement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 294 
Appendix 2: Burke-Fahn and Marsden Dystonia Scale 
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Appendix 3: “The 35 perceptual dimensions from Darley et al (1972) scale” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 297 
Appendix 4: Example from the “Assessment of Intelligibility of the dysarthric 
speaker” 
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Appendix 5: The Voice Handicap Index (Jacobson et al, 1997) 
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